ML20154D346
| ML20154D346 | |
| Person / Time | |
|---|---|
| Site: | Wolf Creek  |
| Issue date: | 12/31/1985 |
| From: | KANSAS GAS & ELECTRIC CO. |
| To: | Martin R NRC OFFICE OF ADMINISTRATION (ADM), NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION IV) |
| References | |
| KMLNRC-86-036, KMLNRC-86-36, NUDOCS 8603050585 | |
| Download: ML20154D346 (109) | |
Text
i Wolf Creek Generating Station Docket No: STN 50-482 Facility Operating License No: NPF-42 SEMIANNUAL RADIOLOGICAL EFFLUENT RELEASE REPORT Report No: 2 l
Reporting Period: July 1, 1985 through December 31, 1985 i
Submitted by:
Kansas Gas and Electric Company 1
0603050505 051231 / \\ I PDR ADOCK 05000402 \\
R PDR
l INTRODUCTION This Semlannual Radiological Effluent Release Report covers the period of July 1, 1985, through December 31, 1985, and satisfies the requirements j speelfied in Technical Specification 6.9.1.7.
l
.Section I provides a summary of the quantitles of radioactive liquid and
! gaseous ef fluents for this reporting period. The format is similar to that provided in Regulatory Guide 1.21, Revision 4. An elevated release pathway does not exist at Wolf Creek Generating Station. Therefore, all airborne ,
releases are considered to be ground level releases. Dose data for the year L
[ 1985 are included in this report. Dose calculations to a member of the
! public for 11guld effluents are based on the actual isotopic analysis of the I radioactive 11guld effluents, the radioactive 11guld effluent flow and the l
dilution flow. This dose comes from drinking the diluted liquid effluent and consuming the fish removed f rom diluted liquid ef fluent. Dose calculations to a member of the public due to gaseous effluents are based on an analysis of the radioactive gaseous effluent, effluent flow and highest annual average (X/Q). Gaseous doses are based on submersion dose calculations for the whole body and skin, while doses to the seven body organs are based on ingestion doses for the following pathwayst inhalation, ground plane, grass-cow-mlik, grass-cow-meat and vegetation. The dose calculations for both 11guld and gaseous effluents were calculated in accordance with the methodology and parameters in the Offsite Dose Calculation Manual. There were no solid radioactive waste shipments during 1985.
Section II provides Supplemental Information as descelhed in Regulatory Guide 1.21, Revision 4 Section III provides a summary of meteorological data for the period of July 1, 1985, through December 31, 1985. A summary of meteorological data for the period of May 1,1985, through June 30, 1985, was provided in S1miannual Radioactive Effluent Release Report Number 1. This information is available on site for review and inspection.
Section IV provides additional information required by Technical Specification 6.9.1.7.
i I
- \
j SECTION I Year __1985
' REPORT'0F'RdDIOACTIVE' EFFLUENTS: ^dIRBORNE
- -- -- . . . .. . Quarter Quarter
. Unit, ,. 3 4
'' ~ ' ' ~~ ~ ~
A. Fission and'Act105 tion Gases ~
~~~' ~~
- 2. ~50ernee' release rate'f$r'p$ ribs~~~~
uC1/nec '5.41E-Ol' 2.43E+01
- 3. 'PercenE'Sf'TechnicAi'Specifiedti5n~Cidiis " ~~ ' ~~
'i ' ~2.46E-04 ~ 3. 4 3 E-01 _
~~~ ~~~~~~~ '
'i. ' Tot 5i~ iodine-i31
'Ci' 'O.00E00' O.00E00
'50erage reienae rate'fEr~ pert $d'
' ' ' ~ ~ ~ '
'I. 'OCi?nec 00E0 'd'00E00~
~ 3. Percent'of'Technicai' Specification Limits
~ ~ ~~
' % ' O'.00E00 ' ' '0.00E00
~ ' '
C.
Particulates
- i. ' 'ParticUlaten with half-110es '5 '8 ' days
~
C1' 't.61E-06' 6.4tE-08
~ 2'. 'i0ernfe' release rite'fEr~perinN' ' ' ~~~ ~
^^$ci/ nee- 2.05E-h7' '5.62E-08'
'). 'PerceAt'hf Technicai'SpecIficatIEn 1.imits ^
'l'61E-10
. '6.41E-12 4 ' Gross Alpha radioactisitv' ' ' '
'CI ~ 0.00E00' ' i . 2 9 E-08 D. Trittun ~ ~ - '
- l. ' Total Reinage
C1'
'2.43E+01" 'l_.68E+0i'
'2. '50erneh' release r$ t e ' f b r ' pe ri Elf '
' ' ' ~ '
$C1/nec '1.33E00 '2.17E00
_3
_.__ Percent of Technic 51 Specification Lintes 't l . 6 2 E-0_3 _ _ _1_.12 E-0 3 l
l l
Page 2 of 26
Year 1935 GASEOUS EFFLUENTS
' Con'inuous' t Mode Batch Mode NUCLIDES. ,
.Q uarter, ,Q uart,er_, , , quarter, Quarter RELEASED . Unit,,,_, 3 4 3 4
^ " ~ ~~ ^' ' ~~~ ~
'i. Fission ~and'55_tiU5 tion dases ir-41'
' ~~
'di .d0E00 'd 00EdO' 'd'38E-03'
. 3.00E-01
'Ks-85 ^ ''Ci ' ~~~ ~
~
' 'd .'60E00 " ^^ .60E00 ~ O.00E00 'O.00E00 Kr-85m di 'O'.ddE00~ O'.0dE0d ' O.00Edo' ~ 7.63E-05
'Kr-87 Ci ' <i.31E+0i ' d i .~ 3 7 E+0 f ' ' d2. 3 3E-02 ' <l.24E-02 Kr-88 'di" ' ^ 2i'.d 5E+d ! ' ~ <i.d5E+di ' d 2 '. 9 3 E-62 ' '< 1 .' 5 5E-02 '
'Xe-flin
^ ~~
l
di' ~ ~ ' O .' 60 E06 ~ ~ 'O.60E00' '0.0dEd0 '4.89E-0$'
~
'X$-i35 "'C1 'dl'.2 E+di' " ' i ". 3 6EiO 2 ' ' N '. 8 3 E-0 2 ' 'i.nss00'
~
Xe-131h ^di <3.3fE+01" ' <3.31E+01 < 8. 46 E-0 2 3.74E-03 X4-13s' 'di ' ' l '. 7 2 s-0 2 ' ' 3 '. 44E+01 ' '4'16E-04'
. 'I'. lie-02 i
'XE-i356 'Ci 6.ddE00' ~~6.ddE60 ' 'd .'dO Ed6 ' O.60E00
'Xo-i38 ~~Ci' di'2RE+02' ~ < l '. 2 s Ei8 2 ' ' 26 '. 20E-0 2 ' ' 23. 3 i E-02 Totni ' 'Ci _ 't.72E-02" 'i.70Ei62 ~ ~~ 9.3fs-02' l.42E00
- 2. 'Halocens (Caseous)
~
' t-III' ~ ~ 'di' '23.025-05' ' <3.02E-65' ~d'0dE00'
. ' '60E00 1-133 'Ci ~ 'd 7. 70E-0 4 ' 'd7.70E-04 0._60E00 ~0.00E00
'I-i35 di ' d. DOE 00' O.00E00' 'd'00EdO'
. 'O.00E00'
'Br-82' Cl 6.00E00 0.00E00 6.0DE00 0.00E00 Total ^di" 'O. DOE 00' O d0k00 ' O'.0dE00' ' 'O.00E00 Page 3 of 26
Year 1985 GASEOUS EFFLUENTS
' ~
Continuous Mode ^ Batch Mode
.NUCLLDES . ,.,,__ _, _Q uarter ,Q uarter ,Q yarter ,Q uarter RELEASED Unit 3 4 3 4
';3 ' 'Ci ~2.43E+01' 't.68E+dt' ' 5.' 3 5 E-0 2 3.14E-02
'di' ' ' '
^ ~
'Sr-90 'i'61E-06
. <5.24$-08' 'O.UGE0d' '0.00E00 dross ~ Alpha _ 'di' 'k2'6iE-d7'
. ' 3 '. 2 9 E-0 8 ' d'0 E0d'
. O.00E00 Sr-89' 'di' ~~ 'dl.04E-07' ' <l.'64E-07' '0.60E06' 'O.00E00 "Sn-54' 'di' ~ <l.23E-05' 'kI'23E-05'
. ' O '. 00 E00 ' 'O 00E O
'Fe-59'
di" 'd3.01E-5 ~ ' d_3. d i E-0 5 ' 'O.00E00' 'O.60E00
'di"
~
Co-58 'di.23E-05' 'il.23E-d5' '0.0hEdO' 'd"d E00'
'Co-60' 'C1 ' ~dl.94E-05 ' <i .94E-0 5 ' '0.00E00 __ '0.00E00
~$n-65 'Ci
~
'2i.23E-05 _Lif.23E-d5' d.0hEd ~ ~ 0.d6E00'
'Mo-99 'C1 ' 'd3.dlE-04' <3.dlE-04' 'O.00E00 '0.00E00
.[St-134'
'dt' 'ki'37E-05'
. ' ii '. 37 E-d 5 'd'.ddE00~ 'd'. DOE O Cn-137' 'Ci ' ^< i.14E-05 __l.14E-05
< 0._00E00' '0.00E00
._'Co-i41' 'Ul' <l.25E-05' ' <I.25E-05 'd'.0hk00 ' O. DOE O__ _
'de-i44 'Ci ' ' <2.87E-05 _ <2.87E-05' d.00E00' _
0.00E00]_ j . . .. . . . There was no detectable Sr-90 or Sr-89 during the sncond quarter of 1985. The detection limit is <2.06E-16 uC1/cc for Sr-90 and <4.12E-16 uC1/cc for Sr-89. This data was not availabic for inclusion in Semlannual Radioactive Effluent Release Report Number 1 for the first half of 1985. l l l l Page 4 of 26 i l l
CUMULATIVE DOSE DATA. GASEOUS RADIOACTIVE RELEASES QUARTER 1 0F 1985 Dose from Radiotodines, Particulates, and Tritium at controlling location: Total Dose (MREM) for Bone 0.00E-01 Total Dosa (MREM) for Liver 0.00E-01 Total Dose (MREM) for Total Body 0.00E-01 Total Dose (MREM) for Thyroid 0.00E-01 Total Dose (MREM) for Kidney 0.00E-01 Total Dose (MREM) for Lung 0.00E-01 Total Dose (MREM) for GI-LLI 0.00E-01 Noble Gas Dose at Site Boundary: Total Body Dose Total (MREM) 0.00E-01 Skin Dose Total (MREM) 0.00E-01 Nobio Gas Airdose at Site Boundary: Total Gamma Airdose (MRAD) 0.00E-01 Total Beta Airdose (MRAD) 0.00E-01 I QUARTER 2 0F 1985 l Dose from Radiolodines, Particulates, and Tritium at controlling location Total Dose (MREM) for Bone 0.00E-01 Total Dose (MREM) for Liver 1.33E-04 i Total Dose (MREM) for Total Body 1.33E-04 Total Dose (MREM) for Thyroid 1.33E-04 Total Dose (MREM) for Kidney 1.33E-04 Total Dose (MREM) for Lung 1.33E-04 i , Total Dose (MREM) for GI-LLI 1.33E-04 i Noble Gas Dose at Site Boundary: Total Body Dose Total (MREM) 0.00E-01 Skin Dose Total (MREM) 0.00E-01 Noble Gas Airdose at Site Boundary: Total Gamma Airdose (MRAD) 0.00E-01 ] i Total Beta Airdose (MRAD) 0.00E-01 l i QUARTER 3 0F 1985 Dose from Radiolodines, Particulates, and Tritium at controlling locationt J Total Dose (MREM) for Bone 1.91E-04 Total Dose (MREM) for Liver 1.19E-02 Total Dose (MREM) for Total Body 1.20E-02 Total Dose (MREM) for Thyroid 1.20E-02 Total Done (MREM) for Kidney 1. 20E-02 Total Dose (MREM) for Lung 1.19E-02 Total Done (MREM) for GI-LLI 1.19E-02 Noble Gas Dose at Site Boundary: Total Body Dose Total (MREM) 8.9 3 E-06 Skin Dose Total (MREM) 1.80E-0$ Noble Gas Airdose at Site Boundary: Total Gamma Airdoso (MRAD) 9.70E-06 Total Beta Airdone (MRAD) 1. 35E-05 Page 5 of 26 a
QUARTER 4 0F 1985 Dose from Radiolodines, Particulates, and Tritium at controlling location: Total Dose (MREM) for Bone 7.12E-11 Total Dose (MREM) for Liver 8.09E-03 Total Dose (MREM) for Total Body 8.09E-03 Total Dose (MREM) for Thyroid 8.09E-03 Total Dose (MREM) for Kidney 8.09E-03 Total Dose (MREM) for Lung 8.09E-03 Total Dose (MREM) for GI-LLI 8.09E-03 Noble Gas Dose at Site Boundary: Total Body Dose Total (MREM) 7.35E-03 Skin Dose Total (MREM) 1.65E-02 Noble Gas Airdose at Site Boundary: Total Gamma Airdose (MRAD) 8.19E-03 Total Beta Airdoso (MRAD) 1.60E-02 TOTALS FOR 1985 Dose from Radiolodines, Particulates, and Tritium at controlling location: Total Dose (MREM) for Bone 1.91E-04 Total Dose (MREM) for Liver 2.02E-02 Total Dose (MREM) for Total Body 2.02E-02 Total Dose (MREM) for Thyroid 2.02E-02 Total Dose (MREM) for Kidney 2.02E-02 Total Dose (MREM) for Lung 2.02E-02 Total Dose (MREM) for GI-LLI 2.02E-02 Noble Gas Dose at Site Boundary: Total Body Dose Total (MREM) 7.36E-03 Skin Dose Total (MREM) 1.66E-02 Noble Gas Airdose at Site Boundary: Total Gamma Airdose (MRAD) 8. 20E-03 Total Beta Airdose (MRAD) 1.60E-02 1 Page 6 of 26
Year 1985 REPORT OF RADI0 ACTIVE EFFLUENTS: LI0tIID Quarter Quarter Onit 3 4_ _
~ Finni5n'abd'Activhtlon' Prod 0 cts ' ^
} 1. Total Release (not' including' tritium,'dasE5,alphdi[ 'Ci 4.44E-Ol_ __ _I_ . 9 t E-0_1_ _ ) 2. kve ra g e "i l 10 t ell co nc e n t ra_ t idn ' i!E r i sg pe r i_o_s ECi'/ mi' _l . 4 7 E-0 6_ l.80E-08
- 3. Percent'Af Appliedble' Lim _li' t' 8.86E00 3.82E00 _ _ _ _
' ^~ ~ '
B. Trittum
~ ~ ~
- 1. ~ Total' Release _
'Ci ' 5.08E+01 1.32E+02 kverace dlisted co_ncentration ilaring pertoil
~
~
- 2. Ehi/mi' 5 .' i 4E414 ' l'15E-05'
'i. Percent'$f'5bplicabie' Limit' '
t' I 3_.87E-03 __ l.nlE-02
'C. ~ Disso_1ved'and'Entralbed Cases
~
- l. ' To t a l Re lo n_s_e _
Ci _3_._3_1_E -0 2 1.23E-01 __
' 2. ' ' 5 v$ ra ge il l l a t oli co_ncon t_r i t i on _ lib r i n g ho r i o_<!_' AC1/mi' 3.11E-09 1.12E-08
'_i. ' ' Pe rcent ' $[^ Abni t cabl e Iftmit __
't' _ 3. 31_E_-0 6 1.23E-05
'D.. ' G ro s s _A l_ph a R ad i_n a c_t_l v l_ t v i
1.T5 tai Releano C1 _0.00E00_ 0.00E00 E. Volumn of wante releaned_ 3.58E+06 1_i t o r s 1 14E+07 F. Volbme_ of dilutlo_n water used ___ litors 4.20E+10 2.28E+10 I I Pago 7 of 26
Year 1985 LIQUID EFFLUENTS
~ ' '
i Batch' Mode
' Con t i_nuous ifode NUCLIDES . , ,
, Quarter. , quarter, _Q uarter Quarter RELEASED Unit 3 4 3 4_
l
'H-3
'Ci[ ' ' [.00_E06 _'__' . 6E00 ~5. 08 E +0_1 1.32E+02 _
l 'Oa-24 'Ci ' *1.d9E-Ol' ^ ^ h .d_0E00 ' ' ' 4 ^. 2 6 E-01 2.40E-04 l
'di'
'Cr-51' ' h'.00Edd ' 'd.h0E00 '9.30E-03 4.27E-02
' ~
'Mn-54 ~ 'Ci ~6.00E00 ' ' ' '0.06E00 ' 7.28E-04 3.60E-03
'Fe-59 'C1 1 'O.6dE00' _' 0_'. 0 0 E 0 0 ' ' ^ 6.24E-04 4.04E IO3 Co- 58 ' 'Ci ~ '0.60E00 ~ '0.00E00' ~ 1.'36E-02 7.24E-02 _
~
Co-60' 'Ci 'O.00E00 'O.0dE00~ '3.49E-04 ~ 4. ~ 3 6E- 0_3_
'Br-83^ 'C L ' '6.66E66 __ '6." 6E66 12.52E-06' O'60E00 Rb-88 C1' ' O '.d OE 00 ' ' 0_'. 00 E00 ' 'l.63E-05' 4.89E-05 Sr-91 'C1 0.00E00 0.00E00 1.37E-05 0.00E00
~
' Z r _9_5_ _ _C 1 ' _ 0.60E00' 'O.00E0d' l '. 5 0 E-0_3 9.01E_-03
'Zr-97 ~ C1 '6.66E60 'O.00E60' ' 8.I5E-05 7_. 5 7 E-0 5
'$b-45 _C1' 'O.00E00~ 0.00E00' '9'58E-04
. 1.04E-02
'So-49' 'Ci ~0.66E60 _0_.00E00 ' [4.55E-04' 9.70E-04 _
'Cl
~
' Tc -9 951 ' O .00f 00_ O_. 00 E 00 ' ~ 1'64E-04
' 4 '. 9_ l E-0 4 _ .
~
'ki-110s' C1 'O.00E00_ ___0.00E00 '7.88E-06_ _ 4.61E-05 _
't-131' 'Ci_ __ 0.00E00 ' _ 0.00EOO
~
__ 1.14E-0_1 _2.05E-03 1-112 Ci [0.00E00' O.'00E00' ' 7_. 3_4 E-0 6 _ 0_.00E00 _ i_- 1 11_ ' _ Cl __'_0_.6dE0_0 _ ' _0 '. 00 E00 '_ 1.07E-03 1. 9 7 E_-0 3_ Notes *Na-24 released during moisture carry over testing Page 8 of 26 l
Year 1985 LIQUID EFFLUENTS
' ' ~
'dontinuous' Mode Batch !! ode NUCLIVES, , Quarter, . guar t,o r .Quarter Quarter RELEASED . Unit . ,, 3 4 3 4 _.
'I-I34'
'di ' d '. h0Ed0 ' 'A'0dE00"
. i^.88E-06 0.00E00
'i-135' di ' ' ' " " .ddE66 6.66E06' 5.73E-04' l.68E-04
'Ci-136' 'di' 'd".d E0 ' d'. hk00' d'. OE00 '3.45E-06
' dial 37' iCi ' '6.'60E00 ' 'O.00E00' '4.62E-06 ' _1.18 E-0 4 _
i B5-140' 'Ui' ' h '. dd E0d' 'O.ddE00~ ' 2 '. l ds.-04 ' 2. 9 7 E-04 ~ i
'La-140' 'Ci __
'6.'00E00 O.'66E00 ~ ' 2. i SE-0 3
'4.}l4EO3 i
._ 'Co-144' C1' ' 0 '. dO E60 ' '0.hhE00 ' 't.2SE-03' ~ 2.36E-03
's-187 ~ 'Ci '0.60E00 ~ '6.00E00 ~ 2.18E-0 3 2.84E-03 _
' Ci'
~ ~$h-239' ' 'd.00Ehd d'.ddE0d'~ ~ 5.35E1 0 ' 't.0$E-03 Kr-85't' Cl 'O . 00 E00_ '_ ^0;00E00' 5. 3 4_E-06 0.00E00 f
Kr-85 C1' O.00E00' _'O.00Eh ' l '. 3 5 E-0 2 ' '7.52E-02 Xc-13tM Cl 0._00E00 _ _ 'O.60E00' ').55E-04 ^ '5.08E-04 Xe-133M' 'C1' 'O'00E00'. '0". OE00' !.50E-04~ '2.69E-64 Xe-133' 'Cl
~
0.00E00' '0.00E00 't._14Eio2 _2.61E-02
'Xe-135M' C1' O.00E00' '0.00E00 1. 20E-0 5 ' 2.39E-04'
^ Xc-135' 'C1' O. DOE 00' O.60E00 8.42E-03_ _ '2.llE-02
'dr-41' _ __
Cl ' .00E00' d'00E00'
. '9.19E-05 'i.96E-05 Fe-55 Cl 0.00E00' 6.~00p00 1.50E-04=-.
<l.79E-05 Be-7' 'C1' O.60E00' 6 ~.h0E66' l'11E-62' . '2.74E-02 Pago 9 of 26 l
Year 1985 LIQUID EFFLUENTS
~ ~ ~
' Continuous Mode ' Batch Mode NUCLIUES. .- ... . Qua. r t.e r. . .Q-- uarter... .Qu. a. r t. e. r- Quarter Sn-ll3 'di' ~~h". Os O' ' O'.hdE00 ' '2.50E-06 2.88E-04 Snil l7M 'C1' .'6dEd6 ' ' DOE 66' '8.'57s-05 2.88E-04__
Br-82' di ' ' d '. 00E00 ' 'O.00E00' 2.3}E-06' 2. 67 E-05 Co-57 ' 'di" ' ' "6. dE0d '6.6dE00 ' 0.'00 E00 ' 't.73E-05 N5-97 "CI' 'O.0d$hh ' ' h'. h0 E00 ' ' ' 2 ' 54$-h 5'
. "'6.86E-06
'Sc-46 'C1' 'O.00E00 0.00E00 'O.00E00' 2.59E-05
'Nn-65' 'di ' ' h". 0hE 0h ' '0'.hhE00' ' Fl .2is-hi '22.02E-04 Ca-134 'C1' '6.00E00 'O.00E00 ' <7.99E-04 < i . 34E-04
'CA-14i ~ Ci' ' d".00 E0h ' ' ' O'.00E00' ' '(1. IGE-03 <2. OE-04' Sr-89' 'C1
^
0.00E00 ~ d.00N6d' 32.i4E-05 4.17E-07
'$r-90' 'Ci' 'O.00E00' ' 0'.hd50h' ~2).h7s-05' ' <i.79E-06 Gemaa Athha Cl 'O.00E00 'O.00E00 <8.09_E _04' < 1_. 3 5_E-0 4 l
There was no detectable Sr-90 or Sr-89 for the necond quarter of 1985. The detectica limit for Sr-90 is 5.0E-10 uCL/mi and for Sr-89 is 1.0E-09 uC1/mi. This data was not available for inclusion in Semlannual Radlonctive Effluent Release Report Number i for the first half of 6985. l l Page 10 of 26 l
- .- -. - . . = - -- .-
LIQUID RADIOACTIVE WASTE CUMULATIVE DOSE DATA QUARTER 1 0F 1985 Total Dose (MREM) for Bone 0.00E-01 Total Dose (MREM) for Liver 0.00E-01 Total Dose (MREM) for Total Body 0.00E-01 Total Dose (MREM) for Thyroid 0.00E-01
- Total Dose (MREM) for Kidney 0.00E-01 Total Dose (MREM) for Lung 0.00E-01 Total Dose (MREM) for GI-LLI 0.00E-01 i
QUARTER 2 0F 1985 i Total Dose (MREM) for Bone 7.87E-07 ,
- Total Dose (MREM) for Liver 1.61E-05 !
Total Dose (MREM) for Total Body 1.58E-05 , Total Dose (MREM) for Thyroid 1.57E-04 l Total Dose (MREM) for Kidney 1.64E-05 Total Dose (MREM) for Lung 1.54E-05 Total Dose (MREM) for GI-LLI 4.66E-05 QUARTER 3 0F 1985 Total Dose (MREM) for Bone 1.13E-01 Total Dose (MREM) for Liver 1.16E-01 Total Dose (MREM) for Total Body 1.16E-01 Total Dose (MREM) for Thyroid 1.17E-01 I Total Dose (MREM) for Kidney 1.16E-01 ) Total Dose (MREM) for Lung 1.16E-01 Total Dose (MREM) for GI-LLI 1.29E-01 i QUARTER 4 0F 1985 Total Dose (MREM) for Bone 5.88E-04 Total Dose (MREM) for Liver 1.19E-02 Total Dose (MREM) for Total Body 1.17E-02 ] Total Dose (MREM) for Thyroid 1. 64E-02 Total Dose (MREM) for Kidney 1.12E-02 Total Dose (MREM) for Lung 1.10E-02 Total Dase (MREM) for GI-LLI 1.69E-01 TOTALS FOR 1985 Total Dose (MREM) for Bone 1.14E-01 Total Dose (MREM) for Liver 1.28E-01 ; Total Dose (MREM) for Total Body 1.28E-01 l
! Total Dose (MREM) for Thyroid 1.34E-01 Total Dose (MREM) for Kidney 1.28E-01 Total Dose (MREM) for Lung 1.27E-01 Total Dose (MREM) for GI-LLI 2.99E-01 4 )
Page 11 of 26 4 s v .- --. , ,-,,.,-,,....m., , , , . . , . , , . , , , , , _ .r,--- -. . , , . -.n- ..e.. , , ., ,, , - - . . . _ _ . _ ,
SECTION II Supplemental Information-Facility: $ oil' Creek"GeneraEing'SEaElon License Number: NPF-42
- 1. Regulatory Limits A. For liquid waste effluents A.1 The concentration of radioactive material released-in liquid effluents to UNRESTRICTED AREAS shall be limited to the concentrations specified in 10 CFR Part 20, Appendix B, Table II, <
Column 2, for radionuclides other than dissolved or entrained noble gases. For dissolved or engrained noble gases, the concentration shall be limited to 2 x 10 microcurle/mi total activity.
-A.2 The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released, from each unit, to UNRESTRICTED AREAS shall be limited:
- a. During any calendar quarter to less than or equal to 1.5 mrems to the whole body and to less than or equal to 5 mrems to any organ, and
- b. During any calendar year to less than or equal to 3 mrems to the whole body and to less than or equal to 10 mrems to any organ.
B. For gaseous waste effluents B.1 The dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY shall be limited to the following:
- a. For noble gases: Less than or equal to 500 mrems/yr to the whole body and less than or equal to 3000 mrems/yr to the skin, and
- b. For Iodine-131 and 133, for tritium, and for all radionuclides in particulate form with half-lives greater than 8 days: Less than or equal to 1500 mrems/yr to any organ.
B.2 The air dose due to noble gases released in gaseous effluents, from each unit, to areas at and beyond the SITE BOUNDARY shall be limited to the following:
- a. During any calendar quarter: Less than or equal to.5 mrads for ganma radiation and less than or equal to 10 meads for beta radiation, and
- b. During any calendar year: Less than or equal to 10 mrads for gamma radiation and less than or equal to 20 mrads for beta radiation.
?
Page 12 of 26 L
- 2. Maximum Pe rmissible Concentrations WATER - covered in section 1.A.
AIR - covered in section 1.B.
- 3. Average energy of fission and activation gaseous effluents 19 r.o t applicable. This information is not utilized for dose a: release calculations.
4 Measurements and Approximations of Total Radioactivity A. Liquid Effluents LIQUID RELEASE SAMPLING METHODS OF TYPE OF ACTIVITY TYPE,,,,,,, ,,FREQUEpCY,,,, ,,,, ANALYSIS,,,, ,,,,,,, ANALYSIS,,,, ,, Principal Gamma
- 1. Batch Waste P , , , P .1,1. A . , ,,,, ,, Emitters ,,, __,,,,,,
Release Each Batch Tanks .
. . P . Ii . A . , _ , , ,1 7 13,1,,,,,,,,,,_,,, ,
- a. Waste Monitor P Dissolved and.
Tank One Batch /M P.II. A. Entrained Gases l (Gamma _Emippers),,,,,,
- b. Secondary ' ' ' ~~~~~~ ~
Liquid P .S. ' H -3 ' ' Waste E. a ch B. a t c. h. . Tank
- '~~'
P O.S.C.' ' S r-89,' ' S r-9 0 ~
....... . .. . . Ea. c. h Ba t ch. . ... . . ...... .. . ............. .
p = prior to each batch ! m = monthly P.H. A. = gamma spectrum pulse height analysis using a liigh Purity l j Germanium detector. L.S. = 11guld scintillation G.F.P. = Gas Flow Proportional counting 0.S.L. = performed by an offsite Laboratory There were no continuous 11guld radioactive waste effluents for this l reporting period. l l i ' l l Page 13 of 26 j
B. Gassous Waste Effluents SAMPLING METHODS OF TYPE OF GASEOUS, RELEASE TYPE
, FREQUENCY, , ANALYSIS , ACTIVITY ANALYSIS P
Waste Gas Decay Tank Each Tank P.H.A. Principal Gamma
...... ... .......... ..Gr.ab . .... .............. . Emitters - .
P ,,,,,,,,,,,,,, , Principal Gamma Containment Purge Each PURGE P.H.A. Emitters
. o r .V. e. n. t. . . ........... .. Grab ...... . .G. a. s . Bu. b b. l. e r. . . .. ;. . ..
. Principal Gamma M P.H.A. Emitters
. . U. n. i. t. . V. e. n. t . . . . . . . . . . . .. .Gr.ab g ....
. Gas. Bubbler . . . . ..
i M l
.Radwasge, Building,,, ,, Grab,,, ,,, ,,,P.H.A.,, ,
, Principal _ Gamma, ,
Vent Sanole Emitters All Release Types ,Conginuous ,
,P.H.A.
as listed above
,I-133 , , ,_,,,,, ,
P.H.A.
. Continuous ,Particulage , , Principal, Gamma ,
, Sample Emitters ! G.F.P. i , Continuous ,Pargiculate Gross Alpha,,,, ,, Composite Sample 0.S.L. Continuous Composite Sr-89, Sr-90 i
.. _ . . . . . ..... _ Particulate, ,,,,,,,,, ,,, ,,,,
Sample C. A conservative error of 4 30% has been estimated. This includes volumetric measurement dIvice, flow measurement device and analytical errors.
- 5. Batch Releases i There were sixty (60) gaseous batch releases during the second half of l
l 1985. The longest gaseous batch release took 151 hours, the shortest occurred over a twenty-one (21) minute interval. The average release I took 6.9 hours with a total gaseous batch release time of 414 hours. There were 422 liquid batch releases during the second half of 1985. l The longest liquid batch release took 115 minutes while the shortest I took only 37 minutes. The average release time for the 11guld batch l releases was 55 minutes. Total release time for all 11guld batch I releases was 386 hours. The meteorological conditions during batch releases are available on I site for review and inspection. Page 14 of 26
- 6. Abnormni Raleassa There were no abnormal 11guld or gaseous releases for this report period.
l
- s. l l
Page 15 of 26
SECTION III HOURS AT EACH WIND SPEED AND DIRECTION All gaseous releases at the Wolf Creek Generating Station are ground level releases. The meteorological data supplied in these tables cover the period from July 1,1985 through December 31, 1985, and indicate the number of hours at each wind speed and direction for each stability class. STABILITY CLASS: A ELEVATION: GROUND WIND
~6iRECTI N' ' ' i l 3 '"4-1 5-i 'i3-i8 '"i9-id >I4' ~ TOTAL' N O 2 0 0 0 0 2 NNE O O 0 0 0 0 0 NE O O O O O O O ENE 0 0 0 0 0 0 0 E O O O 0 0 0 0 ESE O 0 0 0 0 0 0 SE O O 0 0 0 0 0 SSE 0 0 0 2 0 0 2 S 0 0 0 5 0 0 5 SSW 0 0 0 0 0 0 0 SW 0 0 0 0 0 0 0 WSW 0 0 0 0 0 0 0 W 0 0 0 0 0 0 0 WNW 0 0 0 0 0 0 0 NW 0 0 0 0 0 0 0 NNW 0 0 1
0 0 '0 1
.g 0
'3' ' ' '6' '7 0' 'O '10 l
l l Page 16 of 26
, , , , , , ..-.n---,- - - - - - - , --r- - - - - - - - - - - - , - - ' - = - " ~ ~
' ~
STABILITY CLASS: B ELEVATION: GROUND WIND
' DIRECTION' i-3 '4-7Tl's-ii' '~i3-18 'i9- 4 '524' 'TOTil N O O 2 0 0 0 2 NNE O O O O O O O NE 0 0 0 0 0 0 0 ENE O 0 0 0 0 0 0 E O O O O O O 0 ESE O 0 0 0 0 0 0 SE O O O O 0 0 0 SSE O O 2 5 0 0 7 S 0 0 1 10 0 0 11 SSW 0 0 1 2 0 0 3 SW 0 0 0 2 0 0 2 WSW 0 0 0 0 0 0 0 W 0 0 0 0 0 0 0 WNW 0 0 1 0 0 0 1 hv 0 0 2 0 0 0 2 NNW 0 0 1 0 4 0 5 STABILITY CLASS: C ELEVATION: GROUND
~~
' ~ -
' WIND' SPEED (MPH)' ~~~ '
WIND
'61RECTION' 'l-3 ~4-7 ~~s f2' 'i3-18 ~~i9-24 524 ' TOTAL N 1 3 4 4 2 0 14 NNE O 1 0 1 0 0 2 NE O 0 0 0 0 'O O ENE O O O O O 0, 0 E 0 0 0 0 0 0 0 ESE O O O 1 0 0 1 SE 0 0 3 1 0 0 4 SSE O O 4 7 0 0 11
_______________ ____________________________________________ l S 0 0 4 15 3 0 22 SSW 0 0 4 8 2 0 14 SW 0 0 3 1 0 0 4 WSW 0 0 0 0 0 0 0 W 0 0 0 0 0 0 0 WNW 0 1 0 0 0 0 1 hv 0 0 4 1 0 1 6 NNW 0 4 9 9 0 0 22
'7'
.. ... . . . .... 35 '48 ~ i' '101 Page 17 of 26
STABILITY CLASS: D ELEVATI0M: GROUND
~ ' ' ' '
WIND'6 PEED (MPH)' WIND
'6fRECTI $' ~ 1-3 ~4-7 '8-ii' ~13-1s~ ~~i92 24' ~5$4 TOT 5L N 1 69 93 51 4 0 218 NNE 5 53 102 43 5 0 208 NE 2 65 75 16 0 0 158 ENE 1 52 46 2 0 0 101 E 5 36 31 10 0 0 82 ESE 3 32 44 19 2 0 100 SE 4 40 61 15 3 0 123 SSE 3 39 60 63 12 4 181 S 2, 23 46 83 44 9 207 SSW 4 15 31 39 14 0 103 SW 1 15 26 2 0 0 44 WSW 0 22 16 7 2 0 47 W 3 24 21 5 1 0 54 WNW 1 16 20 11 0 1 49 NW 0 32 40 35 32 9 148 NNW 5 24 53 49 13 1 145 STABILITY CLASS: E ELEVATION: GROUND p
WIND
biRECTION' '~ 1-3 'd-7~~ '8-12 ~i3-18 '19-24~~ ~5s4 'T6TAL' N 2 10 40 5 0 0 57 NNE 1 23 31 3 0 0 58 NE 8 41 13 0 0 0 62 ENE 7 57 24 1 0 0 89 E 5 45 49 1 0 0 100 ESE 2 46 40 6 0 0 94 SE 1 37 66 0 0 1 105 SSE 5 26 120 86 12 2 251 S 7 11 92 95 21 5 231 SSW 6 39 30 31 2 0 108 SW 1 19 19 5 0 0 44 WSW 1 20 7 2 0 0 30 W 2 16 13 2 0 0 33 WNW 1 11 15 14 0 0 41 NW 4 11 28 23 1 0 67 NNW 0 31 19 7 1 0 58
..606' '
'~~ 7'
~
'282 ~ ~ ~~37' 1428 I
Page 18 of 26
-r -- - - - . . a , , -- --
STABYLITY CLASS: F ELEVATION: GROUND WIND
'DiRECTid$' 'i13 ' ' 41'I ' ' ' 8 2 ii' 132 is i624 ~524 'TOTil N O 8 8 1 0 0 17 NNE O 15 6 0 0 0 21 NE 5 22 1 0 0 0 28 ENE 8 35 3 0 0 0 46 E 2 46 15 0 0 0 63 ESE 2 36 14 0 0 0 52 SE 1 36 27 0 0 0 64 SSE 2 22 34 0 0 0 58 S 2 18 30 4 0 0 54 SSW 0 10 6 0 0 0 16 SW 2 20 4 0 0 0 26 WSW 0 8 1 0 0 0 9 W l 3 2 0 0 0 6 WNW 4 8 3 0 0 0 15 NW 1 19 6 0 0 0 26 NNW 1 26 17 0 0 1 45
. 546 STABILITY CLASS: G ELEVATION: GROUND
~ '~~ ~ '
l ~ WIND SPEED'(MPH) ~~~ i WIND
'DIRECTI N' 'i-3 ^ '4-7 's-12 'i3-18' '19-24' ~>24 TOTAL i N O 7 0 1 0 0 8 NNE O 6 4 0 0 0 10 NE 0 13 0 0 0 0 13 ENE O 18 0 1 0 0 19 E 1 12 2 0 0 0 15 ! ESE O 9 1 0 0 0 10 SE I 10 0 0 0 0 11 SSE 0 2 3 0 0 j _
0 5 S 0 0 1 0 0 0 1 SSW 0 0 3 0 0 0 3 SW 0 0 0 0 0 0 0 i WSW 0 0 0 0 0 0 0 i W 0 0 0 0 0 0 0 WNW 0 0 0 0 0 0 0 NW 0 7 0 0 1 0 8
- NNW 0 3 5 0 0 0 8
' TOTAL' ' '2 ' '87' ~22
^
'O'
~
~0' O 111 Page 19 of 26
, - - - - ~ . . . - - _ - , . _ _ - -- , . _ . . , , - _ _ _ , , , _ . , _ . . . , - - . . - . - . , , . ,-.- - . _ _ . - _ - - . , ,
STABILITY CLASS: ALL ELEVATION: GROUND
.p g . gp ) .. . .
WIND
~6fRECTI N' 'i-3'- '4-7' '8-12' 'i3-18 'i9-24' '>24' T TAL' N 4 99 148 61 6 0 318 NNE 6 98 143 47 5 0 299 NE 15 141 89 16 0 0 261 ENE 16 162 74 3 0 0 255 E 13 139 97 11 0 0 260 ESE 7 123 99 26 2 0 257 SE 7 123 157 17 3 0 307 SSE 10 89 223 163 24 6 515 S 11 52 174 212 68 14 531 SSW 10 64 75 80 18 0 247 SW 4 54 52 10 0 0 120 WSW 1 50 24 9 2 0 86 W 6 43 36 7 1 0 93 WNW 6 36 39 25 0 1 107 NW 5 69 81 59 33 10 257 NNW 6 89 104 66 18 1 284
. .. 615 ~~812 ~~~186' ~ ~ "32 ' '4197
The computer that supplies the wind speed and direction data foe the Wolf Creek Generating Station does not report hours unless there are three 15 minute intervals of good data per hour. The 219 missing hours of data are due to this criteria. In most cases there is at least one good fifteen minute interval for each hour. This data is available for review at the Wolf Creek site. 1 4 Page 20 of 26
, - , - - - - m,-. _ - , . -m_- .- m.,, .~ - - - - - - - - - - ,
SECTION IV Additional Information
- 1. Un p lann e d Re l e a s e s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pa ge 2 2
- 2. Proc e s s Co n t ro l P rog ram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 2 2
- 3. Of f site Dose Calcula tion Manua1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Page 23
- 4. Maj o r Change s to Radvas te Sys tems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Page 26
- 5. Technical Specification Action Statement Information.............Page 26
- 6. La nd Us e Ce n s u s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pa g e 2 6 Page 21 of 26
- 1. Unplanned Rales 2ss The performance of a surveillance test on the containment purge isolation valves inadvertently led to an unplanned release of the containment atmosphere to the environment. The survelliance procedure had two sets of isolation dampers open at the same time.
Samples of the containment atmosphere were subsequently obtained and analyzed. There was no detectable radioactive noble gas, radiolodines or radioactive particulates detected. A review of the installed radiation monitor trends showed no increase of activity during the forty minute release period. The radiation monitor's setpoint was set in accordance with the Offsite Dose Calculation Manual (ODCM) and would have initiated a Containment Purge Isolation had the setpoint been reached. The surveillance procedure has been revised, requiring a release permit be obtained prior to exercising the isolation dampers and/or eliminating the damper movement step. There were no liquid ef fluent unplanned releases during the reporting period. 1
- 2. Process Control Program The Process Control Program was revised to allow an alternate method of processing solid radioactive waste. This change was approved by the Plant Safety Review Committee on September 4, 1985. The revised section is highilghted by revision bars on Attachment I which has been excerpted from the Process Control Program.
l l l l Page 22 or 26 i
- 3. Offsite vore Calculation Manual Revision I of the Of fsite Dose Calculation Manual was approved by the Plant Safety Review Committee on July 18, 1985. Provided below is a ,
summary of the changes and the justification for each change. Attachment 2 provides the revised pages of the Offsite Dose Calculation Manual which are dated July 9, 1985. p;...g..g. 3 ........ gg.7 7. ........ 11 Titles and page numbers for Tables A.5-2 through A.5-5 were changed. 111 This is a new page that includes Tables A.5-6 through A.5-16; titles as well as page numbers. 1 The last paragraph from section 1 was deleted. Emergency offsite dose calculations are not included in the ODCd but are included in site emergency plan procedures. I 3 A sentence allowing the high alarm trip set point to be set at 1.5 times the background count rate was added to the last paragraph of this page. This was done to remove these two monitors from a constant alarm condition. 8 This was an editorial change: "I"was added to the formula at the bottom of this page. 9 Editorial change: Added the "A=" to the fmax/fp notation. 12 Deleted the last two sentences from 2.4.2. Cneck source actuation is covered in the ! plant monitor calibration procedures. 19 Added the bar (-) over "X/Q" used in the last two equations at the bottom of page 19. The highest annual average relative concentration : factor is used. This was done to make all l the equations consistent throughout the ODCM. 20 Added the bar (-) over all the "X/Q" notations on this page. Reason for change same as page 19. 22 Added the bar (-) over all the "X/Q" notation on this this page. Reason for change same as page 19, 23 Added the bar (-) over all the "X/Q" notations on this page. Also enclosed "X/Q" in parenthesis on this page. Parenthesis were added for consistency. Other change same reason as page 19. Page 23 of 26
~
Pagn R5 vie 5d
" ~ ~
~
~ Rhvialon 24 Only "
Eliminatedthe"f"forclarity.used which matches NU 24 Paragraph 3.3.2 a & b separated the word "to" from " mrem". Editorial change. 24 Added the bar (-) over "X/Q". Reason for change same as page 19. 31 Deleted the last two sentences of 3.4.1.3. Reason for change same as page 12. 32 Deleted the last two sentences of 3.4.2.2. Reason for change same as page 12. 32 Deleted the last two sentences of 3.4.3.2. Reason for change same as page 12. 33 Changed notation " Table 4-2" to " Table 4.2" for consistency. 34 Table 4.1, Section 1: The air par:1culate sampling location was changed from 31 to 32 to be more representative of the town of New Strawn in compliance with Technical Specification 3.12.1. The new location is also identical to that used by the Kansas Department of Health and Environment in their monitoring program and therefore should provide a better comparison of results. 35 Table 4.1, Section 3.a: The addition is to provide a better description of the sampling location. 35 Table 4.1, Section 3.c: The addition is to reference the appropriate figure. 35 Table 4.1, Section 3.d: The change is to provide a more conservativn campling location in complying with Technical Specification 3.12.1, Table 3.12-1, Section 3.d. 36 Table 4.1, Section 4.a: Sampling locations C-11 and B-8 were deleted because residents have sold the milk animals at these locations. Location P-2 was added as a replacement because it is the location with the next highest D/Q within five miles of the plant site; aductionally, the milk from location P-2 is goat's milk, which is potentially a more sensitive indicator of radiolodine than is cow's milk. Page 24 of 26
Reference to an alternate location'was removed for better conformance with the fir.a1 format of the corresponding. Technical ! Specification 3.12.1, Table 3.12-1, Section 4.a. 36 Table 4.1, Section 4.b: The change is to make terminology consistent. 36 Table 4.1, Section 4.c: Reference to alternate broad leaf vegetation sampling locations was removed for better conformance with the final format of Technical Specification 3.12.1, Section 4.c. Irrigated crops were added to comply with Technical Specification 3.12.1, Table 3.12-1, Section 4.c. 37 TLD and Air Particulate location distances were changed to reflect.elther location changes or minor corrections to earlier distance measurements. Milk and food product location deletions reflect the deletions described above (see justifications 6 and 8). New RI factor tables were calculated since Technical Specification 3.11.2.3 refers to any organ and not some imaginary organ that accumulates all the organ doses. NUREG-0133 methodology as well as Regulatory Guide 1.109 methodology calculate seven separate organ doses. Therefore new RI factor tables were generated and added to the ODCM. These tables are found on pages A-44 through A-100. i I" t i i Page 25 of 26
. _ . ~ ~ . . ._ . . . -
1 4 Major Changes to Liquid, Gaseous, or Solid Radwaste Systems J This information will be provided in the next annual FSAR update, as allowed by Technical Specification 6.15.
- 5. Technical Specification Action Statement Information On January 23, 1986, it was discovered that certain survelliances required by Technical Specification 3.3.3.11 had been inadvertently omitted from the. surveillance testing program. These surveillances are utilized to demonstrate the operability of the radioactive gaseous
- effluent monitoring instrumentation. The survelliances which had not been performed were the daily channel check and quarterly analog channel
- operational test on the Unit Vent Sampler Flow Rate Monitor for the particulate and lodine monitoring skid and the daily channel check on the Radwaste Building Vent System Sampler Flow Rate Monitor for the particulate and lodine monitoring skid.
j Since these required survelliances were not being performed during the time period of this report, this Technical Specification violation existed during this report period. The required survelliances were i satisfactorily performed on January 22, and have been incorporated into the survelliance program. Since the analog channel operational test confirmed that no setpoint " drift" had occurred, there is no evidence to indicate that this situation af fected the validity of monitor readings taken during this report period. ThLo event is discussed in Wolf Creek Licensee Event Report 86-003-00. The 11guld effluent monitoring instrumentation time limits for i inoperability, as listed in Technical Specification 3.3.3.10 were not l exceeded during this reporting period. The quantity of radioactive material contained in the liquid hoidup
, tanks or gas storage tanks did not exceed the limita specified in Technical Specifications 3.11.1.4 or 3.11.2.6, respectively, during this reporting period. ,
- 6. Land Use Census ,
There were no new locations for dose calculations identified during this reporting period. i 1
)
.I i l i 1 l Page 26 of 26
., _ ,_- __ _ _.__-__. - _.__. _,.,_______..,-,.,_m_... , _ . . _ _ _ _ - , - , . . - ,
. . . , . - _ _ . ,...,m_,-._,--._._,,m.. ._
ATTACHMENT 1 (EXCERPT FROM THE PROCESS CONTROL PROGRAM) 3.10 CORRECTIVE'dCTIONS 3.10.1 At_ predetermined intervals a portion of the solidified containers will be inverted and allowed to stand for a period of time. Each of these containers will then be inspected for free standing water. The results of each inspection shall be recorded. Should any container be found to exhibit free standing water greater than the FSW criteria established by the low level radioactive waste disposal facility, the following actions shall be taken: ; 3.10.1.1 Secure solidification until new solidification ratios can be determined and proven. 3.10.1.2 Inspect all available containers from the same batch of radioactive waste solidified using the formulas which provided the unsatisfactory results. 3.10.2 Drums that exhibit free standing water shall either be dewatered or reprocessed by determining the quantity of water and adding proper quantitles of cement and additive chemicals as required by a sample verification test.
- 4. BACK-UP' PROCESSING 4.1 In the event that the stock solid radwaste processing system is unavailable, or that extra processing capacity becomes necessary, Kansas Gas & Electric Company will use vendor processing from NUS Process Services Corporation.
4.1.1 The latest revision of the NUS Process Control Program will < be used to control waste processing whenever this service is ' in use. 1-31 Rev. 3 4/85
\
l
- l
ATTACHMENT II EXCERPTS FROM THE ODCM
! LIST OF TAULES Table Page 4-1 Radiological Environmental Monitoring Program '
34 4-2 Sampling Location Numbers, Distance (miles) at 1 Directions 37 A.1-1 Bioaccumulation Factors to be Used in the Absence A-2 of Site Specific Data i A.1-2 Dose Factors for Noble Gases and Daughters A-3 I A.2-1 Inhalation Dose' Factors for Adults A-4 A.2-2 Inhalation Dose Factors for Teenagers A-7 i A.2-3 Inhalation Dose Factors for Child A-10 n.2-4 Inhalation Dose Factors for Infant A-13 J4 A.2-5 External Dose Factor for Standing on A-16 Contaminated Ground t A.3-1 Ingestion Dose Factor for Adults A-18
) A.3-2 Ingestion Dose Factor for Teenagers A-21 A.3-3 Ingestion Dose Factor for Child A-24 <
A.3-4 Ingestion Dose Factor for Infant A-27 1 A.3-5 Stable Element Transfer Data A-30 1 A.4-1 Site Related Ingestion Dose Commitment for Adult A-31 : A.4-2 Site Related Ingestion Dose Commitment Factor for A-34 Teenager A.4-3 Site Related Ingestion Dose Commitment Factor for A-37 Child A.4-4 Site Related Ingestion Dose Commitment Factor for A-40
; Infant ] A.5-1 Inhalation Dose Parameter for the Child A-43 1
A.5-2 Inhalation Pathway Factor for Adult (RI Factor) A-44 A.5-3 Inhalation Pathway Factor for Teenager (RI Factor) A-49
- A.5-4 Inhalation Pathway Factor for Child (RI Factor) A-53 !
! A.5-5 Inhalation Pathway Factor for Infant (RI Factor) A-57
- 11- 7-8-85
- - , - - . . - . , - , . . _ , . . - - . . _ , - - _ - - - - . . - - , - , - - . - , , . - - ~ , - . - . . , , , , , . .
.,_,,,.-,.,m__y-. - . . _ ,--.,--..----...-y-----..m.-.,,s- ,-.m,,7- - - - . - - - - - - - - - ,
Tacle t' a #
) A.5-6 Grass-Cow-Milk Pathway Factor Adult (RI Factor) A-61 A.5-7 Grass-Cow-Milk Pathway Factor Teen (RI Factor) A-65 A.5-8 Grass-Cow-Milk Pathway Factor Child (RI Factor) A-69 A.5-9 Grass-Cow-Milk Pathway Factor Infant (RI Factor) A-73 A.5-10 Grass-Cow-Meat Pathway Factor Adult (RI Factor) A-77 A.5-ll Grass-Cow-Meat Pathway Factor Teen (RI Factor) A-81 A 5-12 Grass-Cow-Meat Pathway Factor Infant (RI Factor) A-85 A.5-13 Vegetation Pathway Factor Adult (RI Factor) A-89 A.5-14 Vegetation Pathway Factor Teen (RI Factor) A-93 A.5-15 Vegetation Pathway Factor Child (RI Factor) A-97 A.5-16 Ground Plane Pathway Factor (RI Factor) A-101 1
LIST OF FIGURES 4.1 Atmospheric Sampling 4.2 Water Sampling Locations 4.3 Milk and Vegetation Sampling Locations 4.4 Distant Sampling Location B-1 Vertical Standard Deviation of Material in a Plume B-2 Plume Travel Distance Versus Fraction Remaining in Plume B-3 Plume Travel Distance Versus Relative Deposition Rate iii 7-8-85 )
- - . - , . ~ . . . - ,. . - . . . _ _ _ . . . - - . - , .-- .--. . . - - - - - - - - , . , - . - - , . , - - , . - - - , . , - . .
1.0 INTRODUCTION
The Offsite Dose Calculation Manual (ODCM) describes the methodology and parameters to be used in the calculation of offsite doses due to radioactive liquid and gaseous effluents. These dose estimates are used to demonstrate compliance with the Radiological Effluent Technical Specifications as requir-ed by 10CFR50.36, 10 CFR 20.106,10 CFR 50 Appendix I, and 40CFR190. The ODCM contents are based on " Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants (NUREG-0133) ," and Regulatory Guide 1.109, Revision 1. The ODCM provides the methodology to be used in the calcula-tion of liquid and gaseous effluent monitor alarm / trip setpoints to assure compliance with the concentration and dose limitations of the Radiological Effluent Technical Specifications. I The ODCM provides the Radiological Environmental Monitoring ! Program. The program consists of monitoring stations and sampling programs designed to confirm the dose estimates made under normal or accident conditions, and conform to NRC requirements in 10 CFR Part 50.
)
2.0 LIQUID EFFLUENTS 2.1 LIQUID EFFLUENT MONITOR SETPOINTS The alarm / trip setpoints for the liquid effluent radiation monitors are based on the instantaneous concentration limits of 10CFR20, Appendix B, Table II, Column 2 applied at the boundary of the restricted area. Specifically, the liigh Alarm setpoint will correspond to the 10 CPR Part 20 limits at the boundary of the restricted area; the alert alarm setpoint is set one order of magnitude below the liigh Alarm / Trip setpoint. Since the !!igh Alarm / Trip initiates isolation of the particular system and termination of the release, this setpoint represents assurance that the instan-taneous liquid release limit of 10 CFR Part 20 is not exceeded. Auditable records shall be maintained indicating
- the actual setpoints used at all times.
l l 1 j ODCM 1 07-08-85
- - - - - - - -. +-,r - , , - . - - - . - , , - , - - - - , . . - - - . - . _ . , -,--------: - -- - ,,-..,,,-- -
2.1.1 CONTINUCUS LIOUID EFFLUENT ONITORS
} The two monitors associated with continuous liquid releases are listed below:
Monitor ID Description 0-BM-RE-52 Steam Generator Blowdown Discharge Monitor 0-LE-RE-59 Turbine Building Drain Monitor The steam generator blowdown discharge effluent monitor continuously monitors the blowdown discharge pump outlet to detect excess radioactivity due to system demineralizer breakthrough or abnormal primary to secondary leakage. The blowdown discharge monitor's high alarm setpoint initiates closure of the blowdown isolation valves and the blowdown discharge valve. Similarly, the high radiation alarm on the turbine building drain monitor initiates closure of the drain line isolation valve to prevent the release of radio-active effluents. Monitor setpoints will be conservatively based on I-131, the most restrictive isotope expected to be present. This is particularly appropriate for the turbine building drain line i monitor since the most probable source is the secondary steam system which is expected to have neglioible activity unless there is a significant primary to secondary leak. Due to changing activities, it will not be possible to select a radionuclide distribution on which to base the monitor sutpoint. Additionally, maximum effluent flows and minimum dilution flows will normally be assumed. i The High Alarm / Trip Setpoint will be set to correspond to the I-131 MPC limit at the boundary of the restricted area from 10 CPR Part 20, Appendix B, Table II, Column 2. The alert alarm is set one order of magnitude below the high alarm / trip setpoint. This high alarm / trip setpoint assures the limits of Specification 3.11.1.1 are not exceeded at the boundary of the restricted area. 1 In the event that an alarm is tripped, an evaluation of the I system will be made by taking an actual isotopic and flow analysis of the discharge. The above continuous liquid effluents are not radioactive effluents until activity has been detected by the liquid effluent monitor, a tritium analysis of the secondary system, or a gross beta analysis of the secondary system. At that time an analysis of the effluent will be made to
.) ,/
verify activity in the system effluent. During periods of time when the above liquid ef fluents are not radioactive the high alarm / trip set point may be set to 1.5 times the back g round count rate. ODCM 3 07-08-85 't
- - - _ - _ . _ - _ . _ = _ _ -
Where: Fm = The expected minimum dilution water flow rate. LCi = Measured concentration of nuclide i in the cooling lake water sample. MPCi = Limiting concentration of radionuclide i from 10CFR20 Appendix B, Table II, Column 2. For the purpose of setpoint calculations the expected minimum dilution flow rate is assigned a value based upon the type 7 and number of pumps running into the circulating water piping. l Having established the values of Fdn and Pegg, the calculated maximum permissible waste tank flow rate is given by fmax i Feff + fp Feff for fp << Fegg Fdn fdn Where fa is the expected effluent flow rate; normally the
, rated c'apacity of the effluent pump. Thus the pump flow rate
- is set at or below fmax. Even though the value of fmax may be larger than the actual effluent pump capacity, f p, it does represent the upper limit to the effluent flow rate, whereby the requirement of 10CFR20 may still De met. If Fd i 1, the effluent pump flow rate may be assigned any value since the waste tank effluent concentration meets the limits of 10CFR20 without dilution and the release may be made without regard to the setpoints for other release pathways.
For those discharge pathways selected to be secured during ! the release under consideration, the pump flow rate should be set at as low a value as practicable to detect any inaavertent release. A setpoint for the dilution stream flow rate is not applicable since the minimum flow rate is administrative 1y set. i 5) The liquid radiation monitor setpoint may now be determined based on the values of E Ci and fmax. The monitor response is primarily tb gam,ma radiation, therefore, the actual setpoint is based on f C g. The calculated monitor setpoint concentration is dete2 mined as follows: i e=A Cg (uCi/ml) i ODCM 8 07-08-85
Where: A = Adjustment factor which will allow the setpoint to be established in a practical manner for convenience and to prevent spurious alarms. fmax A= fp If A > 1, Calculate c and determine the maximum vaJue for the actual monitor setpoint (uCi/ml) .
- f A 1, :c c;; ease ma;. ce mace.
If Fd< 1, no further dilution is required and the release may be made without regard to available dilution or to other releases made simultaneously. Ilo w e v e r , it is necessary to establish a monitor setpoint which will provide alarm should
, the release concentration inadvertently exceed 10CFR20 limits. This can be accomplished by establishing the adjust-ment factor as follows:
A= 1/Fd 2.2 LIOUID EFFLUENT CONCENTRATION - COMPLIANCE WITl! 10 CFR 20 Specification 3.11.1.1 requires that the radioactive material released in liquid effluents to unrestricted areas shall be lin.ited to:
- a. The concentrations specified in 10 CFR Part 20, Appendix B, Table II, Column 2 for radionuclides l other than dissolved or entrained noble gases,
- b. For dissolved or entrained noble gases, the concen-tration shall be limited to 2 x 10-4 A%Ci/ml total activity.
To show compliance with this specification, concentrations of actual liquid effluents will be determined by performing an isotopic analysis. The liquid ef fluent monitors will provide l
) assurance that the liquid concentration limits are not exceeded.
j ODCM 9 07-08-85 l
I
)
2.4 CALIBRATION OF LIQUID EFFLUENT MONITORS The four monitors associated with liquid releases are listea below Monitor ID Description O-BM-RE-52 Steam Generator Blowdown Discharge Monitor O-LE-RE-59 Turbine Building Drain Monitor O-HF-RE-45 Secondary Liquid Waste System Monitor 0-HB-RE-18 Liquid Radwaste Discharge Monitor 2.4.1 Liquid effluent streams are monitored by an NaI(Tl) detector. The detector operates in a gross counting mode and is gamma sensitive.
\
2.4.2 Calibration of the liquid monitors shall be performed
- using three standard solutions of Cs-137. The solu-tions shall cover the appropriate range of the detector and have concentrations of approximately 5 x 10-t uCi/cc, 1 x 10-5 uCi/cc, and 1 x 10-3 uCi/cc. The solutions shall be presented to the detector and the meter reading in counts per minute shall be recorded. A graph of counts per minute versus concentration shall be produced from the data.
3.0 GASEOUS EFFLUENTS 3.1 GASEOUS EFFLUENT MONITOR SETPOINTS Technical Specification 3.3.3.11 requires the gaseous effluent monitoring instrumentation channels shown in Table 3.3-13 to be operable with their Alarm / Trip setpoints set to ensure that the limits of Specification 3.11.2.1 are not exceeded. Specification 3.11.2.1 states that the dose rate due to radioactive materials released in gaseous effluents from the site shall be limited to less than or equal to 500 mrem /yr to the total body and less than or equal to 3000 mrem /yr to the skin due to noble gases. ODCM 12 07-08-85
where: MPCi = 5 x 10-10 uCi/cc for Cs-137
= 1 x 10-10 uCi/cc for I-131 AF = as defined previously SF = .0625 for I-131 *
= .9375 for C 3-137 *
- derived from ratio of isotope activity (either I-131 or Cs-137) to sum of activity of Cs-137 and I-131 found in FSAR Table 11.1-1 for reactor coolant.
Q = Vent flow in M3/sec This will provide the Hi alarm setpoint. The alert alarm setpoint is 10% of the Hi alarm setpoint.
) 3.2 GASEOUS EFFLUENT CONCENTRATION / DOSE RATE
- Compliance with 10 CPR 20 The Standard Technical Specification 3.11.2.1 requires that the instantaneous dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond the site boundary shall be limited to the following values:
- a. The dose rate limit for noble gases shall be <500 j mrem /yr to the total body and <3000 mrem /yr to the skin, and
- b. The dose rate limit for I-131 and I-133 and for all radioactive materials in particulate form and radio-nuclides other than noble gases with half lives greater than 8 days shall be <l500 mrem /.yr to any organ.
Based on the methodology of NUREG-0133;
- a. Release rate limit for noble gases:
fK i (X/0) Qi '500 mrem /yr for the total body, and
}f(Li+ 1.1 M)i (X/9) Qi <3000 mrem /yr for the skin.
I ODCM 19 07-08-85
3 - where: Ki = Total body dose factor due to gamma emissions for each identified noble gas radionuclide, in mrem /yr per AuCi/m3 , from Table A.1-2. (X/Q) = 2.2 E-06 sec/m3, The highest calculated annual average relative concentration at the restricted area boundary in the North Sector. Qi = Release rate of radionuclide i from vent, in 2Aci/sec. Li = Skin dose factor due to beta emissions for each identified noble gas radionuclide, in mrem /yr per4&Ci/m3, from Table A.1-2. Mi = Air dose factor due to gamma emissions for each identified noble gas radionuclide, in mrad /yr per /ACi/m3 from Table A.1-2. 1.1 = Conversion constant of air dose to skin dose.
- b. Release rate limit for all radionuclides and radio-active materials in particulate form and radionuclides I other than noble gases:
4 (X/Q) - Qi) <l500 mrem /yr to any organ,
]7(P(i)IN where:
Qi = The release rate of radionuclides, i, in i gaseous ef fluent from all vent releases, in
/ACi/sec. -
P ( i) 13
= The dose parameter for radionuclides other than noble gases for the inhalation ,
pathway, in mrem /yr per aci/m3 s See Table A.5-1. (X/Q) = 2.2 E-06 sec/m3 (the highest annual average) . The highest calculated relative concentration for estimating the dose to an ind iv id ual at the unrestricted area boundary in the N sector. 1 1 CDCM 20 07-08-85'
\
The Pi value for tritium is: Pi (Inhalation) = 3.7 x 109 DFAi 3.3 GASEOUS EFFLUENT DOSES
- Compliance with 10 CPR 50 Appendix I 3.3.1 NOBLE GASES Specification 3.11.2.2 requires that the air dose due to noble gases released in gaseous effluents to areas at and beyond the site boundary shall be limited to the following:
- a. During any calendar quarter, to i 5 mrad for gamma rad iation and 5 10 mrad for beta radiation;
- b. During any calendar year, to i 10 mrad for gamma radiation and i 20 mrad for beta radiation.
; To show compliance with this specification, the dose calculations for the actual releases of radioactive noble gases in gaseous
) effluent will be consistent with the methodology provided in Reg. Guide 1.109, Rev. 1. The following dose calculations will be performed:
- a. During any calendar quarter; For gamma radiation; D= 3.17 E-8 fy Mi [(Xfg) .Q]i 1 5 mrad.
For beta radiation; D= 3.17 E-8 p,y S. N i ((X/Q) - Qi] 1 10 mrad,
- b. During any calendar year:
For gamma radiation: j D= 3.17 E-8 g]py Mi [(X/Q) - Qi] i 10 mrad. For beta radiation: 4 D= 3.17 E-8 {[~y N i [(X/g) . Oil i 20 mrad l l t ODCM 22 07-08-85
- I
. .. . _ _ = . - . _ - - . .- - _ _ - -. - . - ,I t
- ) -
where: l 3.17 E-8 = The inverse of the number of seconds in a year. Mi = The air dose factor due to. gamma emissions for each identified noble gas radionuclide, in mrad /yr i perXcCi/m3 from Table A.1-2 (Reg. Guide 1.109, l Table B-1, Col. 4) l ! Ni = The air dose f actor due to beta emissions for each identified noble gas radionuclide, in
- mrad / year per /ACi/m3 from Table A.1-2 (Reg.
j Guide 1.109, Table B-1, Column 2) . 1 l (X/Q) = 2.2 E-6 sec/m3 The highest calculated l ! annual average relative concentration for any 1 area at the unrestricted area boundary. j Qi = The release of noble gas radionuclides, 4 'i', in gaseous effluents, inALCi. Releases i shall be cumulative over the calendar quarter or I year as appropriate. I An average monthly air dose schedule should be setup to ensure section 3.11.2.2 of Wolf Creek Technical Specifications are not exceeded. The , average monthly air dose should be as follows: 1
- a. For gamma radiation f 1.6 mrad /mo.
t For beta radiation < 3.3 mrad /mo. i If the monthly average air dose for: (a) is exceeded, it should be noted that if the release is continued at the same (or higher) i f requencies or activities the quarterly limit of Technical ; l Specification 3.ll.2.2.A will be exceeded. ' i - t j b. For gamma radiation 1 0.8 mrad /mo. ! 4 For beta radiation i 1.6 mrad /mo. If the monthly average air done for: (b) is, exceeded, it should ! j be noted that if the release is continued at the same (or higher) frequencies or activities the annual limit of Technical Specifica-t io n 3.11. 2. 2. 8 will be exceeded. j If any of the above monthly average air doses are exceeded, evaluation of the causes of the high air dose should be performed
; and steps should be taken to reduce the activity or frequency (e.g. delay the release of a Waste Gas Decay Tank) of the release.
I i , i ODCM 23 07-d8-85 1
3.3.2 RADIOIODINES, PARTICULATES, AND OTHER RADIONUCLIDES Specification 3.11.2.3 requires that the dose to an individual f rom iodine-131 and 133, tritium, and all radioactive materials in particulate form with half-lives greater than 8 days in gaseous effluents released to areas at and beyond the site boundary shall be limited to the following: 1
- a. During any calendar quarter to 1 7.5 mrer to any organ; and
- b. During any calendar year to i 15 mrem to any organ.
To show compliance with this specification, the dose calculations for the actual releases of the subject materials are consistent with the methodology provided in Regulation Guide 1.109, Revision
- 1. The following dose calculations will be performed:
l 4 ) a. D (mrem) = 3.17E-8 f' Ri (WQi)] 1 7.5 mrem
- b. D (mrem) = 3.17E-8 i Ri (WQi )] 1 15 mrem where:
3.17 E-8 = The inverse of the number of seconds in a year.
=
Qi The release of radiciodines, rad ioactiv e materials in particulate form and radionuclides other than noble gases in gaseous ef fluents, 'i', in Ci. Releases shall be cumulative over the calendar quarter or year as appropriate. The Qi value shall be determined as the product of the flow rate through the release point and grab samples of the effluent analyzed in accordance with Radiological Effluent Technical Specifica-tion 3.11.2.1. W = The annual average dispersion parameter for estimating the dose to an individual at the controlling location. l W= (X/Q) , 2.2 x 10-6 geef'm3 for the inhalation pathway. W= (D/Q) , 1.8 E-8 m-2, for the food and ground plane pathways.
=
Ri The dose factor for each identified rad ionuclide,
'i', in mrem /yr per ALCi/m3 See Table A.5-2 !
through Table A.5-5. ODCM 24 07-08-85
PARTICULATE DETECTOR CALIBRATION
} 3.4.1 3.4.1.1 ; Beta particulate is monitored by a 50 mm diamter by 0.25 mm thick plastic scintillator optically coupled to a 50 mm diameter photomultiplier tube. This detector shall be calibrated over its range of energy and rate capabilities. '. a 3.4.1.2- For energy range calibration four sources shall be used. Each source consists of a filter paper impregnated with a beta emitting radionuclide. The radionuclides used should be Tc-99, Cs-137, Cl-36, and'Rh-106. Each source shall be positioned in the filter paper retaining ring and counted separately.
The count rates for each radionuclide source shall be recorded and the data plotted on a graph of cpm /uCi versus average beta energy. This curve represents the detectors response characteristics over the range of beta energies observed. The efficiency for setpoint calculations shall be based on the efficiency of the detector for Cs-137. 3.4.1.3 The detector shall be calibrated for its rate capabilities using a filter paper impregnated with stand activities
) of Cs-137. Increasing amounts of a standard Cs-137 solution shall be impregnated on a filter paper. The counts per minute for each Cs-137 standard shall be recorded and the data plotted on a graph of counts per minute versus activity. At least three sources covering approximately 1/4, 1/2, and 3/4 of full scale shall be checked.
3.4.2 IODINE DETECTOR CALIBRATION 3.4.2.1 Iodine gas is monitored by absorbing the gas on a charcoal filter element. The charcoal filter is viewed by an NaI(Tl) integral line gamma scintillator assembly. 3.4.2.2 Because of its short half life and the difficulty in handling gaseous iodine, barium sources shall be used for calibration. The photo peaks of interest are as follows: A. Ba-133: 356 kev gamma is 0.69 efficient / disintegration
. B. I-131: 364 Kev gamma is 0.82 efficient / disintegration ODCM 31 07-08-85
C Therefore, each iodine disintegration will produce 0.82/0.69 x barium disintegrations. Assuming that the detector efficiency for 356 kev is the same as for the 364 kev, the sensitivity for I-131 equals 1.19 x Ba-133 (coun ts/ min) /uCi . The standard sources shall oe construc-ted by impregnating a standard Ba-133 solution into the charcoal filter element. The geometry shall simulate the iodine retention on the first surface of the charcoal. Sources shall be prepared to cover approximately 1/4, 1/2, and 3/4 of full scale. The barium counts per minute for each standard shall be adjusted to iodine counts per minute as described above. The adjusted counts per minute shall be plotted on a graph of. counts per minute versus activity. 3.4.3 GAS DETECTOR CALIBRATION 3.4.3.1 The gas detectors associated with monitors 0-GT-RE-22&33, 0-GT-RE-31&32 and the low-range detectors of monitors O-GT-RE-21B and 0-GH-RE-10B are a plastic scintillator identical to the particulate detector. The mid-range and high-range detectors of monitors O-GT-RE-218 and ( O-GH-RE-10B are cadmium telluride, solid. state sensors. 3.4.3.2 Sources for all gas detectors shall be produced by evacuating the sample chamber with a vacuum pump. The sample chamber then shall be backfilled to the desired pressure with a source of standard Xe-133. The source is then counted and the counts per minute recorded. A graph of counts per minute versus concentration shall be produced from the data. Sources shall be prepared to cover approximately 1/4, 1/2, and 3/4 of full scale for the detectors associated with monitors 0-GT-RE-22&33, 0-GT-RE-31&32 and the low-range detectors of monitors O-GT-RE-21B and 0-GH-RE-10B. Sources shall be prepared for the mid/high range detector to cover two points on the mid-range scale. For ALARA purposes, response for the high-range scale shall be extrapolated using the data from the mid-range calibration. (t ODCM 32 07-08-85
4.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Table 4.1 gives specific Radiological Environmental sampling pathways, locations and frequencies corresponding to Table 3.12-1 of Wolf Creek Technical Specifications. Maps showing these locations in relation to the Wolf Creek site are shown in Figures 4-1, 4-2 and 4-3; Table 4.2 lists distances and directions from the site to the sampling locations. 4.1 INTERLABORATORY COMPARISON PROGRAM Analysis of KG&E Radiological Environmental samples is presently performed by Teledyne Isotopes, which takes part in the EPA Laboratory Intercomparison Program. Results of intercomparisons are then provided to KG&E in revisions to Teledyne's Quality Control Manual (IWL-0 0 3 2- 3 61) which is maintained at KG&E corporate offices. i I ODCM 33 07-08-85
i s' V v v O C
@ TABLE 4.1 Sheet 1 of 3 RADIOLOGICAL ENVIRCNMENTAL MONITORING PROGRAM Number of Samples Exposure Pathway and Sampling and Type and Frequency and/or Sample Sample Locations Collection Frequency of Analysis
- 1. AI RBO RN E Radioiodine and Five locations, Continuous operation Radiciodine canister.
Particulates station numbers 2, of sampler with sample Analyze weekly for 3, 32, 37 and 40 collection as required I-131. (control) Figure 4-1. by dust loading but at least weekly. Analyze for gross beta radioactivity not less than 24 hours following u filter change. Perform gamma isotopic analysis on each sample when gross beta activity is greater than 10 times the yearly mean of control samples. Perform gamma isotopic analysis on composite (by location) once per quarter.
- 2. DIRECT RADIATION 38 TLD locations within Quarterly at each Gamma dose quarterly. ,
5-mile radiur of site location - (station numbers 1-38 o on Figure 4-1) and ,
-a two offsite locations -l 5 (stations 39 and 40) ;
- two TLD dosimeters at -
m each location. w i
C' O
- A O
C n TABLE 4.1 Sheet 2 of 3
'1 RADIOLOGICAL ENVIROtJMEtJTAL MO!!ITORItJG PROGilAM Number of Samples Exposure Pathway and Sampling and Type and Frequency and/or Sample Sample Locations Collection Frequency of Analysis _,_
- 3. WATERBORNE
- a. Surface One upstream location Monthly grab sample Monthly gamiaa isotopic near the John Redmond analysis. Quarterly Reservoir spillway, one trituim analysis of sample from Wolf Creek composite saicple.
Cooling Lake discharge cove.
- b. Ground Three locations at Quarterly Quarterly gamma iso-C-10, C-49, D-65, topic and trituam w" one control location anal fuis.
at B-12 (see Figure 4-2).
- c. Drinking Municipal water Monti.ly cos..pua i t i_ ^ Monthly grosu beta and supplies at Burlington gamma i otopic analysis.
(upstream) and Le lloy Quarterly tritiuia analysis (downstream) (see Figure 4-2). of composite sample.
- d. Sediment from One cample from Se;oiannually Semiannual gamma iso-Shore 1ine Uolf Creek Cooling topic analysis, l.ake discharge cove.
o 4 I o m I m w
- Compositea s'irpling shall be performed by collecting an aliquot at intervals lo t exceeding 2 hours.
G - J o o TAB 5E 4.1 Sheet 3 of 3 3 RADIOLOGICAL ENVIRONM 3N'2AL MONITORING PROGRAM Number of Samples Exposure Pathway and Sampling and Type and Frequency and/or Sample Sample Locations Collection Frequency of Analysis
- 4. INGESTION S ample s from F-1, 0-5, Semimonthly when Gamma isotopic and P-2, and a control animals are on pasture; I-131 analysis of each
- a. Milk sample from S-3 monthly at other times. sample.
(see Figure 4-3) .
- b. Fish One sample from Wolf Semiannually Gamma isotopic analysis Creek Cooling Lake, on edible portions similar sample from John Redmond u Reservoir spillway
- as control
- c. Food Produc ts Broad leaf vegetation Monthly during harvest. Gamma isotopic analysis saaples locations 0-1 on edible portions, and A-1 on Figure 4-3:
control at S-4 Two sanples of crops At time of harvest Gamma isotopic analysis irrigated with Neosho on edible portions. River water from loca-tions downstream of'the Neosho-Wolf Creek Con-fluence and one control o sample upstream of the Con-y fluence; (Locations will o vary f rom year to year) . m I c
- W
O s O o TABLE 4.2 3 SAMPLING LOCATION NUMBERS, DISTANCES (miles) AND DIRECTIOtJS TLD and Air Particulate Location Distance / Location Distance / Locat ion Distance / Location Distance Number Direction E2mber Direction Number Direction Number Direction 1 1.4/N 11 1.6/E 21 3.8/S 31 3.0/WNW 2 2.7/N 12 1.8/ESE 22 4.1/SSW 32 3.2/WNW 3 3.0/NNE 13 1.5/SE 23 4.5/SW 33 3.7/WNW 4 4.0/NNE 14 2.6/SE 24 4.1/WSW 34 4.0/NW 5 4.0/NE 15 4.5/ESE 25 3.6/W 35 4.6/NNW 6 4.4/ENE 16 4.2/E 26 2.6/WSW 36 4.2/N 7 1.9/NE 17 3.6/SE 27 2.1/SW 37 2.1/NNW 8 1.6/NNE 18 3.2/SSE 28 2.8/SW 38 1.2/NW l 9 2.0/ENE 19 4.0/SSE 29 2.6/SSW 39 13.0/N l w 10 2.4/ENE 20 3.3/S 30 2.2/W 40 15.0/WNW 1 l ( Groundwater l l B-12 2.2/NE C-10 2.8/W C-49 2.9/SW D-65 3.9/S Milk and Food Products A-1 1.4/N F-1 1.6/ESE Q-1 1.3/NW R-1 2.2/NNW S-3 15.0/WNW P-2 2.9/hNW 0-5 3.6/NW S-4 15.0/WNW l l8 i
?
5 l
Ng I s , i *
/
i :.
'j \ /
!/ : /
=f/
l . . . .. . l \ s I,a
._ ./ . .. w!NA
;,* i
] 3,y\ . , .
tsg r
/ ..
z . - - - a -
--.y
> s. / r '
- , n.m .. /[
.(
/
./
I_.T...Y, \ .
. . . _I ' I. - . 1 b ...
7,., , .ts i
,' W s/N ;
',t L W /i
&, / / h.
.( Ns 19 / -7Wi
- ;/
M ..m- . , _ . . . . . . ......
,. d!
'N %l ! M.kF . ! -$.
N ..,. L. .._.. ........+ t ).. ,.I ..
,)--
m,;i %m J - ?,h ... .i~ m. _ ! : ,. L.( 3 ,m a !
- \
- i. 3 7 h/ V ...l..L.J.?.,e QM ! ., ..
\! L
%l ,
- V T 8 . .
M :-
'~r,'l . A %- M. ( .N i
/ . :i M:x hu 'wA"' w/l.__: '
s ) l s
- m. :b
_..<.e.. t of : :
/DN;i l., m'N@f T ;i
.M,{
m -( i% JN: .l bl I
,.u s
%.,;\ .
.c .! s, us /g y , g - ,f .. xi . . : .
. s.c.N.f- ,
t
. . : s< ,m g
s,3, / .x N. xq .__
- w. ~ \
.(. c' . j,
\ a e.\. ,, :
.... .. . ns.... _ - _.
l hg . e.....,.... l W \;l i- w,/ n ff --h--. N /+
/ !
-;r[.-
/
w
- h-l ,.
L[. ...- ;. x r ... 7:h %,
-{g\ q g../N 1 .:
t i i
- ) s u..
,s s., ,
..y ,.
.a. , j : : u ':. ,- - . ,
r
' j. .. - . ,
x .. n_a. . .-
/
/ k i ( ._ 4\ g J
] ey< ',;
n _ _. .J
/
i ts ,l 3 ,>
.' \ ;(
V
.X...\l
..1 .*
g w, , 'f : *
/ - ,{ : .A; ." T.'3 (. 0 t
g 0 f' ' ~, ol,t,Q 'M-. ,e- I"h:/, .
.s _ .-
- l ../.4),*DW
' E?"~.a - ,f ;x, s
~ < !
,.___l.,,..,_,es_>'
f ;i . t \isr*? _. _>/ l N x 1 7 s n' /
- w_ -
, J -
e ',- xr'?x t-3:- f ., * " 4, . l3 e '\'} ,, l
, ,e
.,.,i' i i
... . c_ j. .
,u.
o . y / x u c . - N i e-- e r j \ l [-
. ~_/_ .'* ;
o -. . ) l J/
, , n
- r. .
/
i
', . l- la ~'
il
. .. .- L - o A
a .g
/ ..
- 1. ,i,
. ! \,
, I . 1 .- . . l . i .
'il L E S o 2
-_s i
i !C'J.'d. II -1
) .-/.TNCSN!ERIC ".Yli".l AY ..:./aPl H.'G
. - TLD 0 - Particula t.e , Ic-line , and TLD 7-08-85
.... i ...e
; I . y
,l
,/ ,
t J l
. (
. . . . .,. .f s
a c.J . . se
'.-. i \ .- .
J / NA }/ y \ 'N/ '.,J
,.....q, . . .
</' . _ _ .. -
__ i N 1- / \ i
/ ,,. , _ . . .
./T s ;'
/ lV, .. f l I- T' y-N,.s/. .
,,,_I,b[ ',
.s
_ . b. . n . /'r,
- n
/
/ ,
' p ,
- h /' ,e ,-
[ ,t I
- \) 7' W/ t '
R .fa" _ I! Y 3.......-
\l . .
ee [ [ ,
.\ .
1_].
.., a : . N \ ':.. ,J., i 1 N :
W ) !~ ~ ! -
- ): [2 / 'i N M, ! \
l/, %.
,.l h l .....!... ... , f ,
- . 4. i': a. "
9 (
- \ l ' ' #
.h f i I ;;
"wi'[/
- i hid vi .g % j ' /.'
-- i l
C# l
;I ~~~~i- l l; I +,.
gs . ,' N '.3N G Q *=..3:.
~
? g( v.u / '(f Ia L#g.
gf .. M, II l I
! *" w '
t, 4, .7
.,s=. P '_ l ' p-
, 4 s ->,f[a/> N '
(,: x t. 1 W. i f A',*I i ~ Y_, y\ \ i __,,N N. j l
,"*j h.] % f ' 4 tk A's/ k'N ' ' .s. ,
N y r.***'--* p.,c -*~ e
. .g\
r , . i .- J n., J N, . ..t
?
. :- w. :,) l t -
, 6- . - . .
.'-v' l \ ,v.
.1 V
. /\ /
, *, ><;8x.
l _/ .
;l} l, I
4- . h.' ...--j x.
\, -
',/
ws. ' i g: s . I
;i N['kN, ' /
7,< ,
's / -f q 'cs C' i [l*-W r
..r a ,,1 i
,e:i..:,.,:.
-/l I -
i e/u l i s '
/(
f,f+d.,.mx / N'
.e u, . f. . . .(e, -
g _ 4. .. . _- t,
--' ~,~ qa,_:, . N ,_ ,j v- J ) ,.' , r.
f -l
- l' , '
. y_.- . / _ _ . .
...___m... .... ______
J. 1,,.- j- t '
t. , ' ; T
.a.
.i1
-\ -
-\%. y .
+
v_ la 6 -- \. e /
,.6 '
,- N- A-s, . - -
y A - lx- - t.".- _v N s ..,y < c
/
)
N\ .- e' j j i , ,
' ' ^ ,, / ;
~- % _._
.__-+':.-
, , .m -
,{ \ .
__i
. / .
. '.. ...._..._- d .
H 7', ( ,4 )
/
[. ! g, . 4.. . _y
/. < ,; ,
, i
& .N
,e
...- . 4 . ..
t . . . . I e MILES T' i o 7 i W.t
'TCUii . 4 - c WMER t.t:0 r.ED: MENT ru.mi.1Nr, t oct.ricNs 4 - EUiiFACE UATER O -imI W.I :G UATED A - GHCUf;D L'A TER o - SHORELI E CEDIt'EtiT
, 7 08-85
i l l ,
) \ l /
[i
' M N'
.. _ _ _ \ -
- j ..
f!
/ i n 1 .
x p3 l
/ .?. * '
,'i . - . -
j
- 1. . lh., \
^
__g
. 3 ..
N ..
], g L.-n
. c.
s-j' ,
't J"rc,n,r.
+: \
. I h
,g i --c
\ s -
/
,, ' Gg
, i, i !
s . s/ L m q_ .-M_. - - f,, '
/ '\
l
- /
/
\l'-- -j;N-- -1 y
..f i :
[': \- 4..,J Li4- )
; , ,,, : Ng
-3d 5 .. ,
c,.,
~
/ }: g N r q ,
I t
/
i... ,. i' as .. , sy ,: - x
.. s .
i /".: % _,.'N M<A ,; V '\ i z
~'~ 4 g ~: .,7, w
..,.i ' ,
- &' .Mi /
,. . , / 1- %
' X,: .
c p\ . 7 ' j
' L gw _ . .y . - . -- : i
. . &~ -. .,
es). : i l
.d,,,r - i{
d ', [ s.
' ' ~ ' .. l ! LW$ bed
\
! 5 1
.n
,*.,- -, _ 7 ,. V i .. ..yw,.Rfv i :1, .vl'~y!s' . _
Y,:y6~ ' ~ L .l .'
. y t, r , ,
. .L - . - . ~ , _-
r . .= ' *
^' y :
l' -
~
' ....:..... ? ; - - . - i L....I r.... ...
9
.',/. , N;. /l\ / . i.[?gn/ 'i(N;,..
l i
,. v vv, '[N i
/ i j' 'M ,
-, l
; -i - ' .
--,,/ -' . ;. , ) i n, -L ; /b ) .
.-. ' l l
.o ly- .--.b k Nl ll ,., , If ;Llr 1 l
, y
~
),/
;= -
N:
- N
/
- r , ~ ._ a_ ./. s.- .n. x..s
{ s
;~,
/
r
.~'y . i. ..: 'A : - j
.m. : .h t m ,J ,lq.
s 44
/s e, a.q,,
. . m .. : /..q. ... Q g; .,;,,,:,
, 'ss, -
- , ,./
,e N g, ;
...'....) g l __. ,
p... , r, l ,.
,'.-..L,---. A $u'..
. m ---~ 4 d - -- - '
s -u . --] $.- l i' /' .;i ; x.... i ,
, 'e.
e /, ss 6 o,, s t. , ' . 3 a) - . , , <. N
\b rT '
g V N ;
^j g g
i
. ~ - .-
i p
,/ , ,,
. ~- sq ~ - .t .- e n*- ., ,
I _-
/ ,
/ . . , , . .
I ,ak J i i d'-'. ,C, . }
,, i l
l
---e.. _ . _ .
'I s ,
f _ t,
, _ t,s,s,. i_. \ r <
.- a - y
/ \
- i. .. < , .
.. t 6
I
' - ~
r.tius O 7 I w .__ _-3 l l FIGuiiE 11-3
) MILK & VEGETATIC:1.c/iMPLI ;;; i.CCATIC :S A Milk l g- Ur cadleaf Vegetafior:
7-08-85
..-r... . . ** * * ,., _ .;
... . . - .... u- . .. _.
*....- ::f.Y
.. 6 r
. - - ..-* d, 'n n .
.s 13 t,a n t.
A ~;C 1 i n r- 'oea . tcns
,....,..._.7
.. t . w ; .- . . .-- . . . . _ . ,... . . &.
.; - - l- .."-.--------~-- - - - - *
.i
. .s r......
. a.
a
;,u M. .
l ; ; ; ;.- - J
- . .Q1 .:
' ' . . , , . . i .i . i -
/ . ... . . -
.-...a.. .
l.. . .. .:. - s _- . . : -- . . . . . .
.........--_--..-.+-----.+-----.-.-..:~.,N._.. .
( . .
.-...;---.-......s.....s._..-'.....
.~ .
.i .
. _.. - :.....v.:'.
,' . . .......---.------------s--H- A -. '.. .
.i 6
--.-_.----L....,_t_.,.
.i . . . /a 4 i
.i i.
1
....a..--s.....--......_~-.-... .-...e.---.:...-.s....-b.
- i
.~
e . . L ...s.
-_. ... . . ... -__.J....
n,o i e i ,. 1.
. .i
..---...---.f.'.\...--..-.:.
t sP. -.4 s.- .
- s __ _ . - - ... . s .... -. . _ .. , .
~..--..a.---.
i
. . . 4 e.- . .. .:. .
.- I*. - -
, .I . - - - .
. 4
, , .s .I .>
s ./ w --.- :....___ '.- >-_--. . - . . . .:. 3, ,m. .. .., -_ - J ,_ _ __L. . . . . /
' ,. .-- . .-.s..,.. .
< .. .~,.3'...___.--..--'--a..-..-J--.s2-----. :
s / . . i .
.s l
me u . .
.--. , s---_a.-- . :- s. .-.
a.... - . . '... . .s, x-m, . ..* .s i
; s s
s.- . I. .
. . . .. .- . s _-
._______e .
m ____
. .,s.,.._,. .
<-., i,.-
.!. _,__ _ -a,..',- ,
l ' . .' ."J. . : ..r-
- y. . . .
,, i
/ - ,y , u.
;.;_./-..- _-.a.., .- . .-.A.-.'..
- b. . ,, ,. -
- m. .. 5
.i ge .
m .
, . t ,
- s. . r,
_ .i . . 1- l 9 ni/ ' - .
% . ./ ' L
,.__.-_._ .i $.:
- . . - . k ,. .
. 4...
, i, . ., .. .. ('- M. . f. s i [ ;
.. l .
iLN p.......-..- .
.. . - ~ - - . . . ....-.4 .e
, a i . . .
. .s . .
. .q .
s . - - . .
..:--u.......... ., 3 .
1
. . . m. r. 3 .
mm
.m..- ..
l
..s.-.-............,.. . . . . . . . . . ~ . .
4
., ,i
.. ........ q..... . ,
...s%. ., .. ,
.. - s . ,
i
. . - -1 . . . - - - - - .. - . . . . - . - . . . . . . . . . _ . . . . ._. ... _ . .
,........,.......s.._..
s .. 15 mi I
=^.,
;,.,....;-____., . . . . , - - - . .. . . . . ........~
,---.--.. ~.. .,. ...
.~.
. .q-_
. l-
. ,s..s __ ;--.;.-_. .... . _ _ - . - _ . , , _ .
. \ , , .
p , p.__.p.- _ . , . . . . . .-._;- - _ . i
.,~. . ..-
,. n, ,. . ,
......,._s,._, .
. . __s_ _ g,, __ ,
. s . ,,. . . .:, - - .. . ._. . ..
. . . , . , i
...s,~ ....I i
, s ,t ..
. , s .
. . . . i . - . . .. .....
. - ,.i-o..
i....J..e....... .~....a..J...., ,
. . i i . ;
. - . . ' . . . ;. . c _ _. _.
i i .b g . .i 'Ne . l ... .. . .
* * * . .x . .
t ( ; . *
;..4..,,,,,,._.. /
;-.....,.. N;.
., ,. ,e l
,..........?.
s
/
* . . ._ : . f .
- i. ..
- w. x . _ . .
g , ,{' 6
. e
--..,....,s,,;..,._-......p...
l
,....,,, , .. y--..~... ....,
.. . . ., ,. . _ _ _ ... .....,...s.. .-
- s. . , , . .
I .. . 3 , - s 4
.4
... , ( s i
..-...........e......, .
l i
?
N, .i i. . . . .; ,-- , ^ . ....~ i
- g i , ; .- -c / .
. ,i ,
i. 4
. . . .s.
..a-...
., e 3,. ,<>
t
. . s.,
--..p._~,-_.......<
. l q
j
. ,.n. g
.i l . .:.
i
. ,. i.x t.
i t, .
.[ ;
;,. p ).....,:._ _ __. .
s.
,........u, .._.a._. .
. . a_ _ _ _s. . . . . s. ...
9 TLD ___,,,u_,_..,_,_,,, A Al. P a t it'ill a t e. O rrout.ai .re ur.ien
, g g, 4) M "** "" 7 08 85
TABLE A.5-2 IIDIALATION PAUMAY FACIOR
) MIEW per uCi/M3 ADULT (RI FACIORS)
NUCLIDE D0tE LIVER T DODY TilYTOID KIDNEY LUtG GI-LLI 11 - 3 0.00E 01 1.26E 03 1.26E 03 1.26E 03 1.26E 03 1.26E 03 1.26E 03 C-14 1.82E 04 3.41E 01. 3.41E 03 3.41E 03 3.41E 03 3.41E 03 3.4LE 03 Na-24 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 P-32 1.32E 06 7.71E 04 5.01E 04 0.00E-01 0.00E-01 0.00E-01 8.64E 04 Cr-51 0.00E 010.00E 01 1.00E 02 5.95E 01 2.28E 01 1.44E 04 3.32E 03 Mn-54 0.00E 01 3.96E 04 6.30E 03 0.00E-01 9.84E 03 1.40E 06 7.74E 04 Mn-56 0.00E 01 1.24E 00 1.83E-01 0.00E-01 1.30E 00 9.44E 03 2.02E 04 Fe-55 2.46E 04 1.70E 04 3.94E 03 0.00E-01 0.00E-01 7.21E 04 6.03E 03 Fe-59 1.18E 04 2.78E 04 1.06E 04 0.00E-01 0.00E-01 1.02E 06 1.8SE 01 i l Gs ;; u.ua~ J1 1.:.2 03 Z.JiE 03 0.0CE-01 0.00E-01 9.20E OS ...._ .. ! Co-60 0.CCE 01 1.15E 04 1.48E 04 0.00E-01 0.00E-01 5.97E 06 2.85E 05 I Ni-63 4.32E 05 3.14E 04 1.45E 04 0.00E-01 0.00E-01 1.78E 05 1.3*i 64 Ni-65 1.54E 00 2.10E-01 9.12E-02 0.00E-01 0.00E-01 5.60E 03 1.23E 04 i Cu-64 0.00E 01 1.46E 00 6.15E-01 0.00E-01 4.62E 00 6.78E 03 4.90E 04 Zn-65 3.24E 04 1.03E 05 4.66E 04 0.00E-01 6.90E 04 8.64E 05 5.34E 04 i i A-44 07-08-85
TABLE A.5-2 (Cont'd) T INilALATION PAT.MAY FACIOR
/ MREM /YR uCi/M3 ADULT (RI FAC'IORS)
NUCLIDE DONE LIVER T DODY 'IIIYPDID KIDNEY WE GI-ILI Zn-69 3.38 E-02 6.51E-02 4.52E-03 0.00 E-01 4.22C-02 9.20E 02 1.63E 01 Br-83 0.00 E-01 0.00E-01 2.41E 02 0.00E-01 0.00 E-01 0.00E-01 2.32E 02 Br-84 0.00 E-01 0.00E-01 3.13E 02 0.00E-01 0.00 E-01 0.00 E-01 1.64E-03 Br-85 0.00 E-01 0.00E-01 1.28E.01 0.00 E-01 0.00E-01 0.00E-01 8.00E-15 Rb-86 0.00 E-01 1.35E 05 5.90E 04 0.00E-01 0.00 E-01 0.00 E-01 1.66E 04 Rb-88 0.00 E-01 3.87E 02 1.93E 02 0.00E-01 0.00 E-01 0.00E-01 3.34B-09 Rb-89 0.00 E-01 2.56E 02 1.70E 02 0.00E-01 0.00 E-01 0.00E-01 9.28E-12 Sr-89 3.04E 05 0.00 E-01 8.72E 03 0.00E-01 0.00 E-01 1.40E C6 3.3CE 05 Sr-90 9.92E 07 0.00E-01 6.10E 06 0.00E-01 0.00 E-01 9.60E 06 7.22E 05 Sr-91 6.19E 01 0.00E-01 2.50E 00 0.00 E-01 0.00 E-01 3.65E 04 1.91E 05 Sr-92 6.74E 00 0.00E-01 2.91E-01 0.00E-01 0.00 E-01 1.65E 04 4.30E 04 Y-90 2.C9E 03 0.00E-OL 5.61E 01 0.00E-01 0.00E-01 1.70E 05 5.06E 05
) Y-91M 2.61 E-01 0.00E-01 1.02E-02 0.00 E-01 0.00 L-01 1.92E 03 1.33E 00 Y-91 4.62E 05 0.00E-01 1.24C 04 0.00E-01 0.00 E-01 1.70C 06 3.85E 05 Y-92 1.03E 01 0.00E-01 3.02E-01 0.00E-01 0.00 E-01 1.57E 04 7.35E 04 Y-93 9.44 E 01 0.00E-01 2.61E 00 0.00E-01 0.00 E-01 4.85E 04 4.22E 05 Zr-95 1.07E 05 3.44E 04 2.33E 04 0.00E-01 5.42E 04 1.778 06 1.50E 05 Zr-97 9.68E 01 1.96E 01 9.04E 00 0.00 E-01 2.97E 01 7.87E 04 5.23E 05 i
A-45 07-08-85
1 TABLE A.5-2 (Cont '.d) 1 INIAUifION PATIMAY FACIOR l MREWYR uCi/M3 l ADULT (RI FACf0RS) MJCLIDE BONE LIVER T DODY THYPOID KIDNEY IDNG GI-LLI Nb-95 1.41E 04 7.82E 03 4.21E 03 0.00E-01 7.74E 03 5.05E 05 1.04E 05 Mo-99 0.00E-01 1.21E 02 2.30E 01 0.00E-01 2.91E 02 9.12E 04 2.48E 05 Tc-99M 1.03E-03 2.91E-03 3.70E-02 0.00E-01 4.42E-02 7.64E 02 4.16E 03 Tc-101 4.18E-05 6.02E-05 5.90E-04 0.00E-01 1.08E-03 3.99E 02 1.09E-11 Ru-103 1.53E 03 0.00E-01 6.58E 02 0.00E-01 5.83E 03 5.05E 05 1.10E 05 Ru-105 7.90E-01 0.00E-01 3.llE-01 0.00E-01 1.02E 00 1.10E 04 4.82E 04 Ru-106 6.91E 04 0.00E-01 8.72E 03 0.00E-01 1.34E 05 9.36E 06 9.12E 05 Ag-110M 1.08E 04 1.00S 04 5.94E 03 0.00E-01 1.97E 04 4.63E 06 3.02E 05 Te-125M 3.42E 03 1.58E 03 4.67E 02 1.05E 03 1.24E 04 3.14E 05 7.06E 04 Te-127 M 1.26E 04 5.77E 03 1.57E 03 3.29E 03 4.58E 04 9.60E 05 1.50E 05 Te-127 1.40E 00 6.42E-01 3.10E-01 1.06E 00 5.10E 00 6.51E 03 5.74E 04 Te-129M 9.76E 03 4.67E 03 1.5EE 03 3.44E 03 3.66E 04 1.16E 06 3.83E 05 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E 03 1.57E 02
)Te-129 Te-131M 6.99E 01 4.36E 01 2.90E 01 5.50E 01 3.09E 02 1.46E 05 5.56E 05 Te-131 1.llE-02 5.95E-03 3.59E-03 9.36E-02 4.37E-02 1.39E 03 1.84E 01 Te-132 2.60E 02 2.15E 02 1.62E 02 1.90E 02 1.46E 03 2.88E 05 5.10E 05 I-130 4.58E 03 1.34E 04 5.28E 03 1.14E 06 2.09E 04 0.00E-01 7.69E 05 I-131 2.52E 04 3.58E 04 2.05E 04 1.19E 07 6.13E 04 0.00E-01 6.28E 03 i
Ac46 07-08-85
TABLE A.5-2 (Cont'd) INIIALATION PA'ITMAY FAC'IOR MREM /YR uCi/M3 ADULT (RI FTCIORS) NUCLIDE DONE LIVER T DODY TilYFOID KIDNEY URE GI-LLI I-132 1.16E 03 3.26E 03 1.16E 03 1.14E 05 5.18E 03 0.00 E-01 4.06E 02 I-133 8.64E 03 1.48E 04 4.52E 03 2.15E 06 2.58E 04 0.00 E-01 8.88E 03 I-134 6.44E 02 1.73E 03 6.15E 02 2.98E 04 2.75E 03 0.00 E-01 1.01E 00 I-135 2.68E 03 6.98E 03 2.57E 03 4.48E 05 1.11E 04 0.00 E-01 5.25E 03 Cc-134 3.73E 05 8.48E 05 7.28E 05 0.00 E-01 2.87E 05 9.76E 04 1.04E 04 Cc-136 3.90E 04 1.46E 05 1.10E 05 0.00E-01 8.56E 04 1.20E 04 1.17E 04 Cc-137 4.78E 05 6.21E 05 4.2SE 05 0.00E-01 2.22E 05 7.52E 04 8.40E 03 Cs-138 3.31E 02 6.21E 02 3.24E 02 0.00E-01 4.80E 02 4.86E 01 1.86E-03 Ba-139 9.36 E-01 6.66E-04 2.74 E-02 0.00E-01 6.22E-04 3.76E 03 8.96E 02 Ba-140 3.90E 04 4.90E 01 2.57E 03 0.00E-01 1.67E 01 1.27E 06 2.18E 05 Ba-141 1.00 E-01 7.53 E-05 3.36E-03 0.00E-01 7.00 E-0 5 1.94E 03 1.16E-07 Ba-142 2.63 E-02 2.70E-05 1.66E-03 0.00E-01 2.29 E-05 1.19E 03 1.57E-16 La-140 3.44E 02 1.74E 02 4.58E 01 0.00E-01 0.00E-01 1.36E 05 4.58E 05
) La-142 6.83 E-01 3.10E-01 7 .72 E-02 0.00E-01 0.00E-01 6.33E 03 2.11E 03 Ce-141 1.99E 04 1.35E 04 1.53E 03 0.00E-01 6.26E 03 3.62E 05 1.20E 05 Co-143 1.86E 02 1.388 02 1.53E 01 0.00E-01 6.08E 01 7.98E 04 2.26E 05 Ce-144 3.43E 06 1.43E 06 1.84E 05 0.00E-01 8.48E 05 7.78E 06 8.16E 05 Pr-143 9.36E 03 3.75E 03 4.64E 02 0.00 E-01 2.16E 03 2.81E 05 2.00E 05 i
I 1 e A-47 07-08-35 l
T? ELF A.5-2 (Cont 'd) INilALATICri PATIMAY FICIOR MREWYR uCi/M3 IOULT (RI FACIORS) IFJCLIDE DONE LIVER T DODY TilYPOID KIDNEY I11NG GI-LLI Pr-144 3.10E-02 1.25E-02 1.53E-03 0.00E-01 7.05E-03 1.02E 03 2.15E-08 Nd-147 5.27E 03 6.10E 03 3.65E 02 0.00E-01 3.56E 03 2.21E 05 1.73E 05 W-187 8.48E 00 7.08E 00 2.48E 00 0.00E-01 0.00E-01 2.90E 04 1.55E 05 Np-239 2.30E 02 2.26E 01 1.24E 01 0.00E-01 7.00E 01 3.76E 04 1.19E 05 2 } l l 1 f i r i ..,
. 'i A-40 07-08-05
-- _. _. - - = - ._. - . - _
TABLE A.5-3 INilALATION PNIlfWAY FACIOR h' MPEWYR uCi/M3 j TEEN (RI FACIORS) , NUCLIDE BONS LIVER T DODY TilYFOID KIDNEY I11NG GI-ILI
!!-3 0.00E-01 1.27E 03 1.27E 03 1.27E 03 1.27E 03 1.27E 03 1.27E 03 i C-14 2.60E 04 4.87E 03 4.87E 03 4.87E 03 4.87E 03 4.87E 03 4.87E 03 Na-24 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1.38E 04 P-32 1.898 06 1.10E 05 7.16E 04 0.00E-01 0.00E-01 0.00E-01 9.28E 04 l Cr-51 0.00E-01 0.00E-01 1.35E 02 7.50E 01 3.07E 01 2.10E 04 3.00E 03 Mn-54 0.00E-01 5.11E 04 8.40E 03 0.00E-01 1.27E 04 1.98E 06 6.68E 04 Mn-56 0.00E-01 1.70E 00 2.52E-01 0.00E 01 1.79E 00 1.53E 04 5.74E 04 Fe-55 3.34E 04 2.38E 04 5.54E 03 0.00E 01 0.00E-01 1.24E 05 6.39E 03 Fe-59 1.59E 04 3.70E 04 1.438 04 0.00C 01 0.00E-01 1.53E 06 1.78E 05 j
Co-58 Co-60 0.00E-01 2.07E 03 0.00E-01 1.51E 04 2.78E 03 1.98E 04 0.00E 01 0.00E 01 0.00E-01 0.00E-01 1.34E 06 8.72E 06 9.52E 04 2.59E 05
/ .
Ni-63 5.80E 05 4.34E 04 1.98E 04 0.00E 01 0.00E-01 3.07E 05 1.42E 04
. . Ni-65 2.18E 00 2.93E-01 1.27E-01 0.00E 01 0.00E-01 9.36E 03 3.678 04
) Cu-64 0.00E-01 2.03E 00 8.48E-01 0.00E 01 6.41E 00 1.llE 04 6.14E 04 Zn-65 3.86E 04 1.34E 05 6.24E 04 0.00E 01 8.64E 04 1.24E 06 4.66E 04 1
Zn-69 4.83E-02 9.20E-02 6.46E-03 0.00E 01 6.02E-02 1.58E 03 2.858 02 Br-83 0.00E-01 0.00E-01 3.44E 02 0.00E 01 0.00E-01 0.00E-01 8.00E-15 Br-84 0.00E-01 0.00E-01 4.33E 02 0.00E 01 0.00E-01 0.00E-01 8.00E-15 , i l l A-49 07-08-85 1
TABLE A.5-3 (Cont 'd) IN!!ALATION PA111WAY FICIOR MREWYR uCi/M3
'IEEN (RI FACIGIG)
NUCLIDE DONE LIVER T DODY TIIYPOID KIDNEY LUNG GI-LLI Br-85 0.00E-01 0.00E-01 1.838 01 0.00E-01 0.00E-01 0.00E-01 8.00E-15 Rb-86 0.00E-01 1.908 05 8.40E 04 0.00E-01 0.00E-01 0.00E-01 1.77E 04 Rb-88 0.00E-01 5.46E 02 2.72E 02 0.00E-01 0.00E-01 0.00E-01 2.92E-05 Rb-89 0.00E-01 3.52E 02 2.33E 02 0.00E-01 0.00E-01 0.00E-01 3.38E-07 Sr-89 4.34E 05 0.00E-01 1.25E 04 0.00E-01 0.00E-01 2.42E 06 3.71E 05 Sr-90 1.08E 08 0.00E-01 6.68E 06 0.00E-01 0.00E-01 1.65E 07 7.65E 05 Sr-91 8.80E 01 0.00E-01 3.51E 00 0.00E-01 0.00E-01 6.07E 04 2.59E 05 Sr-92 9.52E 00 0.00E-01 4.06E-01 0.00E-01 0.00E-01 2.74E 04 1.19E 05 Y-90 2.98E 03 0.00E-01 8.00E 01 0.00E-01 0.00E-01 2.93E 05 5.59E 05 Y-91M 3.70E-01 0.00E-01 1.42E-02 0.00E-01 0.00E-01 3.20E 03 3.02E 01 Y-91 6.61E 05 0.00E-01 1.77E 04 0.00E-01 0.00E-01 2.94E 06 4.09E 05 Y-92 1.47E 01 0.00E-01 4.29E-01 0.00E-01 0.00E-01 2.68E 04 1.65E 05 I 1.35E 02 0.00E-01 3.72E 00 0.00E-01 0.00E-01 8.32E 04 5.798 05
)Y-93 Zr-95 1.46E 05 4.58E 04 3.15E 04 0.00E-01 6.74E 04 2.69E 06 1.49E 05 Zr-97 1.38E 02 2.72E 01 1.26E 01 0.00E-01 4.12E 01 1.30E 05 6.30E 05 Nb-95 1.86E 04 1.03E 04 5.66E 03 0.00E-01 1.00E 04 7.51E 05 9.68E 04 Mo-99 0.00E-01 1.69E 02 3.22E 01 0.00E-01 4.lle 02 1.54E 05 2.698 05 Tc-99M 1.38E-03 3.86E-03 4.99E-02 0.00E-01 5.76E-02 1.15E 03 6.13E 03 i
i l l A-50 07-08-85 I
1 TABLE A.5-3 (Cont'd) INilALATION PAUMAY FACIOR -) MREM /YR uCi/M3 TEEN (RI PACIORS) NUCLIDE DONE LIVER T IODY TIYROID KIDNEY IUNG GI-LLI Te-101 5.92E-05 8.40E-05 8.24E-04 0.00E-01 1.52 E-03 6.67E 02 8.72E-07 Ru-103 2.10E 03 0.00E-01 8.96E 02 0.00E-01 7.43E 03 7.83E 05 1.09E 05 Ru-105 1.12E 00 0.00E-01 4.34 E-01 0.00E-01 1.41E 00 1.82E 04 9.04E 04 Ru-106 9.84E 04 0.00E-01 1.24E 04 0.00E-01 1.90E 05 1.61E 07 9.608 05 Ag-110M 1.38E 04 1.31E 04 7.99E 03 0.00E-01 2.50E 04 6.75E 06 2.73E 05 Te-125M 4.88E 03 2.24E 03 6.74E 02 1.408 03 0.00 E-01 5.36E 05 7.50E 04 Te-127M 1.80E 04 8.16E 03 2.18E 03 4.38E 03 6.54E 04 1.66E 06 1.59E 05 Te-127 2.01E 00 9.12 E-01 4.42 E-01 1.42E 00 7.28E 00 1.12E 04 9.08E 01 Te-129M 1.39E 04 6.58E 03 2.25E 03 4.58E 03 5.19E 04 1.98E 06 4.05E 05 Te-129 7.10 E-02 3.38E-02 1.76 E-02 5.18E-02 2.66 E-01 3.30E 03 1.62C 03 Te-131M 9.84E 01 6.01E 01 4.20E 01 7.25E 01 4.39E 02 2.38E 05 6.21E 05 Te-131 1.58 E-02 8.32E-03 5.04E-03 1.24E-02 6.18 E-02 2.34E 03 1.51E 01 Te-132 3.60E 02 2.90E 02 2.19E 02 2.46E 02 1.95E 03 4.49E 05 4.63E 05 I-130 6.24E 03 1.79E 04 7.17E 03 1.49E 06 2.75E 04 0.00 E-01 9.12E 03 I-131 3.51E 04 4.91E 04 2.64E 04 1.46E 07 8.40E 04 0.00 E-01 6.49E 03 I-132 1.59E 03 4.38E 03 1.58E 03 1.51E 05 6.92E 03 0.00E-01 1.27E 03 I-133 1.22E 04 2.05E 04 6.22E 03 2.92E 06 3.59E 04 0.00 E-01 1.03E 04 I-134 8.88E 02 2.32E 03 8.40E 02 3.95E 04 3.66E 03 0.00E-01 2.04E 01 O A-51 07-08-85
i TABLE A.5-3 (Cont'd) INHALATION PAT!MAY FACIOR I r
} MRFN YR uCi/M3 TEEN (RI FACIORS)
NUCLIDE DONE LIVER T BODY T!!YROID KIDNEY IIRC GI-LLI l' I-135 3.708 03 9.44E 03 3.49E 03 6.21E 05 1.49E 04 0.00 E-01 6.95E 03 Cs-134 5.02E 05 1.13E 06 5.49E 05 0.00E-01 3.75E 05 1.46E 05 9.76E 03 Cc-136 5.15E 04 1.94E 05 1.37E 05 0.00E-01 1.10E 05 1.78E 04 1.09E 04 i , Cs-137 6.70E 05 8.488 05 3.11E 05 0.00E-01 3.04E 05 1.21E 05 8.48E 03 Cs-138 4.66E 02 8.56E 02 4.46E 02 0.00E-01 6.62E 02 7.87E 01 2.70E-01 Ba-139 1.34E 00 9.44E-04 3.90E-02 0.00E-01 8.88 E-04 6.46E 03 6.45E 03 Ba-140 5.47E 04 6.70E 01 3.52E 03 0.00E-01 2.28E 01 2.03E 06 2.29E 05 Ba-141 1.42 E-01 1.06E-04 4.74 E-03 0.00E-01 9.84 E-05 3.29E 03 7.46 E-04 Ba-142 3.70 E-02 3.70 E-05 2.27 E-03 0.00E-01 3.14 E-05 1.91E 03 4.79E-10 1 1 i La-140 4.79E 02 2.36E 02 6.26E 01 0.00E-01 0.00 E-01 2.14E 05 4.87E 05 i La-142 9.60 E-01 4.25E-01 1.06 E-01 0.00E-01 0.00 E-01 1.02E 04 1.2CE 04 j Ce-141 2.84 E 04 1.90E 04 2.17E 03 0.00E-01 8.88E 03 6.14E 05 1.26E 05 Cc-14 3 2.66E 02 1.94E 02 2.16E 01 0.00E-01 8.64E 01 1.30E 05 2.55E 05
- Cc-144 4.89E C6 2.02E 06 2.62E 05 0.00E-01 1.21E 06 1.34E 07 3.64E 05
; Pr-143 1.34E 04 5.31E 03 6.62E 02 0.00E-01 3.09E 03 4.03M 05 2.14E 05 i
Pr-144 4.30 E-02 1.76E-02 2.18 E-03 0.00E-01 1.01E-02 1.75C 03 2.35E-04 i Nd-147 7.86E 03 8.56E 03 5.13E 02 0.00 E-01 5.02E 03 3.72E 05 1.82E 05 W-187 1.20E 01 9.76E 00 3.43E 00 0.00E-01 0.00 E-01 4.74E 04 1.77E 05 Np-239 3.38E 02 3.19B 01 1.77E 01 0.00 E-01 1.00E 02 6.49E 04 1.32E 05 I 6 s
~. . :
, A-52 07-08-85
I T\BLE A.5-1 INHALATION PAUMAY L'ACIOR
}
MREM /YR UCi/M3 CHILD (RI EACTORS) NUCLIDE FONE LIVER T BODY THYICID KIDNEY [U'E GI-LLI H-3 0.00 E-01 1.12E 03 1.12E 03 1.12E 03 1.12E 03 1.12E 03 1.12E 03 C-14 3.59E 04 6.73E 03 6.73E 03 6.73E 03 6.73E 03 6.73E 03 6.73E 03 Na-24 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 P-32 2.60E 06 1.148 05 9.88E 04 0.00 E-01 0.00 E-01 0.00E-01 4.22E 04 l Cr-51 0.00 E-01 0.00E-01 1.54E 02 0.00 E-01 2.43E 01 1.70E 04 1.08E 03 Mn-54 0.00 E-01 4.29E 04 9.51E 03 0.00E-01 1.00E 04 1.58E 06 2.29C 04 Pn'-56 0.00 E-01 1.66E 00 3.12 E-01 0.00E-01 1.67E 00 1.31E 04 1.23E 05 e'e- 55 4.74 E C4 2.52E 04 7.77E 03 0.00 E-01 0.00 E-01 1.llE 05 2.37F 03 Fe-59 2.07 E 04 3.34E 04 1.67E 04 0.00E-01 0.00 E-01 1.27E 06 7.07E 04 Co-53 0.00 E-01 1.77E 03 3.16E 03 0.00E-01 0.00 E-01 1.11E 06 3.44E 04 Co-60 0.00 E-01 1.31E 04 2.26E 04 0.00E-01 0.00 E-01 7.07E 06 9.62E 04 N i-63 8.21E G5 4.63E 04
- 2.80E 04 0.00E-01 0.00 E-01 2.75E 05 6.33E 03 Ni-65 2.99E 00 2.96 E-01 1.64 E-01 0.00E-01 0.00E-01 8.13E 01 3.40E 04 i
Cu-64 0.00 E-01 1.998 00 1.07E 00 0.0E-01 6.03E 00 9.58E 03 3.67E 04 n-65 4.26 E 04 1.13E 05 7.03E 04 0.00 E-01 7.14E 04 9.952 05 1.62E 04 l l Z n-69 6.70E-02 9.66 E-02 8.92E-03 0.00E-01 5.85 E-02 1.42E 03 1.02E 04 Br-83 0.00 E-01 0.00E-01 4.74E 02 0.00E-01 0.00 E-01 0.00E-01 3.70E-15 Br-84 0.COE-01 0.00 E-01 5.43E 02 0.00 E-01 0.00E-01 0.00E-01 3.70 E-15 i, i 4
, A-53 07-08-85
TABLE A.5-4 (Cont'd) g IMIALATION PNI1?MAY WCIOR J MREM /YR uCi/M3 OIILD (RI FACTORS) NUCLIDE BONE LIVER T DODY 'IIIYROID KIDNEY IIRC GI-LLI Br-85 0.00 E-01 0.00E-01 2.53E 01 0.00E-01 0.00 E-01 0.00E-01 3.70E-15 Rb-86 0.00 E-01 1.98E 05 1.14E 05 0.00E-01 0.00 E-01 0.00E-01 7.99E 03 Rb-88 0.00 E-01 5.62E 02 3.66E 02 0.00E-01 0.00 E-01 0.00E-01 1.72E 01 M)-89 0.00 E-01 3.45E 02 2.90E 02 0.00E-01 0.00 E-01 0.00E-01 1.89E 00 Sr-85 5.99E 05 0.00E-01 1.72E 04 0.00E-01 0.00 E-01 2.16E 06 1.67E 05 Sr-90 1.01E 08 0.00E-01 6.44E 06 0.00E-01 0.00 E-01 1.48E 07 3.43E 05 Sr-91 1.21E 02 0.00E-01 4.95E 00 0.00E-01 0.00 E-01 5.33E 04 1.748 05 Sr-92 1.31 E 01 0.00E-01 5.25E-01 0.00E-01 0.00 E-01 2.40E 04 2.42E 05 Y-90 4.11E 03 0.00E-01 1.llE 02 0.00E-01 0.00 E-01 2.62E 05 2.68E 05 Y-91M 5.07 E-01 0.00E-01 1.84 E-02 0.00E-01 0.00E-01 2.81E 03 1.72E 03 Y-91 9.14 E 05 0.00E-01 2.44E 04 0.00E-01 0.00 E-01 2.63E 06 1.84E 05 Y-92 2.04E 01 0.00E-01 5.81E-01 0.00E-01 0.00 E-01 2.39E 04 2.39E 05 Y-93 1.86E 02 0.00E-01 5.llE 00 0.00E-01 0.00 E-01 7.44E 04 3.89E 05 Zr-95 1.90E 05 4.198 04 3.70E 04 0.00E-01 5.968 04 2.23E 06 6.11E 04 Zr-97 1.88E 02 2.72E 01 1.60E 01 0.00E-01 3.88E 01 1.13E 05 3.51E 05 Mb-95 2.35E 04 9.ldE 03 6.55E 03 0.00 E-01 9.62E 03 6.14E 05 3.70E 04 Mo-99 0.00 E-01 1.728 02 4.25E 01 0.00E-01 3.92E 02 1.35E 05 1.27E 05 Tc-99M 1.73E-03 3.48E-03 5.77C-02 0.00E-01 5.07 E-02 9.51E 02 4. file 03 i P e ,N A-54 07-08-B5 m_ -
??3L1 A.5 t (Cont' !'
T IN!!AIATION PAT!!WAY FACIOR
) SUU2tn(R uCi/M3 CIIILD (RI FACTOPS)
NUCLIDE IONE LIVER T DODY 'llIYiOID KIDNEY IIRKi GI-LLI To-101 8.10 E-05 8.51E-05 1.08 E-03 0.00 E-01 1.45 E-03 5.858 02 1.63E 01 Ru-103 2.798 03 0.00 E-01 1.07E 03 0.00E-01 7.03E 03 6.62E 05 4.48E 04 Ru-105 1.53E 00 0.00E-01 5.55E-01 0.00 E-01 1.348 00 1.59E 04 9.95E 04 Ru-106 1.36E 05 0.00 E-01 1.69E 04 0.00E-01 1.848 05 1.43E 07 4.29E 05 Ag-110M 1.69E 04 1.148 04 9.14E 03 0.00 E-01 2.12E 04 5.48E 06 1.00E 05 Te-125M 6.73E 03 2.33E 03 9.148 02 1.92E 03 0.00 E-01 4.77E 05 3.38E 04 Te-127 M 2.49E 04 9.55E 03 3.02E 03 6.07E 03 6.36E 04 1.49E 06 7.14C 04 ! To-127 2.77E 00 9.51 E-01 6.10 E-01 1.96E 00 7.07E 00 1.00E 04 5.62E 04 Te-129M 1.92E 04 6.85E 03 3.04E 03 6.33E 03 5.03E 04 1.76E 06 1.82E 05 Te-129 9.77 E-02 3.50E-02 2.38 E-02 7.14E-02 2.57 E-01 2.93E 03 2.55E 04 Te-131M 1.34E 02 5.92E 01 5.07E 01 9.77E 01 4.00E 02 2.06E 05 3.00E 05 Te-131 2.17 E-02 8.44 E-03 6.59 E-03 1.70 E-02 5.88E-02 2.05E 03 1.33E 03 Te-132 4.81E 02 2.72E 02 2.63E 02 3.17E 02 1.77E 03 3.77E 05 1.38E 05 I-130 8.18E 03 1.64E 04 8.44E 03 1.85E 06 2.45E 04 0.00E-01 5.118 03 1-131 4.81E 04 4.81E 04 2.73E 04 1.62E 07 7.88E 04 0.00E-01 2.84E 03 I-132 2.128 03 4.07E 03 1.88E 03 1.94E 05 6.25E 03 0.00E-01 3.208 03 I-133 1.666 04 2.03E 04 7.70E 03 3.85E 06 3.38E 04 0.00 E-01 5.488 03 1-134 1.17E 03 2.16E 03 9.95E 02 5.07E 04 3.30E 03 0.00E-01 9.55E 02 j i l l l 1 , I I i i A-55 07 0g.85
TALL., A. s -4 ( 2 nt dj 3 INilALATION PA'IllWAY FACIOR
) MREM /YR uCi/M3 OlILD (RI FACIORS) tUCLIDE DONE LIVER T BODY 'ITIYPOID KIDNEY URE GI-LLI I-135 4.928 03 8.73E 03 4.14E 03 7.92E 05 1.34E 04 0.00E-01 4.448 03 Cc-134 6.51E 05 1.01E 06 2.25E 05 0.00E-01 3.30E 05 1.21E 05 3.85E 03 Cc-136 6.51E 04 1.71E 05 1.16E 05 0.00E-01 9.55E 04 1.45E 04 4.18E 03 Cs-137 9.07E 05 8.25E 05 1.2fst 05 0.00E-01 2.82E 05 1.04E 05 3.62E 03 i Cc-138 6.33E 02 8.40E 02 5.55E 02 0.00E-01 6.22E 02 6.81E 01 2.70E 02 Ba-139 1.84E 00 9.84 E-04 5.36E-02 0.00E-01 8.62E-04 5.77E 03 5.77E 04 Ba-140 7.40E 04 6.48E 01 4.33E 03 0.00E-01 2.11E 01 1.74E 06 1.023 05 Ba-141 1.96 E-01 1.09 E-04 6.36E-03 0.00E-01 9.47 E-05 2.92E 03 2.75E 02 Ba-142 4.99 E-02 3.60 E-05 2.79 E-03 0.00E-01 2.91 E-05 1.64E 03 2.749 M La-140 6.44E 02 2.25E 02 7.55E 01 0.005-01 0.00 E-01 1.83E 05 2.26E 05 La-142 1.29E 00 4.11E-01 1.29E-01 0.00E-01 0.00 E-01 8.70E 03 7.59E 04 1
Co-141 3.92E 04 1.95E 04 2.90E 03 0.00 E-01 8.55E 03 5.44E 05 5.66E 04 s Ce-143 3.66E 02 1.99E 02 2.87E 01 0.00E-01 8.36E 01 1.15E 05 1.27E 05 l Cc-144 6.77E 06 2.12E 06 3.61E 05 0.00E-01 1.17E 06 1.20E 07 3.898 05 Pr-143 1.85E 04 5.55E 03 9.14E 02 0.00E-01 3.00E 03 4.33E 05 9.73E 04 Pr-144 5.96E-02 1.03E-02 3.00 E-03 0.00 E-01 9.77 E-03 1.57C 03 1.97E 02
!;d-147 1.08E 04 8.73E 03 6.81E 02 0.00E-01 4.81E 03 3.28E 05 8.218 04 W-187 1.63E 01 9.66E 00 4.335 00 0.00E-01 0.00 E-01 4.llE 04 9.10E 04 tip-239 4.66E 02 3.34E 01 2.35E 01 0.00E-01 9.73C 01 5.818 04 6.40E 04 i
l 1 N ! A-56 07-08-85
INilALATION PNI1MAY FACIOR m) MREWYR uC1/M3 INFNTP (RI FAC1DRS) NUCLIDE DONE LIVER T DODY TIIYROID KIDNEY IIRE GI-LLI
!!-3 0.00E-01 6.47E 02 6.47E 02 6.47E 02 6.47E 02 6.47E 02 6.47E 02 C-14 2.65E 04 5.31E 03 5.31E 03 5.31E 03 5.31E 03 5.31E 03 5.31E 03 Na-24 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 P-32 2.038 06 1.12E 05 7.74E 04 0.00E-01 0.00E-01 0.00E-01 1.61E 04 Cr-51 0.00E-01 0.00 E-01 8.95E 01 5.75E 01 1.32E 01 1.288 04 3.57E 02 Mn-54 0.00E-01 2.53E 04 4.98E 03 0.00E-01 4.98E 03 1.00E 06 7.06E 03 Mn-56 0.00E-01 1.54E 00 2.21E-01 0.00E-01 1.10E 00 1.25E 04 7.17E 04 Fe-55 1.97E 04 1.17E 04 3.33E 03 0.00E-01 0.00E-01 8.69E 04 1.09E 03 Fe-59 1.36E 04 2.35E 04 9.48E 03 0.00E-01 0.00E-01 1.02E C6 2. ; 2E v .
00-58 0.00E-01 1.22E 03 1.82E 03 0.00E-01 0.00E-01 7.77E 05 1.11E 04 Co-60 0.00E-01 8.02E 03 1.18E 04 0.00E-01 0.00 E-01 4.51E 06 3.19E 04 Ni-63 3.39E 05 2.04E 04 1.16E 04 0.00E-01 0.00E-01 2.09E 05 2.42E n? Ni-65 2.39E 00 2.84E-01 1.23E-01 0.00E-01 0.00E-01 8.12E 03 5.01E 04
) Cu-64 0.00E-01 1.88E 00 7.74E-01 0.00E-01 3.988 00 9.30E 03 1.50E 04 2n-65 1.93E 04 6.26E 04 3.11E 04 0.00E-01 3.25E 04 6.47E 05 5.14E 04 2n-69 5.39E-02 9.67E-02 7.18E-03 0.00E-01 4.02E-02 1.47E 03 1.32E 04 Br-83 0.00C-01 0.00E-01 3.81E 02 0.00E-01 0.00E-01 0.00E-01 1.40E-15 Br-84 0.00E-01 0.00E-01 4.00C 02 0.00E-01 0.00E-01 0.00E-01 1.40E-15 A-57 07-08-85
TABLE A.5-5 (Cent'd) ItalAIATION PATIMAY FACIOR
) . MREM /YR uCi/M3 INFN4T (RI FACIORS)
NUCLIDE DONE LIVER T BODY Tl!YROID KIDNEY URG GI-ILI Br-85 0.00E-01 0.00E-01 2.048 01 0.00E-01 0.00R-01 0.00E-01 1.40E-15 Rb-86 0.00E-01 1.90E 05 8.32E 04 0.00E-01 0.00d-01 0.00E-01 3.04E 03 Rb-88 0.00E-01 5.57E 02 2.87E 02 0.00E-01 0.00E-01 0.00E-01 3.39E 02 Rb-89 0.00E-01 3.21E 02 2.06E 02 0.00E-01 0.00E-01 0.00E-01 6.82E 01 Sr-89 3.9dE 05 0.00E-01 1.148 04 0.00E-01 0.00E-01 2.03E 06 6.40E 04 Sr-90 4.09E 07 0.00E-01 2.59E 06 0.00E-01 0.00E-01 1.12E 07 1.31E 05 Sr-91 9.56E 01 0.00E-01 3.46E 00 0.00E-01 0.00E-01 5.26E 04 7.34E 04 Sr-92 1.05E 01 0.00E-01 3.91E-01 0.00E-01 0.00E-01 2.38E 04 1.408 05 Y-90 3.29E 03 0.00E-01 8.82C 01 0.00E-01 0.00E-01 2.69E 05 1.04E 05 Y-91M 4.07E-01 0.00E-01 1.39E-02 0.00E-01 0.00E-01 2.79E 03 2.35E 03 Y-91 5.88E 05 0.00E-01 1.57E 04 0.00-E01 0.00E-01 2.45E 06 7.03E 04 Y-92 1.64E 01 0.00E-01 4.61E-01 0.00E-01 0.00E-01 2.45E 04 1.27E 05 Y-93 1.50B 02 0.00E-01 4.07E 00 0.00E-01 0.00E-01 7.64E 04 1.67E 05
) Zr-95 1.15E 05 2.795 04 2.038 04 0.00E-01 3.11E 04 1.75E 06 2.17E 04 Zr-97 1.50E 02 2.56E 01 1.17E 01 0.00E-01 2.59C 01 1.10E 05 1.40E 05 Nb-95 1.57E 04 6.43E 03 3.73E 03 0.00E-01 4.72E 03 4.79E 05 1.27E 04 M)-99 0.00E-01 1.65E 02 3.23E 01 0.00E-01 2.65C 02 1.35E 05 4.87E 04 Tt-99M 1.40E-04 2.88E-03 3.72E-02 0.00E-01 3.llE-02 8.llE 02 2.03E 03 e
?
'ed A-58 07-08-115
-m- - _ - - . - _ , , , - - ae TABLE A.5-5 (Cont'd)
IlftlALATION PNIlf.iAY FACTOR MRFJVYR uCi/M3 INFAfTP (RI PACIORS) NUCLIDE BONE LIVER T DODY TirHOID KIDNEY Il1NG GI-ILI Tc-101 6.51E-05 8.23E-OS 8.12E-04 0.00E-01 9.79E-04 5.84E 02 8.44E 02 Ru-103 2.02E 03 0.00E-01 6.79E 02 0.00E-01 4.24E 03 5.52E 05 1.61E 04 Ru-105 1.22E 00 0.00E-01 4.10E-01 0.00E-01 8.99E-01 1.57E 04 4.84E 04 Ru-106 8.68E 04 0.00E-01 1.098 04 0.00E-01 1.07E 05 1.168 07 1.64E 05 Ag-110M 9.98E 03 7.22E 03 5.00E 03 0.00E-01 1.09E 04 3.67E 06 3.30E 04 i Tu-125M 4.76E 03 1.99E 03 6.58E 02 1.62E 03 0.00E-01 4.47E 05 1.29E 04 Te-127M 1.67E 04 6.90E 03 2.07E 03 4.87E 03 3.75E 04 1.31E 06 2.73E 04 i Te-127 2.23E 00 9.53 E-01 4.89E-01 1.85E 00 4.86E 00 1.038 04 2.44E 04 ] Te-129M 1.41E 04 6.09E 03 2.232 03 5.47E 03 3.18E 04 1.68E 06 6.90E 04
- Te-129 7.88E-02 3.47E-02 1.88E-02 6.75E-02 1.75E-01 3.00E 03 2.63E 04 1 Te-131M 1.07E 02 5.50E 01 3.63E 01 8.93E 01 2.65E 02 1.99E 05 1.19E 05 Te-131 1.74E-02 8.22E-03 5.00E-03 1.58E-02 3.99E-02 2.06E 03 8.225 03 Te-132 3.72E 02 2.37E 02 1.76E 02 2.79E 02 1.03E 03 3.40E 05 4.41E 04 I-130 6.36E 03 1.39E 04 5.57E 03 1.60E 06 1.53E 04 0.00E-01 1.99E 03 I-131 3.79E 04 4.44E 04 1.96E 04 1.48E 07 5.18E 04 0.00E-01 1.06E 03 I-132 1.698 03 3.545 03 1.26E 03 1.69E 05 3.95E 03 0.00E-01 1.90E 03 I-133 1.32E 04 1.92E 04 5.60E 03 3.56E 06 2.24E 04 0.00E-01 2.16E 03 I-134 9.21E 02 1.88E 03 6.65E 02 4.45E 04 2.098 03 0.00E-01 1.29E 03 i
j i l i i i i i l i A-59 07-08-8.c
c . TNILE A.5-5 (Cent'd) 3 IhE\LATION PAUMAY FAC10R J MREWYR uCi/M3 INFANT (RI FACIORS) hUCLIDE BONE LIVER T BODY TlYIOID KIDNEY LIR G GI-LLI I-135 3.86E 03 7.60E 03 2.77E 03 6.96E 05 8.47E 03 0.00 E-01 1.83E 03 Cs-134 3.96E 05 7.03E 05 7.45E 04 0.00E-01 1.90E 05 7.97E 04 1.33E 03 Cs-136 4.83E 04 1.35E 05 5.29E 04 0.00E-01 5.64E 04 1.18E 04 1.43E 03 Cs-137 5.49E 05 6.12E 05 4.55E 04 0.00E-01 1.72E 05 7.13E 04 1.33E 03 Cs-138 5.05E 02 7.81E 02 3.98E 02 0.00E-01 4.10E 02 6.54E 01 8.76E 02 Ba-139 1.48E 00 9.84 E-04 4.30E-02 0.00 E-01 5.92 E-04 5.95E 03 5.10E 04 Ba-140 5.60E 04 5.60E 01 2.90E 03 0.00E-01 1.34E 01 1.60C 06 3.84E 04 Sa-141 1.57 E-01 1.08 E-04 4.97 E-03 0.00 E-01 6.50 E-05 2.'97E 03 4.75E 03 Ba-142 3.93 E-02 3.30E-05 1.96E-03 0.00E-01 1.90 E-05 1.55E 03 6.93E 02 La-140 5.05E 02 2.00E 02 5.15E 01 0.00 E-01 0.00 E-01 1.68E 05 8.48E 04 La-142 1.03E 00 3.77E-01 9.04 E-02 0.00E-01 0.00 E-01 8.22E 03 5.95E 04 Ce-141 2.77E 04 1.67E 04 1.99E 03 0.00E-01 5.25E 03 5.17E 05 2.16E 04 g Ce-143 2.93E 02 1.93E 02 2.21E 01 0.00E-01 5.64 E 01 1.16E 05 4.97E G4
/ Co-144 3.19E 06 1.21E 06 1.76E 05 0.00 E-01 5.38E 05 9.84E 06 1.48E 05 Pr-143 1.40E 04 5.24E 03 6.99E 02 0.00E-01 1.97E 03 4.33E 05 3.72E 04 P r-144 4.79 E-02 1.85 E-02 2.41E-03 0.00E-01 6.72 E-03 1.61E 03 4.28E 03 Nd-147 7.94E 03 8.13E 03 5.00E 02 0.00E-01 3.15E 03 3.22E 05 3.12E 04 W-187 1.30E 01 9.02E 00 3.12E 00 0.00E-01 0.00 E-01 3.96E 05 3.56E 04 ,
NP-239 3.71E 02 3.32E 01 1.88E 01 0.00E-01 6.62E 01 5.95E 04 2.49E 04 l l l s. A-60 07-08-85
TABLE A.5-6 GRSS-CGi-MIM PATIMAY FACER M2 ,MRC4/YR PER uCi/sec ADULT (RI FACIORS) NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI H-3 0.00 E-01 7.63E 02 7.63E 02 7.63E 02 7.63E 02 7.63E 02 7.63E 02 C-14 2.63E 08 5.27E 07 5.27E 07 5.27E 07 5.27E 07 5.27E 07 5.27E 07 Na-24 2.44E 06 2.44E 06 2.44E 06 2.44E 06 2.44E 06 2.44E 06 2.44E 06 P-32 1.71E 10 1.06E 09 6.60E 08 0.00E-01 0.00E-01 0. 00E-01 1.92E 09 Cr-51 0.00E-01 0.00E-01 2.86E 04 0.00E-01 6.30E 03 3.79E 04 7.198 06 Mn-54 0.00 E-01 8.41E 06 1.61E 06 0.00 E-01 0.00E-01 0.00E-01 2.58E 07 Mn-56 0.00E-01 4.16E-03 7.38E-04 0.00E-01 5.28E-03 0.00E-01 1.33E-01 Fe-55 2.51E 07 1.73E 07 4.04E 06 0.00E-01 0.00E-01 9.67E 06 9.95E 06 Fe-59 2.97E 07 6.98E 07 2.68E 07 0.00E-01 0.00 E-01 1.95E 07 2.33E 08 C0-58 0.00E-01 4.71E 06 1.06E 07 0.00E-01 0.00E-01 0.00E-01 9.56E 07 Co-60 0.00E-01 1.64E 07 3.62E 07 0.00E-01 0.00E-01 0.00E-01 3.08E 08 Ni-63 6.73E 09 4.71E 08 2.26E 08 0.00E-01 0.00E-01 0.00E-01 9.73E 07 Ni-65 4.63E-01 6.02E-02 2.75E-02 0.00E-01 0.00E-01 0.00E-01 1.53E 00
) Co-64 0.00E-01 2.39E 04 1.12E 04 0.00E-01 6.02E 04 0.00E-01 2.03E 06 Zn-65 1.37E 09 4.37E 09 1.97E 09 0.00E-01 2.92E 09 0.00E-ul 2.75E 09 Zn-69 5.22E-12 9.99E-12 6.95 E-13 0.00E-01 6.49E-12 0.00E-01 1.50E-12 Br-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01
.l l
1 l l l l l l A-61 07-08-85 1 i
TABLE A.5-6 (Cont'd) GRASS-CGi-MILK PAT!WAY FAC'IOR
) M2 MREM /YR PER uCi/sec ADULT (RI EAC'IORS)
NUCLIDE EONE LIVER T BODY TIIYROID KIDNEY LUNG GI-LLI Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 2.59E 09 1.21E 09 0.00E-01 0.00E-01 0.00E-01 5.12E 08 Rb-88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Sr-89 1.45E 09 0.00E-01 4.16E 07 0.00E-01 0.00 E-01 0.00E-01 2.33E 08 Sr-90 4.68E 10 0.00E-01 1.15E 10 0.00E-01 0.00E-01 0.00E-01 1.35E 09 Sr-91 2.87E 04 0.00E-01 1.16E 03 0.00E-01 0.00E-01 0.00E-01 1.37E 05 Sr-92 4.90E-01 0.00E-01 2.12E-02 0.00E-01 0.00E-01 0.00E-01 9.70E 00 Y-90 7.07E 01 0.00E-01 1.90E 00 0.00E-01 0.00E-01 0.00E-01 7.50E 05 Y-91M 6.03E-20 0.00E-01 2.34E-21 0.00E-01 0.00E-01 0.00E-01 1.77 E-19 Y-91 8.59E 03 0.00E-01 2.30E 02 0.00E-01 0.00E-01 0.00E-01 4.73E 06 Y-92 5.59E-05 0.00E-01 1.63E-06 0.00E-01 0.00E-01 0.00 E-01 9.79E-01 Y-93 2.33E-01 0.00 E-01 6.44E-03 $.00E-01 0.00E-01 0.00E-01 7.39E 03 Zr-95 9.44E 02 3.03E 02 2.05E 02 0.00E-01 4.75E 02 0.00E-01 9.59E 05 Zr-97 4.33E-01 8.75E-05 4.00E-02 0.00 E-01 1.32E-01 0.00E-01 2.71E 04 Nb-95 8.26E 04 4.59E 04 2.47E 04 0.00E-01 4.54E 04 0.00E-01 2.79E 08 Mo-99 0.00E-01 2.48E 07 4.71E 06 0.00E-01 5.61E 07 0.00E-01 5.74E 07 Tc-99M 3.33E 00 9.40E 00 1.20E 02 0.00E-01* 1.43E 02 4.60E 00 5.56E 03 l A-62 07-08-85
- - - - - . - , . ~ . - - _ _
TABLE A.5-6 (Cont'd) GRASS-COA-MILK PNUMAY FACIOR
) M2 ,MRE*4/YR PER uCi/see ADULT (RI FACDORS)
NUCLIDE BONE LIVER T DCOY 'I11YPOID KIDNEY LCC GI-LLI Tc-101 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Ru-103 1.02E 03 0.00E-01 4.38E 02 0.00E-01 3.R8E 03 0.00E-01 1.19E 05 Ru-105 8.58 E-04 0.00 E-01 3.39E-04 0.00E-01 1.llE-02 0.00 E-01 5.25E-01 , 1 Ru-106 2.04E 04 0.00E-01 2.58E 03 0.00E-01 3.94E 04 0.00E-01 1.32E 06 Ag-110M 5.82E 07 5.39E 07 3.20E 07 0.00E-01 1.06E 08 0.00 E-01 2.20E 10 Te-125M 1.63E 07 5.90E 06 2.18E 06 4.90E 06 6.63E 07 0.00E-01 6.50E 07 To-127M 4.58E 07 1.64E 07 5.53E 06 1.17E 07 1.86E 08 0.00 E-01 1.54E 08 Te-127 6.54E 02 2.35E 02 1.41E 02 4.84E 02 2.66E 03 0.00E-01 5.16E 04 Te-129M 6.02E 07 2.25E 07 9.53E 06 2.07E 07 2.51E 08 0.00E-01 3.03E 08 Te-129 2.54 E-10 1.07E-10 6.29E-11 2.13E-10 1.19E-09 0.00E-01 2.14 E . Te-131M 3.61E 05 1.77E 05 1.47E 05 2.80E 05 1.79E 06 0.00E-01 1.73E 07 Te-131 3.67 E-33 1.53E-33 1.16E-33 3.01E-33 1.61E-32 0.00E-01 0.00E-01 Te-132 2.40E C6 1.55E C6 1.46E 06 1.72E 06 1.50E 07 0.00E-01 7.35E 07
) I-130 4.20E 05 1.24E 06 4.89E 05 1.05E 08 1.94E 06 0.00 E-01 1.07E C6 I-131 2.96E 03 4.24E 08 2.43E 08 1.39E 11 7.26E 08 0.00E-01 1.12E 08 I-132 1.65 E-01 4.41E-01 1.54 E-01 1.54E 01 7.02 E-01 0.00E-01 8.28E-02 I-133 3.87E C6 6.73E 06 2.05E 06 9.90E 08 1.18E 07 0.00E-01 6.05E 06 I-134 2.03 E-12 5.52E-12 1.98 E-12 9.57 E-ll 8.78 E-12 0.00E-01 4.81E-15 A-63 07-08-85
TN3LE A.5-6 (Cont'd) GRASS-CCW-MILK PASMAY FAC'IOR
) q2,MREWYR PER uCi/sec ADULT (RI FICIORS) 1 tUCLIDE BONE LIVER T DODY TIYROID KIDNEY LUNG GI-LLI I-135 1.29E 04 3.37E 04 1.24E 04 2.22E 06 5.40E 04 0.00E-01 3.80E 04 Cs-134 5.65E 09 1.35E 10 1.10E 10 0.00E-01 4.35E 09 1.45E 09 2.35E 08 Cs-136 2.61E 08 1.03E 09 7.42E 08 0.00E-01 5.73E 08 7.86E 07 1.17E 08 Cs-137 7.38E 09 1.01E 10 6.61E 09 0.00 E-01 3.43E 09 1.14E 09 1.95E 08 Cs-138 9.16 E-24 1.81E-23 8.97 E-24 0.00E-01 1.33E-23 1.31E-24 7.72E-29 Ba-139 4.56 E-08 3.25E-ll 1.34 E-09 0.00E-01 3.04 E-ll 1.84E-ll 8.09E-08 Ba-140 2.69E 07 3.38E 04 1.76E 06 0.00E-01 1.15E 04 1.93E 04 5.54E 07 Ba-141 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Ba-142 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 La-140 4.52E 00 2.2SE 00 6.02E-01 0.00E-01 0.00 E-01 0.00E-01 1.67E C5 La-142 9.39 E-12 4.27 E-12 1.06 E-12 0.00E-01 0.00 E-01 0.00E-01 3.12E-08 Ce-141 4.84E 03 3.28E 03 3.72E 02 0.00E-01 1.52E 03 0.00E-01 1.25E 07 Ce-143 4.16E 01 3.07E 04 3.40E 00 0.00E-01 1.35E 01 0.00E-01 1.15E 06 Ce-144 3.58E 05 1.50E 05 1.92E 04 0.00E-01 8.87E 04 0.00E-01 1.21E 08 Pr-143 1.58E 02 6.33E 01 7.83E 00 0.00E-01 3.66E 01 0.00E-01 6.92E 05 Pr-144 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Nd-147 9.46E 01 1.098 02 6.55E 00 0.00E-01 6.40E 01 0.00E-01 5.25E 05 W-187 6.56E 03 5.49E 03 1.92E 03 0.00E-01 0.00 E-01 0.00E-01 1.80E 06 NP-239 3.67 E 00 3.61 E-01 1.99 E-01 0.00 E-01 1.13E 00 0.00E-01 7.41E 04 I._
A-64 07-08-85
TABLE A.5-7 GR/LSS-CXH1 ILK PA'UlWAY FALTR ') M2 .MREWYR PER uCi/sec TEEN (RI FAC'ICRS) NUCLIDE BONE LIVER T BODY TilYROID KIDNEY LUNG GI-LLI 11 - 3 0.00E-01 9.94E 02 9.94E 02 9.94E 02 9.94E 02 9.94E 02 9.94E 02 C-14 4.86E 08 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 Na-24 4.26E 06 4.26E 06 4.26E 06 4.26E 06 4.26E 06 4.26E 06 4.26E 06 P-32 3.15E 10 1.95E 09 1.22E 09 0.00E-01 0.00E-01 0.00E-01 2.65E 09 Cr-51 0.00E-01 0.00E-01 4.99E 04 2.77E 04 1.09E 04 7.13E 04 8.39E 06 Mn-54 0.00E-01 1.40E 07 2.78E 06 0.00E-01 4.18E 06 0.00E-01 2.87E 07 Mn-56 0.00E-01 7.37E-03 1.31E-03 0.00E-01 9.33E-03 0.00E-01 4.85E-01 Fe-55 4.45E 07 3.16E 07 7.36E 06 0.00E-01 0.00E-01 2.00E 07 1.37E 07 Fe-59 5.18E 07 1.21E 08 4.67E 07 0.00E-01 0.00E-01 3.81E 07 2.86E 08 Co-58 0.00E-01 7.94E 06 1.83E 07 0.00E-01 0.00E-01 0.00E-01 1.09E CS Co-60 0.00E-01 2.78E 07 6.26E 07 0.00E-01 0.00E-01 0.00E-01 3.62E 08 Ni-63 1.18E 10 8.35E 08 4.01E 08 0.00E-01 0.00E-01 0.00E-01 1.33E 08 Ni-65 8.48E-01 1.08E-01 4.94E-02 0.00E-01 0.00E-01 0.00E-01 5.88E 00 Co-64 0.00E-01 4.25E 04 2.00E 04 0.00E-01 1.08E 05 0.00E-01 3.30E 06 Zn-65 2.11E 09 7.31E 09 3.41E 09 0.00E-01 4.68E 09 0.00E-01 3.10E 09 Zn-69 9.62E-12 1.83E-11 1.28E-12 0.00E-01 1.20E-11 0.00E-01 3.38E-11 Br-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.006-01 0.00E-01 0.00E-01 A-65 07-08-85
TleLE A.5-7 (Cont' d) GRASS-CQi-MILK PA'ITMAY FAC1DR I M2 , MREM /YR PER uCi/see TEEN (RI PACIORS) NUCLIDE BONE LIVER T BODY TilYFOID KIDNEY IIRC GI-LLI Br-35 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Pb-86 0.00 E-01 4.73E 09 2.22E 09 0.00E-01 0.00 E-01 0.00E-01 7.00E 08 Rb-88 0.00 E-01 0.00E-01 0.00 E-01 0.00 E-01 0.00 E-01 0.00E-01 0.00E-01 Pb-39 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Sr-89 2.67E 09 0.00E-01 7.66E 07 0.00E-01 0.00 E-01 0.00E-01 3.19E 08 Sr-90 6.61E 10 0.00E-01 1.63E 10 0.00E-01 0.00 E-01 0.00E-01 1.86E 09 Sr-91 5.27E 04 0.00E-01 2.10E 03 0.00E-01 0.00 E-01 0.00E-01 2.39E 05 Sr-92 8.95 E-01 0.00E-01 3.82 E-02 0.00E-01 0.00 E-01 0.00E-01 2.28E 01 Y-90 1.30E 02 0.00 E-01 3.50E 00 0.00E-01 0.00 E-01 0.00E-01 1.07E 06 Y-91M 1.llE-19 0.00 E-01 4.22E-21 0.00E-01 0.00 E-01 0.00E-01 5.22E-18 Y-91 1.5S E 04 0.00E-01 4.24E 02 0.00E-01 0.00 E-01 0.00E-01 6.4RE 06 Y-92 1.03 E-04 0.00E-01 2.99E-06 0.00E-01 0.00 E-01 0.00E-01 2.83E 00 Y-93 4. 30 E-01 0.00E-01 1.18E-02 0.00E 0.00 E-01 0.00E-01 1.31E 04 Zr-95 1.65E G3 5.21E 02 3.58E 02 0.00E-01 7.65E 02 0.00 E-01 1.20E 06 Zr-97 7 .89 E-01 1.56E-01 7.19 E-02 0.00E-01 2.37 E-01 0.00 E-01 4.23E 04 Nb-95 1.41E 05 7.81E 04 4.30E 04 0.00E-01 7.57E 04 0.00 E-01 3.34E 08 Mc>-99 0.00 E-01 4.47E 07 8.53E 06 0.00E-01 1.02E 08 0.00 E-01 8.01E 07 Tc-99M 5.77 E 00 1.61E 01 2.08E 02 0.00E-01 2.40E 02 8.93E 00 1.06E 04 g A-66 07-08-85
TAFLE A.5-7 i Ccnt' S GRASS-C04-MILK PADlWAY FACTOR M2 , MREM /YR PER uCi/sec TEEN (RI PACIOR3) NUCLIDE BCNE LIVER T BODY TlYEDID KIDNEY IITNG GI-LLI Tc-101 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Ru-103 1.81E 03 0.00E-01 7.74E 02 0.00E-01 6.38E 03 0.00 E-01 1.51E 05 Ru-105 1.57 E-03 0.00E-01 6.08 E-04 0.00E-01 1.98 E-02 0.00E-01 1.27E 00 Ra-106 3.75E 04 0.00E-01 4.73E 03 0.00E-01 7.23E 04 0.00E-01 1.80E 06 Ag-110M 9.63E 07 9.llE 07 5.54E 07 0.00E-01 1.74E 08 0.00E-01 2.56E 10 c. Te-125M 3.00E 07 1.08E 07 4.02E 06 8.39E 06 0.00 E-01 0.00E-01 8.86E 07 Te-127M 8.44E 07 2.99E 07 1.00E 07 2.01E 07 3.42E 08 0.00E-01 2.10E 08 Te-127 1.21E 03 4.29E 02 2.61E 02 8.36E 02 4.91E 03 0.00E-01 9.35E 04 Te-129M 1.10E 08 4.09E 07 1.74E 07 3.55E 07 4.61E 08 0.00E-01 4.13E 08 Te-129 5.23 E-10 1.95E-10 1.27E-10 3.74E-10 2.20E-09 0.00E-01 2.86E-09 Te-131M 6.57E 05 3.15E 05 2.63E 05 4.74E 05 3.29E 06 0.00 E-01 2.53E 07 Te-131 6.70 E-33 2.76 E-33 2.09E-33 5.16E-33 2.93 E-32 0.00E-01 5.50E-34 4.29E C6 2.72E 06 2.56E 06 2.87E 06 2.61E 07 0.00E-01 8.61E 07
) Te-132 I-130 7.39E 05 2.14E 06 8.54E 05 1.74E 08 3.26E 06 0.00E-01 1.64E 06 I-131 5.37E 08 7.52E 08 4.04E 08 2.20E 11 1.30E 09 0.00E-01 1.49E 08 I-132 2.92 E-01 7.65E-01 2.74 E-01 2.58E 01 1.20E 00 0.00E-01 3.33E-01 I-133 7.07E 06 1.20E 07 3.66E 06 1.67E 09 2.10E 07 0.00E-01 9.0RE 06 I-134 3.61 E-12 4.58E-12 3.44E-12 1.60 E-10 1.51E-ll 0.00E-01 1.26E-13 '
' e% A-67 07-08-85
TABLE A.5-7 (Cont'd) GRASS-COV-MIIK PAT:MAY FtTIOR
) [4% MREW YR PER uCi/sec
'IEEN (RI FACTORS)
NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI I-135 2.28E 04 5.88E 04 2.18E 04 3.78E 06 9.28E 04 0.00E-01 6.51E 04 Cs-134 9.82E 09 2.31E 10 1.07E 10 0.00E-01 7.34E 09 2.80E 09 2.87E 08 Cs-136 4.44E 08 1.75E 09 1.17E 09 0.00E-01 9.52E 08 1.50E 08 1.41E 08 Cs-137 1.34E 10 1.78E 10 6.20E 09 0.00E-01 6.06E 09 2.35E 09 2.53E 08 Cs-138 1.66 E-23 3.19E-23 1.60E-23 0.00E-01 2.36E-23 2.74E-24 1.45E-26 Ba-139 8.44E-08 5.94E-11 2.46E-09 0.00E-01 5.60E-11 4.09E-ll 7.53E-07 Ba-140 4.85E 07 5.95E 04 3.13E 06 0.00E-01 2.02E 04 4.00E 04 7.49E 07 Ba-141 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 aa-142 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 La-140 8.12E 00 3.99E 00 1.06E 00 0.00E-01 0.00 E-01 0.00E-01 2.29E 05 La-142 1.69E-ll 7.52E-12 1.87E-12 0.00E-01 0.00E-01 0.00E-01 2.29 E-07 Ce-141 8.88E 03 5.93E 03 6.81E 02 0.00E-01 2.79E 03 0.00E-01 1.70E 07 Ce-143 7.64E 01 5.56E 04 6.21E 00 0.00E-01 2.49E 01 0.00E-01 1.67E 06
) Ce-144 6.58E 05 2.72E 05 3.54E 04 0.00E-01 1.63E 05 0.00E-01 1.66E 08 Pr-143 2.90E 02 1.16E 02 1.44E 01 0.00E-01 6.73E 01 0.00E-01 9.55E 05 .
Pr-144 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 Sd-147 1.82E 02 1.98E 02 1.19E 01 0.00E-01 1.16E 02 0.G0E-01 7.15E 05 W-187 1.20E 04 9.78E 03 3.43E 03 0.00 E-01 0.00E-01 0.00E-01 2.65E 06 Np-239 7.01E 00 6.61E-01 3.67E-01 0.00E-01 2.07E 00 0.00E-01 1.06E 05 1 ) A-68 07-08-85 1
TABLE A.5-8
) GRMiS-CCW-MILK PAT!MAY FACTOR M2 .,MFDVIR PER uCi/sec CliILD (RI FACTORS)
NUCLIDE EONE LIVER T BC07 111YROID KIDNEY IIRU GI-LLI H-3 0.00 E-01 1.57E 03 1.57E 03 1.575 03 1.57E 03 1.57E 03 1.57E 03 C-14 1.19E 09 2.39E 08 2.39E 08 2.39E 08 2.39E 08 2.39E 08 2.39E 08 Na-24 8.86E 06 8.86E 06 8.86E 06 8.86E 06 8.86E 06 8.86E 06 8.86E 06 P-32 7.77E 10 3.64E 09 3.00E 09 0.00 E-01 0.00 E-01 0.00E-01 2.15E 09 Cr-51 0.0 E-01 0.00E-01 1.02E 05 5.65E 04 1.54E 04 1.03E 05 5.40E 06 Mn-54 0.00 E-01 2.10E 07 5.59E 06 0.00E-01 5.88E 06 0.00E-01 1.76E 07 Mn-56 0.C0E-01 1.29E-02 2.90 E-03 0.00 E-01 1.56 E-02 0.00E-01 1.86E 00 Fe-55 1.12E 08 5.93 E07 1.84E 07 0.00E-01 0.00 E-01 3.35E 07 1.10E 07 Fe-59 1.20E 08 1.94E 08 9.69E 07 0.00E-01 0.00 E-01 5.645 07 2.02E 08 Co -58 0.CC E-01 1.21E 07 3.71E 07 0.00E-01 0.00 E-01 0.00E-01 7.07E 07 C&60 0.00 E-01 4.32E 07 1.27E 08 0.00E-01 0.00 E-01 0.00E-01 2.39E 08 Ni-63 2.96 E 10 1.59E 09 1.01E 09 0.00E-01 0.00 E-01 0.00E-01 1.07E 03
) Ni-65 2.07 E 00 1.95E-01 1.14 E-01 0.00 E-01 0.00 E-01 0.00E-01 2.39E 01 Cu-64 0.00 E-01 7.47E 04 4.51E 04 0.00E-01 1.81E n5 0.00E-01 3.51E 06 2n-65 4.13 E 09 1.10E 10 6.85E 09 0.00E-01 6.94E 09 0.00E-01 1.93E 09 Zn-69 2.36 E-ll 3.4 2E-ll 3.16 E-12 0.00E-01 2.07 E-ll 0.00E-01 2.15E-09 Br-83 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Br-84 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01
'4 A-69 07-08-85
,,.y CRASS-CLM-MIIK PA'IWAY FACICR
) M2 , MREM /YR PER uCi/sec QIID (RI FACIORS) NUCLIEE BONE LIVER T BODY THYPOID KIDNEY LU!E GI-LLI Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 8.77E 09 5.39E 09 0.00E-01 0.00E-01 0.00E-01 5.64E 08 Rb-88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 Sr-89 6.62E 09 0.00E-01 1.89E 08 0.00E-01 0.00 E-01 0.00E-01 Sr-90 1.12E 11 0.00E-01 2.83E 10 0.002-01 0.00E-01 0:00E-01 2.56EOJ) 1.50E m Sr-91 1.29E 05 0.00E-01 4.88E 03 0.00E-01 0.00E-01 0.00E-01 2.85E 05 Sr-92 2.19E 00 0.0GE-01 8.78E-02 0.00E-01 0.00E-01 0.00E-01 4.15E 01
- - :...- s. .. .. u.:-- . '. 3. C T '- L. 3.Cr.
Y-91M 2.70E-19 0.00E-01 9.82E-21 0.00E-01 0.00E-01 0.00E-01 5.29E-16 Y-91 3.90E 04 0.00E-01 1.04E 01 0.00E-01 0.00 E-01 0.00E-01 5.20E 06 Y-92 2.54E-04 0.00E-01 7.26E-06 0.00E-01 0.00E-01 0.00E-01 7.33E 00 Y-93 1.06E 00 0.00E-01 2.90E-02 0.00E-01 0.00E-01 0.00E-01 1.57E 04 2r-95 3.838 03 8.43E 02 7.50E 02 0.00E-01 1.21E 03 0.00E-01 8.79E 05 Zr-97 1.92E 00 2.77E-01 1.64E-01 0.00E-01 3.98E-01 0.00E-01 4.20E 04 No-95 3.16E 0 5 1.245 05 8.85E 04 0.00E-01 1.16E 05 0.00E-01 2.29E 08 Mo-99 0.00E-01 8.14E 07 2.01E 07 0.00E-01 1.74E 08 0.00E-01 6.73E 07 Tc-99M 1.32E 01 2.59E 01 4.30E 02 0.00E-01 3.77E 02 1.325 01 1.48E 04 l l e l A-70 07-08-85
, . , ~ - .,%
GiniS-CCW-MIIK PA'IlfWAY FACIOR
} M2 MREM /YR PER uCi/see QiIID (RI PACIORS)
NUCLIDE BCNE LIVER T BODY TliYROID KIDNEY IENG GI-LLI Tc-101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ru-103 4.28E 03 ; 0.00E-01 1.65E 03 0.00E-01 1.08E 04 0.00E-01 1.llE 05 Ru-105 3.83E-03 0.00E-01 1.39E-03 0.00E-01 3.36E-02 0.00E-01 2.50E 00 Ru-106 9.24E 04 0.00E-01 1.15E 04 0.00E-01 1.25E 05 0.00E-01 1.44E 06 Ag-110M 2.09E 08 1.41E 08 1.13E 08 0.00E-01 2.63E 08 0.00E-01 1.68E 10 Te-125M 7.38E 07 2.00E 07 9.84E 06 2.07E 07 0.00E-01 0.00E-01 7.12E 07 Te-127M 2.08E 08 5.60E 07 2.47E 07 4.97E 07 5.93E 08 0.C0E-01 1.68E 08 Te-127 2.98E 03 8.03E 02 6.39E 02 2.06E 03 8.47E 03 0.00E-01 1.16E 05
"' 2 '. :? *' 2 . ' 'l " ~.5r^~ 2 . ; r ^, ' 3.7 2 07 7.97E c' 3. .:c m 3.31E v; i Te-129 1.29E-09 3.60E-10 3.06E-10 9.21E-10 3.78E-09 0.00E-01 8.03E-08 Te-131M 1.60E 06 5.53E 05 5.89E 05 1.14E 06 5.36E 06 0.00E-01 2.24E 07 Te-131 1.64E-32 ~5.01E-33 4.89E-33 1.26E-32 4.97E-32 0.00E-01 8.64E-32 Te-132 1.02E 07 4.54E 06 5.48E 06 6.61E 06 4.21E 07 0.00E-01 4.57E 07
) I-130 1.73E 06 3.49E 06 1.80E 06 3.85E 08 5.22E 06 0.00E-01 1.63E 06 I-131 1.30E 09 1.31E 09 7.45E 08 4.33E 11 2.15E 09 0.00E-01 1.17E 08 I-132 6.91E-01 1.27E 00 5.84E-01 5.89E 01 1.94E 00 0.00E-01 1.498 00 1-133 1.72E 07 2.12E 07 8.04E 06 3.95E 09 3.54E 07 0.00E-01 8.56E 06 I-134 8.55E-12 1.59E-ll 7.31E-12 3.65E-10 2.43E-ll 0.00 E-01 1.05E-ll 4
I "s A-71 07-08-85
.-, - . _ . _ - . _ . _ . . - - , , _ , , , . , . _ . - . _ - - - , . _ _ _ __ _r.__,_-__m-r_, _ . . . . . , , _ , _ , _ . ,
GRASS-COW-MIIK PA'I1MAY FACIOR
) PhMREWYR PER uCi/sec GIIID (RI FACIORS)
NUCLIDE BONE LIVER T DODY THYROID KIDNEY LUNG GI-ILI I-135 5.41E 04 9.73E 04 4.60E 04 8.62E 06 1.498 05 0.00E-01 7.41E 04 ; Cs-134 2.27E 10 3.72E 10 7.84E 09 0.00E-01 1.15E 10 4.13E 09 2.00E 08 ) Cs-136 1.00E 09 2.76E 09 1.78E 09 0.00E-01 1.47E 09 2.19E 08 9.69E 07 Cs-137 3.22E 10 3.09E 10 4.55E 09 0.00E-01 1.01E 10 3.62E 09 1.93E 08 ) Cs-138 4.03E-23 5.60E-23 3.55E-23 0.00E-01 3.94E-23 4.24E-24 2.58E-23 ; Ba-139 2.07E-07 1.11E-10 6.01E-09 0.00E-01 9.67E-11 6.51E-ll 1.20E-05 3 Ba-140 1.17E 08 1.03E 05 6.84E 06 0.00E-01 3.34E 04 6.12E 04 5.94E 07 Ba-141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i Ba-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 La-140 1.94E 01 6.80E 00 2.29E 00 0.00E-01 0.00E-01 0.00E-01 1.89E 05 : La-142 4.09E-11 1.30E-ll 4.08E-12 0.00E-01 0.00E-01 0.00E-01 2.58E-06 t Ce-141 2.19E 04 1.09E 04 1.62E 03 0.00E-01 4.78E 03 0.00E-01 1.36E 07 ;
, Ce-143 1.88E 02 1.02E 05 1.47E 01 0.00E-01 4.27E 01 0.00E-01 1.49E 06 -
Ce-144 1.62E 06 5.09E 05 8.66E 04 0.00E-01 2.82E 05 0.00E-01 1.33E 08 Pr-143 7.18E 02 2.16E 02 3.56E 01 0.00E-01 1.17E 02 0.00E-01 7.75E 05 Pr-144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Nd-147 4.47E 02 3.62E 02 2.80E 01 0.00E-01 1.99E 02 0.00E-01 5.73E 05 : W-187 2.91E 04 1.72E 04 7.73E 03 0.00E-01 0.00E-01 0.00E-01 2.42E 06 ; Np-239 1.72E 01 1.24E 00 8.70E-01 0.00E-01 3.58E 00 0.00E-01 9.16E 04 ., v ed A-72 07-08-85
GRASS-CW-MILK PNHMAY FACIOR M2 , MREM /YR PER uCi/sec INFANT (RI FACIORS) NUCLIDE DONE LIVER T BODY 'ITIYFOID KIDNEY LUNG GI-LLI H-3 0.00 E-01 2.38E 03 2.38E 03 2.38E 03 2.38E 03 2.83E 03 2.83E 03 C-14 2.34E 09 5.00E 08 5.00E 08 5.00E 08 5.00E 08 5.00E 08 5.00E 08 Na-24 1.54E 07 1.54E 07 1.548 07 1.54E 07 1.54E 07 1.548 07 1.54E 07 P-32 1.60E 11 9.42E 09 6.21E 09 0.00E-01 0.00 E-01 0.00E-01 2.17E 09 Cr-51 0.00 E-01 0.00E-01 1.61E 05 1.05E 05 2.30E 04 2.05E 05 .._4.70E 06 Mn-54 0.00 E-01 3.90E 07 8.84E 06 0.00E-01 8.64E 06 0.00E-01 1.43E 07 Mn-56 0.00 E-01 3.15E-02 5.43E-03 0.00E-01 2.71E-02 0.00E-01 2.86E 00 Fe-55 1.35E 08 8.72E 07 2.33E 07 0.00E-01 0.00 E-01 4.26E 07 1.llE 07 Fe-59 2.24E 08 3.92E 08 1.54E 08 0.00E-01 0.00 E-01 1.16E 08 1.87E 08 Co-55 0.00Z-01 2.43E 07 6.05E 07 0.00 E-01 0.00 E-01 0.00E-01 6.x 07 Co-60 0.00 E-01 3.82E 07 2.08E 08 0.00E-01 0.00 E-01 0.00E-01 2.10E 08 Ni-63 3.49E 10 2.16E 09 1.21E 09 0.00 E-01 0.00 E-01 0.00E-01 1.07E 08
)
Ni-65 4.39E 00 4.97 E-01 2.26E-01 0.00E-01 0.00 E-01 0.00E-01 3.78E 01
- Cu-64 0.00 E-01 1.86E 05 8.60E 04 0 .00 E-01 3.14 E 05 0.00E-01 3.RIE 06 2n-65 5.55E 09 1.90E 10 8.78E 09 0.00 E-01 9.23E 09 0.00E-01 1.61E 10 2n-69 5.04 E-ll 9.07E-11 6.75 E-12 0.00 E-01 3.77 E-11 0.00E-01 7.40E-09 Br-83 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Br-84 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 1
s l l A-73 07-08-85
i TAJLE A.5-3 (Ccnt'd, I }. GRASS-CCW-MILK PNI1MAY FAC'IOR
'44 EMR PER uCi/r/m I
INFAVP (RI PAC'IORS) NUCLIDE DONE LIVER T BODY 'I11YIOID KIDNEY Urn GI-III Br-85 0.00 E-01 0.00 E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Rb-86 0.00 E-01 2.23E 10 1.10E 10 0.00E-01 0.00 E-01 0.00E-01 5.70E 08 Rb-88 0.00 E-01 0.00 E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Rb-89 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Sr-89 1.26E 10 0.00E-01 3.61E 08 0.00E-01 0.00 E-01 0.00E-01 2.59E 08 Sr-90 1.22E 11 0.00E-01 3.10E 10 0.00E-01 0.00 E-01 0.00E-01 1.52E 09 Sr-91 2.69E 05 0.00 E-01 9.75E 02 0.00E-01 0.00 E-01 0.00E-01 3.19E 05 Sr-92 4.66E 00 0.00E-01 1.73 E-01 0.00E-01 0.00 E-01 0.00E-01 5.02E Cl Y-90 6.80E 02 0.00E-01 1.82E 01 0.00 E-01 0.00 E-01 0.00E-01 9.39E 05 Y-91M 5.72 E-19 0.00E-01 1.95E-20 0.00E-01 0.00 E-01 0.00E-01 1.91E-15 Y-91 7.33E 04 0.00E-01 1.95E 03 0.00El-0 0.00 E-01 0.00E-01 5.25E 06 Y-92 5.39 E-04 0.00E-01 1.51E-05 0.00E-01 0.00 E-01 0.00E-01 1.03E 01 ) Y-93 2.25E 00 0.00E-01 6.13 E-02 0.00E-01 0.00 E-01 0.00E-01 1.78E 04 2r-95 6.81E 03 1.66E 03 1.18E 03 0.00E-01 1.79E 03 0.00E-01 8.26E 05 Zr-97 4.06 E 00 6.98E-01 3.19E-01 0.00E-01 7.03 E-01 0.00E-01 4.45E 04 Nb-95 5.94E 05 2.45E 05 1.41E 05 0.00E-01 1.75E 05 0.00 E-01 2.06E 08 Mo-99 0.00 E-01 2.08E 08 4.06E 07 0.00E-01 3.11E 03 0.00E-01 6.85E 07 To-99M 2.75E 01 5.68E 01 7.31E 02 0.00E-01 6.llE 02 2.97E 01 1.65E 04 A-74 07-08-85
l l i 1 i TABLE A.5-9 (Cont'd) T GRASS-CCW-MILK PAtrdAY WCIOR MA MREM /YR PER uCi/sec INFA!TP (RI FACORS) NUCLIDE BONE LIVER T BODY '11PH OID KIDNEY IRC GI-LLI Tc-101 0.00 E-01 3.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Ru-103 8.67E 03 0.00E-01 2.90E 03 0.00E-01 1.80E 04 0.00E-01 1.05E 05 Ru-105 3.07 E-03 0.00E-01 2.72E-03 0.00E-01 5.93 E-02 0.00E-01 3.21E 00 Ru-106 1.90E 05 0.00E-01 2.38E 04 0.00E-01 2.25E 05 0.00E-01 1.44E 06 Ag-110M 3.86E 08 2.82E 08 1.86E 08 0.00E-01 4.03E 08 0.00E-01 1.46E 10 l Te-125M 1.51E 08 5.04E 07 2.04E 07 5.07E 07 0.00 E-01 0.00E-01 7.18E 07 l l Te-127M 4.21E 08 1.40E 08 5.10E 07 1.22E 08 1.04E 09 0.00E-01 1.70E 08 i Te-127 6.32E 03 2.12E 03 1.36E 03 5.15E 03 1.54E 04 0.00E-01 1.33E 05 Te-129M 5.57E 08 1.91E 08 8.58E 07 2.14E 08 1.39E 09 0.00e-01 3.33E 08 Te-129 2.74 E-09 9.43E-10 6.39E-10 2.29E-09 6.81E-09 0.00E-01 2.19E-07 Te-131M 3.33E 06 1.36E 06 1.12E 06 2.76E 06 9.36E 06 0.00E-01 2.29E 07 Te-131 3.49 E-32 1.29E-32 9.78E-33 3.ll E-32 8.91E-32 0.00 E-01 1.41 E-30
) Te-132 2.11: 07 1.055 07 3.75E 06 1.54E 07 6.53E 07 0.00E-01 3.87E 07 l I-130 3.55E C6 7.81E 06 3.14E 06 8.76E 08 3.58E 06 0.00E-01 1.68C 06 I-131 2.725 09 3.21E 09 1.41E 09 1.05E 12 3.74 E 04 0.00E-01 1.14E OR I-132 1.43E 00 2.91E 00 1.04E 00 1.37E 02 3.25E 00 0.00E-01 2.36E 00 I-133 3.63E 07 5.28E 07 1.55E 07 9.61E 09 6.21E 07 0.00E-01 8.94E C6 I-134 1.77 E-ll 3.63E-11 1.29E-ll 8.47E-10 4.06 E-11 0.00E-01 3.76E-ll l
l l i l 1 I A-75 07-08-85
TABIE. A.5-9 (Cent'd) GRASS-CD4-MILK PNIllWAY %'CIOR
}
M4 MREM /YR PER uCi/sec INFANI' (RI FAC'IORS) NUCLIDE BONE LIVER T BODY 'I11YROID KIDNEY UJNG GI-LLI I-135 1.12E 05 2.24E 05 8.15E 04 2.00E 07 2.49E 15 0.00E-01 3.09E 04 Cs-134 3.65E 10 6.80E 10 6.87E 09 0.00E-01 1.75E 10 6.21E 09 1.85E 08 Cs-136 1.96E 09 5.76E 09 2.15E 09 0.00E-01 2.30E 09 4.70E 08 8.75E 07 Cs-137 5.15E 10 6.02E 10 4.27E 09 0.00E-01 1.62E 10 6.55E 09 1.88E 08 Cs-138 8.50 E-23 1.38E-22 6.70 E-23 0.00E-01 6.89 E-23 1.08E-23 2.21E-22 Ba-139 4.41 E-07 2.93E-10 1.28 E-08 0.00E-01 1.76 E-10 1.77 E-10 2.80E-05 Ba-140 2.41E 08 2.41E 05 1.24 E 07. 0.00E-01 5.72E 04 1.48E 05 5.92E 07 Ba-141 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Ba-142 0.00 E-01 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 La-140 4.06E 01 1.60E 01 4.12E 00 0.00E-01 0.00E-01 0.00E-01 1.83E 05 La-142 8.59 E-11 3.15E-11 7.55E-12 0.00E-01 0.00 E-01 0.00 E-01 5.36E-06 Ce-141 4.34E 04 2.64E 04 3.11E 03 0.00E-01 8.16E 03 0.00E-01 1.37E 07
) Ce-143 3.97 E 02 2.63E 05 3.00E 01 0.00E-01 7.67E 01 0.00E-01 1.54E 06 Ce-144 2.33E 06 9.52E 05 1.30E 05 0.00E-01 3.85E 05 0.00E-01 1.33E 03 Pr-143 1.49E 03 3.56E 02 7.36E 01 0.00E-01 2.07E 02 0.00E-01 7.R4R 05 Pr-144 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.0CE-01
'ki-147 8.36E 02 9.10E 02 5.57E 01 0.00E-01 3.51E 02 0.00E-01 5.77E 05 W-187 6.12 E 04 4.26E 04 1.47E 04 0.00E-01 0.00 E-01 0.00E-01 2.50E 06 Np-239 3.65E 01 3.26E 00 1.84E 00 0.00E-01 1.50E 00 0.00E-01 9.43E 04 l
l t A-76 07-08-85 _ . _ _ _ _ _ _ _ _ _ . . _ , _ - _ . - - , _ _ . _ . . . _ . . _ ~ _ _ _ _ . - . _ . . . _
TABLE A.5-10 GRASS-031-MEAT PATIMAY FACIOR i M2 eMPEWYR PER uCi/sec ADULT (RI PACIORS) NUCLIDE BDNE LIVER T BCDY TilYIOID KIDNEY LLitG GI-LLI H-3 0.00E-01 3.25E 02 1.25E 02 3.25E 02 3.25E 02 3.25E 02 3.25E 02 C-14 2.41E 08 4.83E 07 4.83E 07 4.83E 07 4.83E 07 4.83E 07 4.83E 07 Na-24 1.36E-03 1.36E-03 1.36E-03 1.36E-03 1.36E-03 1.36E-03 1.36E-03 P-32 4.65E 09 2.89E 08 1.80E 08 0.00E-01 0.00E-01 0.00E-01 5.23E 08 Cr-51 0.00E-01 0.00E-01 7.05E 03 4.21E 03 1.55E 03 9.35E 03 1.77E 06 Mn-54 0.00E-01 9.18E 06 1.75E 06 0.00E-01 2.73E 06 0.00E-01 2.81E 07 Pn-56 0.00E-01 0.0CE-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Fe-55 2.93E 08 2.02E 08 4.72E 07 0.00E-01 0.00E-01 1.13E 08 1.16E 08 Fe-59 2.65E 08 6.245 08 2.39E 08 0.00E-01 0.00E-01 1.74E 08 2.08E 09 CO-59 0.CCE-01 '. . ' :S .:9^ C" .. ^E . _ '~ 0 9 Co-60 0.00E-01 7.52E 07 1.66E 08 0.00E-01 0.00E-01 0.00E-01 1.41E 09 Ni-63 1.89E 10 1.32E 09 6.33E 08 0.00E-01 0.00E-01 0.00E-08 2.73E 08 Ni-65 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Cu-64 0.00E-01 2.73E-07 1.2SE-07 0.00E-01 6.89E-07 0.00E-01 2.33E-05 Zn-65 3.56E 08 1.135 09 5.12E 06 0.00E-01 7.57E 08 0.00E-01 7.13E 08 Zn-69 0.CCE-01 0.00E-01 d.0CE-J1 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-83 0.00E-01 0.0CE-01 0.00E-OL 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.CCE-01 3.CCE-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i l A-77 07-08-85
. . . - - - - - - - - - . - . - - , - , , - - - - - , . - - . . .-n,--,---,. - - , , . . . ..-.---.-----.,_,-c. , . - - - - -, , , ,
l TABLE A.5-10 (Cor.t'd) s GRA3S-CCW-MEAT PNDrdAY FACIOR M2 + AtREM/YR PER uCi/sec ADULT (RI FACTORS) NUCLIDE IDNE LIVER T BODY 'IliYIDID KIDtEl UIE GI-ILI Br-85 0.C0 E-31 0.00 E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Rb-96 0.00 E-01 4.87E 08 2.27E 08 0.00E-01 0.00 E-01 0.00E-01 9.61E 07 Rb-88 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Rb-89 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Sr-89 3.02E 08 0.00E-01 9.66E 06 0.00E-01 0.00E-01 0.00E-01 4.84E 07 Sr-90 1.24E 10 0.00E-01 3.05E 09 0.00E-01 0.00 E-01 0.00E-01 3.59E 08 i Sr-91 1.43 E-10 0.00E-01 5.73 E-12 0.00E-01 0.00 E-01 0.00E-01 6.76E-10 Sr-92 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Y-90 1.07 E 02 0.00E-01 2.86E 00 0.00E-01 0.00 E-01 0.00E-01 1.13E 06 Y-91M 0.00 E-01 0.00 E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-Ci Y-91 1.13E 06 0.00 E-01 3.03E 04 0.00E-01 0.00 E-01 0.00E-01 6.23E 08 Y-92 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 3 Y-93 6.59 E-12 0.00E-01 1.82E-13 0.00E-01 0.00 E-01 0.00E-01 2.09E-07 Z r-95 1.87 E C6 6.01E 05 4.07E 05 0.00E-01 9.43E 05 0.00E-01 1.90E 09 2r-97 2.C8 E-05 4.19E-06 1.92E-06 0.00E-01 6.33E-06 0.00E-01 1.30E C0 Nb-95 2.20E C6 1.2SE C6 6.88E 05 0.00E-01 1.26E 06 0.00E-01 7.76E 09 Mo-99 0.00 E-01 3.99E 04 1.90E 04 0.00E-01 2.26E 05 0.00E-01 2.32E 05 . Te-99M 4.50E-21 1.27E-20 1.62E-19 0.00E-01 1.93E-19 6.23E-21 7.53E-13 1 i A-78 07-08-85
l I TMILE A.5-10 (Cont'd) GtASS-GM-MEAT PA'IWAY FACIOR M2 , MREM /YR PER uCi/sec IDULT (RI FACIORS) NUCLIDE BONE LIVER T EODY 'lllYPOID KIDNEY LlRKi GI-LLI Tc-101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ru-103 1.05E 08 0.00E-01 4.53E 07 0.00E-01 4.01E 08 0.00E-01 1.23E 10 Ra-105 5.87E-28 0.00E-01 2.32E-28 0.00E-01 7.58E-27 0.00E-01 3.59E-25 Ru-106 2.80E 09 0.00E-01 3.54E 08 0.00E-01 5.40E 09 0.00E-01 1.81E 11 Ag-110M 6.6SE 06 6.18E 06 3.67E 06 0.00E-01 1.22E 07 0.00E-01 2.52E 09 Te-125M 3.59E 08 1.30E 08 4.81E 07 1.08E 08 1.46E 09 0.00E-01 1.43E 09 i Te-127M 1.12E 09 3.99E 08 1.36E 08 2.85E 08 4.53E 09 0.00E-01 3.74E 09 Te-127 2.14E-10 7.68E-ll 4.63E-11 1.58E-10 8.71E-10 0.00E-01 1.69E-08 Te-129M 1.13E 09 4.23E 08 1.80E 08 3.90E 08 4.73E 09 0.00E-01 5.71E 09 Te-129 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.0CE-01 Te-131M 4.52E 02 2.21E 02 1.84E 02 3.50E 02 2.24E 03 0.00E-01 2.20E 04 Te-131 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ! Te-132 1.42E 06 9.19E 05 8.63E 05 1.01E 06 8.85E 06 0.00E-01 4.35E 07 I-130 2.12E-06 6.26E-06 2.47E-06 5.30E-04 9.76E-06 0.00E-01 5.39E-06 I-131 1.07E 07 1.54E 07 8.81E 06 5.04E 09 2.64E 07 0.00E-01 4.06E 06 I-132 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I-133 3.67E-01 6.38E-01 1.94E-01 9.37E 01 1.11E 00 0.00E-01 5.73E-01 I-134 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 [ A-7') 07-08-85
-.~ .--.----,.,-..n,.---.--,.n.---,---
TABLE A.5-10 (Cont'd) GWdi3-CCU-MEAT PA'I1MAY FICIOR M2 -MRDt/YR PER uCi/sec ADJLT (RI FAC'IORS) t7JCLIDE BONE LIVER T BODY 'ITIYIOID KIDNEY UJ!E GI-LLI 1 I-135 4.47 E-17 1.17E-16 4.32E-17 7.73E-15 1.88 E-16 0.00E-01 1.32E-16 Cs-134 6.58E 08 1.56E 09 1.2SE 09 0.00E-01 5.06E 08 1.68E 08 2.74E 07 Cs-136 1.18E 07 4.66E 07 3.35E 07 0.00E-01 2.59E 07 3.55E 06 5.24E 06
, Cs-137 8.72E 08 1.19E 09 7.81E 08 0.00 E-01 4.05E 08 1.35E 08 2.31E 07 Cs-138 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Ba-139 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Ba-140 2.87E 07 3.61E 04 1.88E 06 0.00 E-01 1.23E 04 2.07E 04 5.92E 07 3a-141 0.00E-01 0.00E-01 1.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Ba-142 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 l La-140 3.76 E-02 1.89E-02 5.00 E-03 0.00E-01 0.00 E-01 0.00E-01 1.39E 03 La-142 0.00 E-01 0.00E-01 0.00 E-01 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 1.40E 04 9.50E 03 Ce-141 1.08E 03 0.00E-01 4.41E 03 0.00E-01 3.63E 07 Ce-143 2.01 E-02 1.49E 01 1.65E-03 0.00E-01 6.55E-03 0.00E-01 5.56E 02 Ce-144 1.46E C6 6.09E 05 9.33E 04 0.00E-01 3.61E 05 0.00E-01 4.93E 08 Pr-143 2.10E 04 3.41E 03 1.04E 03 0.00E-01 4.R6E 03 0.00E-01 9.19E 07 Pr-144 0.00 E-01 0.00 E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00 E-01 0.00E-01 Nd-147 7.17 E 03 0.29E 03 4.96E 02 0.00E-01 4.84E 03 0.00E-01 3.998 07 . *d-137 2.17 E-02 1.81E-02 6.33E-03 0.00E-01 0.00 E-01 0.00E-01 5.93E 00 Sp-239 2.59 E-01 2.55E-02 1.40 E-02 0.00E-01 7.94 E-02 0.00E-01 5.228 03 1
i l i t l A-80 07-08-85
- - - - - - - - - - - - - - - . , , - - - - , . - , . , - - , , , ~ , . , . - . , . - _ _ . . - . . - . . - . - - . . - - ,
I rABLE A.5-11 GRASS-T.?-MEAT PAT 1Mid FACTCR M2 MREM /YR PER uCi/sec TEEN (RI FACIORS) NUCLIDE DONE LIVER T BODY TIIYIDID KIDNEY LUNG GI-LLI H-3 0.00E-01 1.94E 02 1.94E 02 1.94E 02 1.94E 02 1.94E 02 1.94E 02 C-14 2.04E 08 4.08E 07 4.08E 07 4.08E 07 4.08E 07 4.08E 07 4.08E 07 Na-24 1.09E-03 1.09E-03 1.09E-03 1.09E-03 1.09E-03 1.09E-03 1.09E-03 P-32 3.93E 09 2.44E 08 1.52E 08 0.00E-01 0.00E-01 0.00E-01 3.30E 08 Cr-51 0.00E-01 0.00E-01 5.64E 03 3.13E 03 1.24E 03 8.05E 03 9.47E 05 Mn-54 0.00E-01 7.00E 06 1.39E 06 0.00E-01 2.09E 06 0.00E-01 1.44E 07 l Mn-56 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00C-01 0.00E-01 Fe-55 2.3SE 06 1.69E 08 3.93E 07 0.00E-01 0.00E-01 1.07E 08 7.30E 07 Fe-59 2.12E 08 4.95E 08 1.91E 08 0.00E-01 0.00E-01 1.56E Od 1.17E 09 1 l Co-58 0.00E-01 1.41E 07 3.24E 07 0.00E-01 0.00E-01 0.00E-01 1.942 06 Co-60 0.00E-01 5.83E 07 1.31E 08 0.00E-01 0.00E-01 0.00E-01 7.60E 08 Ni-63 1.52E 10 1.07E 09 5.15E 08 0.00E-01 0.00E-01 0.00E-01 1.71E 08 Ni-65 0.00E-01 0.COE-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Cu-64 0.00E-01 2.23E-07 1.05E-07 0.00E-01 5.640-07 0.00E-01 1.732-05 Zn-65 2.50E 08 3.69E 08 4.05E 08 0.00E-01 5.56E 08 0.002-01 3.68E 08 l Zn-69 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-Oi 0.00E-ul 0.006-01 l Br-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.0CE-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 4 l
)
i A-81 07-08-85
- - - - - , . - - , - - . - - - , . , -- - - - . . - - - . , . -,.,,.-_..,..--------~--,,n... ..--.-,,,,.,-.nn.-n- .
TABLE A.5-11 (Cont'd) G. MSS-COW-MEAT PATIMAY F/CIOR
- S MREM /YR PER uCi/ cec TEEN (RI FAC'IORS)
?AJCLICE FONE LIVER _T BODY T!IYIOID KIDNEY wtC GI-LLI Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-06 0.00E-01 4.07E 08 1.91E 08 0.00E-01 0.00E-01 0.00E-01 6.02E 07 P >-68 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-07 Sr-89 2.55E 08 0.00E-01 7.29E 06 0.00E-01 0.00E-01 0.00E-01 3.03E 07 Sr-90 8.05E 09 0.00E-01 1.99E 09 0.00E-01 0.00E-01 0.00E-01 2.26E 08 Sr-91 1.19E-10 0.00E-01 4.75E-12 0.00E-01 0.00E-01 0.00E-01 5.41E-10 Sr-92 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y-90 3.98E 01 0.00E-01 2.42E 00 0.00E-01 0.00E-01 0.00E-01 7.41E 05 Y-91M 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y-91 9.54E 05 0.00E-01 2.565 04 0.00E-01 0.00E-01 0.00E-01 3.91E Go Y-92 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y-93 5.56E-12 0.00E-01 1.53E-13 0.00E-01 0.00E-01 0.00E-01 1.70E-07 Cr-95 1.50E 06 4.73E 05 3.26E 05 0.00E-01 6.96E 05 0.00E-01 1.09E 09 2r-97 1.73E-05 3.42E-06 1.58E-06 0.00E-01 5.19E-06 0.00E-01 9.27E-01 Sb-95 1.30E 06 9.96E 05 5.48E 05 0.00E-01 9.66E 05 0.00E-01 4.26E 09
- 4>-99 0.00E-01 d.26E 04 1.58E 04 0.00E-01 1.89E 05 0.00S-01 1.488 05 Tc-99M 3.58E-21 9.97E-21 1.29E-19 0.00E-01 1.49E-19 5.54E-21 6.55E-18
\
- l
) A-82 07-08-85
r T! ALE A.5-11 (Cont'd) grids-CC.+-EW PATHWM PAC 1DR M2 -MREM /YR PER uCi/see TEEN (RI FACIURS) NUCLIDE BONE LIVER T ECDY 'IliYIDID KIDNEY LUNG GI-LLI Tc-101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ru-103 8.56E 07 0.00E-01 3.66E 07 0.00E-01 3.02E 08 0.00E-01 7.15E 09 Ru-105 4.91E-28 0.00E-01 1.91E-28 0.00E-01 6.91E-27 0.00E-01 3.96E-25 l Ra-106 2.36E 09 0.00E-01 2.97E 08 0.00E-01 4.55E 09 0.00E-01 1.13E 11 Ag-110M 5.06E 06 4.79E 06 2.91E 06 0.00E-01 9.13E 06 0.00E-01 1.35E 09
- Te-125M 3.03E 08 1.09E 08 4.05E 07 8.47E 07 0.00E-01 0.00E-01 8.94E 08 i
Te-127M 9.42E 08 3.34E 08 1.12E 08 2.24E 08 3.82E 09 0.00E-01 2.35E 09 Te-127 1.81E-10 6.43E-11 3.91E-ll 1.25E-10 7.35E-10 0.00E-01 1.40E-08 Te-129M 9.50E 08 3.53E 08 1.50E 08 3.07E 08 3.97E 09 0.00E-01 3.57E 09 l ) Te-129 0.07-01 1.'CE-01 0.COE-31 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Te-131M 3.77E 02 1.81E 02 1.51E 02 2.72E 02 1.88E 03 0.00E-01 1. c c - , re-131 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 T 3-132 1.16E 06 7.36E 05 6.93E 05 7.76E 05 7.06r 16 0.00E-01 2.33E 07 I-130 1.71E-06 4.94E-06 1.97E-06 4.03E-04 7.616-06 0.00E-01 3.80E-06 I-13; 3.93E 06 1.25E 07 6.72E 06 3.65E 09 2.15. 07 0.00E-01 2.47E 06 I-132 0.00E-01 0.002-01 0.00E-01 0.00E-01 0.00E-01 0.GCE-01 0.00E-01 i I-133 3.07E-01 5.20E-01 1.59E-01 7.26E 01 9.12E-01 0.00E-01 3.93E-01 I-134 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 3.00E-01 0.00E-01 ] l l l I l f l l l
> l t
! A-83 07-08-85
. , - . - - . . - - . -----n-,-- ,--..--,_,,-,-,----e,---,--,nrn,, .- - ,- n -, , . - - , - ~ ~ , - - . , . . v. , ,.
TABLE A.5-ll (Cont'd) GIMSS-GM-MEAT PATl!WAY FACIOR
) ML MRDt/YR PER uCi/sec TEEN (RI FACTORS)
NUCLIDE BONE LIVER T BODY TIIYFOID KIDNEY IEXi GI-LLI I-135 3.64E-17 9.37E-17 3.47E-17 6.03C-15 1.48E-16 0.00E-01 1.04E-16 Cs-134 5.23E 08 1.23E 09 5.71E 08 0.00E-01 3.91E 08 1.49E 08 1.53E 07 Cs-136 9.20E 06 3.62E 07 2.43E 07 0.00E-01 1.97E 07 3.11E 06 2.91E 06 Cs-137 7.24E 08 9.63E 08 3.36E 08 0.00E-01 3.28E 08 1.27E 08 1.37E 07 Cs-138 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-139 0.00E-01 0.008-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-140 2.38E 07 2.91E 04 1.53E 06 0.00 E-01 9.88E 03 1.96E 04 3.67E 07 Ba-141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-142 0.00E-01 0.00E-Ol 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 LA-140 3.09E-02 1.52E-02 4.04E-03 0.00E-01 0.00E-01 0.00E-01 8.72E 02 La-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ce-141 1.18E 04 7.88E 03 9.05E 02 0.00E-01 3.71E 03 0.00E-01 2.25E 07 Ce-143 1.69E-02 1.23E 01 1.38E-03 0.00E-01 5.53E-03 0.00E-01 3.70E 02 Ce-144 1.23E 06 5.08E 05 6.60E 04 0.00E-01 3.04E 05 0.00E-01 3.09E 08 Pr-143 1.77E 04 7.05E 03 8.78E 02 0.00E-01 4.10E 03 0.00E-01 5.81E 07 Pr-144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Nd-147 6.32E 03 6.87E 03 4.11E 02 0.00E-01 4.03E 03 0.00E-01 2.48E 07 W-187 1.81E-02 1.48E-02 5.18E-03 0.00E-01 0.00E-01 0.00E-01 4.00E 00 Np-239 2.26E-01 2.13E-02 1.19E-02 0.00E-01 6.70E-07 0.00E-01 3.43E 03 ) A-84 07-08-85
TAPLE A.5-12 GRASS-CM-MEAT PATliWAY FAC'IOR i :S MPENYR PER uCi/sec GiIID (RI FACIORS) NUCLIDE BONE LIVER T BODY T!!YIOID KIDNEY IENG GI-LLI 11 - 3 0.00E-01 2.34E 02 2.34E 02 2.34E 02 2.34E 02 2.34E 02 2.348 02 C-14 .3.83E 08 7.67E 07 7.67E 07 7.67E 07 7.67E 07 7.67E 07 7.67E 07 Na-24 1.73E-03 1.73E-03 1.73E-03 1.73E-03 1.73E-03 1.73E-03 1.73E-03 P-32 7.41E 09 3.47E 08 2.86E 08 0.00E-01 0.00E-01 0.00E-01 2.05E 08 Cr-51 0.00E-01 0.00E-01 8.79E 03 4.883 03 1.33E 03 8.91E 03 4.66E 05 s Mn-54 0.00E-01 8.01E 06 2.13E 06 0.00E-01 2.25E 06 0.00E-01 6.72E 06
.i Mn-56 1.19E-10 0.00E-01 4.75E-12 0.00E-01 0.00E-01 0.00E-01 5.41E-10 Fe-55 4.57E 08 2.42E 08 7.50E 07 0.00E-01 0.00E-01 1.37E 08 4.49E 07 Fe-59 3.76E 08 6.09E 08 3.03E 08 0.00E-01 0.00E-01 1.76E 08 6.34E 08 Co-58 0.00E-01 1.64E 07 5.03E 07 0.00E-01 0.00E-01 0.00E-01 9.58E 07 Co-60 0.00E-01 6.93E 07 2.04E 08 0.00E-01 0.00E-01 0.00E-01 3.84E 08 Ni-63 2.91E 10 1.56E 09 9.91E 08 0.00E-01 0.00E-01 0.00E-01 1.05E 08 Ni-65 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Cu-64 0.00E-01 3.00E-07 1.81E-07 0.00E-01 7.24E-07 0.00E-01 1.41E-05 2n-65 3.75E 08 1.00E 09 6.22E 08 0.00 E-01 6.30E 08 0.00E-01 1.76E 08 Zn-69 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i
l
)
A-85 07-08-85
. 1 - . _ _ _ , _ _ . . _ _ _ . , , _ ~ . . . _ . _ ~ , . , . _ - _ . ,m_-.m,.____rm,__-u-__ -
TABLE A.5-12 (Cont'd) CCGS-O -:ZYP FATE' FICA FN MREW PER uCi/sec GIIID (RI FACIURS) NUCLIDE BONE LIVER T BODY TilYPOID KIDNEY LUtG GI-LLI Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 5.77E 08 3.55E 08 0.00E-01 0.00E-01 0.00E-01 3.71E 07 Rb-88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00F-01 0.00E-01 0.00E-01 Rb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Sr-89 4.82E 08 0.00E-01 1.38E 07 0.00E-01 0.00E-01 0.00E-01 1.87E 07 Sr-90 1.04E 10 0.00E-01 2.64E 09 0.00E-01 0.00E-01 0.00E-01 1.40E 08 Sr-91 2.24E-10 0.00E-01 8.45E-12 0.00E-01 0.00E-01 0.00E-01 4.94E-10 Sr-92 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y-90 1.70E 02 0.00E-01 4.55E 00 0.00E-01 0.00E-01 0.00E-01 4.84E 05 Y-91M 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y-91 1.80E 06 0.00E-01 4.82E 02 0.00E-01 0.00E-01 0.00E-01 2.40E 08 Y-92 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 l Y-93 1.04E-ll 0.00E-01 2.87E-13 0.00E-01 0.00E-01 0.00E-01 1.56E-07 Zr-95 2.66E 06 3.86E 05 5.21E 05 0.00E-01 8.38E 05 0.00E-01 6.llE 08 Zr-97 3.22E-05 4.65E-06 2.74E-06 0.00E-01 6.68E-06 0.00E-01 7.05E-01 Nb-95 3.10E 06 1.21E 06 8.63E 05 0.00E-01 1.13E 06 0.00E-01 2.23E 09 33-99 0.00E-01 1.15E 05 2.84E 04 0.00E-01 2.45E 05 0.00E-01 9.51E 04 Tc-99M 6.27E-21 1.23E-20 2.04E-19 0.00E-01 1.79E-19 6.24E-21 7.00E-18 A-86 07-08-85 i .
TABLE A.5-12 (Cont'd) GFASS-CCd-ET PAT!!WAY FACIUR 2
) MpMREWYR PER uCi/sec Ci!ILD (RI FACIORS)
NUCLIDE WNE LIVER T BODY 'ITIYROID KIDNEY UJNG GI-LLI Tc-101 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 Ru-103 1.55E 08 0.00 E-01 5.95E 07 0.00E-01 3.90E 08 0.00E-01 4.00E 09 Ru-105 9.16 E-28 0.00E-01 3.32 E-28 0.00E-01 8.05E-27 0.00E-01 5.98E-25 Ru-106 4.44E 09 0.00E-01 5.54E 08 0.00E-01 5.99E 09 0.00E-01 6.90E 10 Ag-100M 8.34E 06 5.67E 06 4.53E 06 0.00E-01 1.06E 07 0.00E-01 6.74E 08 Te-125M 5.69E 08 1.54E 08 7.59E 07 1.60E 08 0.00 E-01 0.00E-01 5.49E 08 Te-127M 1.77 E 09 4.78E 08 2.11E 08 4.24E 08 5.06E 09 0.00 E-01 1.44E 09 Tel27 3.41E-10 9.20E-ll '.32E-11 2.36E-10 9.71E-10 0.00 E-01 1.33E-08 Te-129M 1.79E C9 5.00E 08 1.68E 08 5.77E 08 5.26E 09 0.00E-01 2.16d 09 To-129 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Te-131M 7.01E 02 2.43E 02 2.58E 02 4.99E 02 2.35E 03 0.00E-01 9.848 03 Te-131M 0.00 E-01 0.00E-01 0.00 E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 Te-132 2.12E 06 9.39E 05 1.13E 06 1.37E 06 8.728 06 0.00 E-01 9.46E 06 i I-130 3.05 E-06 6.17E-06 3.18E-06 6.80E-04 9.22 E-06 0.00E-01 2.89 E-06 I-131 1.66E 07 1.67E 07 9.47E 06 5.51E 09 2.74E 07 0.00E-01 1.48E 06 I-132 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 I-133 5.70 E-01 7.04E-01 2.66 E-01 1.31E 02 1.17E 00 0.00 E-01 2.84 E-01 I-134 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 i I I t i A-87 07-08-85
TABLE A.5-12 (Cont'd) GPlas-COM1 EAT PNI1MAY FAC'IOR , T M4 MIet/YR PER UCi/sec CHILD (RI PAC'IORS) NUCLIDE BONE LIVER T BCDY THYROID KIDNEY LUNG GI-LLI I-135 6.59E-17 1.19 E-16 5.61E-17 1.05E-14 1.82E-16 0.00E-01 9.04E-17 Cs-134 9.22E 08 1.51E 09 3.19E 08 0.00E-01 4.69E 08 1.68E 08 8.16E 06 Cs-136 1.59E 07 4.36E 07 2.82E 07 0.00E-01 2.32E 07 3.46E 06 1.53E 06 Cs-137 1.33E 09 1.28E 09 1.88E 08 0.00E-01 4.16E 08 1.50E 08 7.99E 06 Cs-138 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i Ba-139 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-140 4.39E 07 3.84E 04 2.56E 06 0.00E-01 1.25E 04 2.29E 04 2.22E 07 Ba-141 0.00E 01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 l La-140 5.66E-02 1.98 E-02 6.66 E-03 0.00E-01 0.00E-01 0.00E-01 5.51E-02 La-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-OL Ce-141 2.22E 04 1.llE 04 1.64E 03 0.00E-01 4.86E 03 0.00E-01 1.38E 07 Ce-143 3.18E-02 1.72E 01 2.50E-03 0.00E-01 7.23E-03 0.00E-01 2.52E 02 Ce-144 2.32E 06 7.26E 05 1.24E 05 0.00E-01 4.02E 05 0.00E-01 1.89E 08 j Pr-143 3.34E 04 1.00E 04 1.66E 03 0.00E-01 5.43E 03 0.00E-01 3.60E 07 Pr-144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Nd-147 1.198 04 9.60E 03 7.43E 02 0.00E-01 5.27E 03 0.00E-01 1.52E 07 l W-187 3.36E-02 1.99E-02 8.94E-03 0.00E-01 0.00E-01 0.00E-01 2.30E 00 l l NP-239 4.26E-01 3.06E-02 2.15E-02 0.00E-01 8.84E-02 0.00E-01 2.26E-03 I A-88 07-08-85
TABLE A.5-13 VEGEI'ATION PNIWAY FACIOR I '12 MPEt/YR PER uCi/sec ADULT (RI FACIORS) NUCLIDE BONE LIVER T DODY 'IIPIROID KIDNEY IL% GI-LLI H-3 0.00 E-01 2.26E 03 2.26E 03 2.26E 03 2.26E 03 2.26E 03 2.26E 03 C-14 2.38E 08 4.55E 07 4.55E 07 4.55E 07 4.55E 07 4.55E 07 4.55E 07 Na-24 2.69E 05 2.69E 05 2.69E 05 2.69E 05 2.69E 05 2.69E 05 2.69E 05 P-32 1.40E 09 8.73E 07 5.42E 07 0.00E-01 0.00E-01 0.00 E-01 1.58E 08 Cr-51 0.00 E-01 0.00E-01 4.64E 04 2.78E 04 1.02E 04 6.16E 04 1.17E 07 Mn-54 0.00E nl 3.13E 08 5.97E 07 0.00E-01 9.31E 07 0.00E-01 9.58E 08 Mn-56 0.00 E-01 1.59E 01 2.82E 00 0.00E-01 2.02E 01 0.00E-01 5.08E 02 Fe-55 2.09E 08 1.45E 08 3.37E 07 0.00E-01 0.00 E-01 8.06E 07 8.29E 07 Fe-59 1.26 E 03 2.96E 03 1.14 E 08 0.00E-01 0.00 E-01 8.28E 07 9.83E CS Co-58 0.00 E-01 3.07E 07 6.89E 07 0.00E-01 0.00 E-01 0.00E-01 6.23E 08 Co-60 0.00 E-01 1.67E 03 3.69E 08 0.00E-01 0.00 E-01 0.00E-01 3.14E Os Ni-63 1.04 E 10 7.28E 08 3.49E 08 0.00E-01 0.00 E-01 0.00E-01 1.50E 08 Ni-65 6.93E 01 9.01E 00 4.llE 00 0.00E-01 0.00 E-01 0.00 E-01 2.2SE 02 Cu-64 0.00 E-01 9.21E 03 4.32E 03 0.00E-01 2.32E 04 0.00 E-01 7.85E 05 2n-65 3.17E 03 1.01E 09 4.56E 09 0.00E-01 6.75E 08 0.00E-01 6.36E 08 Zn-69 8.77 E-06 1.68E-05 1.17E-06 0.00E-01 1.09 E-0 5 0.00 E-01 2.52E-06 Br-33 0.00 E-01 0.00E-01 3.11E 00 0.00E-01 0.00 E-01 0.00 E-01 4.48E 00 Br-84 0.00 E-01 0.00E-01 2.49E-ll 0.00 E-01 0.00 E-01 0.00 E-01 1.96E-16 I 1 1
)
A-89 07-08-85
TABLE A.5-13 (Cont'd) VEGETATICN PAT 10AY FACTOR
) -2 e MREM /YR PER uCi/sec
*1 ADULT (RI FACTORS)
NUCLIDE BCNE LIVER T BODY DIYPOID KIDNEY LIRC GI-LLI Br-85 0.00 E-01 0.00 E-01 0.00 E-01 0.00 E-01 0.00 E-01 0.00 E-01 0.00E-01 Rb-86 0.00 E-01 2.19E 08 1.02E 08 0.00E-01 0.00 E-01 0.00 E-01 4.33E 07 Rb-88 0.00 E-01 3.47E-22 1.84 E-22 0.00 E-01 0.00 E-01 0.00 E-01 0.00E-01 Rb-89 0.00 E-01 1.41E-26 9.88E-27 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Sr-89 9.97E 09 0.00E-01 2.86E 08 0.00E-01 0.00E-01 0.00 E-01 1.60E 09 S r-90 6.05E 11 0.00E-01 1.48E 11 0.00E-01 0.00 E-01 0.00EH01 1.75E 10 Sr-91 3.03E 05 0.00E-01 1.22E 04 0.00E-01 0.00 E-01 0.00E-01 1.44E 06 Sr-92 4.27 E 02 0.00 E-01 1.85E 01 0.00 E-01 0.00 E-01 0.00 E-01 S.46E 03 Y-90 1.33E 04 0.00E-01 3.56E 02 0.00 E-01 0.00 E-01 0.00 E-01 1.41E 08 Y-91M 5.24 E-09 0.00E-01 2.03E-10 0.00E-01 0.00 E-01 0.00E-01 1.54S-08 Y-91 5.11E 06 0.00E-01 1.37E 05 0.00E+01 0.00 E-01 0.00 E-01 2.81E 09 Y-92 9.16 E-01 0.00E-01 2.68 E-02 0.00E-01 0.00 E-01 0.00E-01 1.60E 04
, Y-93 1.74E 02 0.00E-01 4.81E 00 0.00 EH01 0.00 E-01 0.00 E-01 5.52E 06 2r-95 1.18E 06 3.77E 05 2.55E 05 0.00EH01 5.92E 05 0.00E-01 1.20E 09 2r-97 3.37 E 02 6.81E 01 3.11E 01 0.00E-01 1.03E 02 0.00EH01 2.llE 07 Nb-95 1.43E 05 7.93E 04 4.26E 04 0.00 E-01 7.84E 04 0.00E-01 4.81E 08 Mo-99 0.00E-01 6.15E 06 1.17E 06 0.00 E-01 1.39E 07 0.00 E-01 1.43E 07 To-99M 3.10E 00 8.77E 00 1.12E 02 0.00E-01 1.33E 02 4.308 00 5.19E 03 Y
A-90 07-08-85 l
i TABLE A.5-13 (Cont'd) VEGETATION PAT!MAY FAC'IOR ) MA MREM /YR PER uCi/sec MXJLT (RI FAC'IORS) , NUCLIDE BONE LIVER T EODY TIIYIOID KIDNEY IEG GI-LLI To-101 3.34 E-31 1.20E-30 1.18E-29 0.00E-01 2.16 E-29 6.14E-31 0.00 E-01 Ru-103 4.76E 06 0.00 E-01 2.05E 06 0.00E-01 1.82E 07 0.00E-01 5.56E 08 Ru-105 5.39E 01 0.00E-01 2.13E 01 0.00E-01 6.97E 02 0.00E-01 3.30E 04 Ru-106 1.93E 08 0.00E-01 2.44E 07 0.00E-01 3.72E 08 0.00E-01 1.25E 10 Ag-100M 1.05E 07 9.75E 06 5.79E 06 0.00E-01 1.92E 07 0.00E-01 3.98E 09 Te-125M 9.66E 07 3.50E 07 1.29E 07 2.90E 07 3.93E 08 0.00E-01 3.86E 08 Te-127M 3.49E 08 1.25E 08 4.26E 07 8.93E 07 1.42E 09 0.00E-01 1.17E 09 Te-127 5.66E 03 2.03E 03 1.23E 03 4.20E 03 2.31E 04 0.00E-01 4.47E 05 Te-129P 2.51E 08 9.38E 07 3.98E 07 8.63E 07 1.05E 09 0.00 E-01 1.27E 09 Te-129 7.65 E-04 2.87 E-04 1.86 E-04 5.87 E-04 3.22 E-03 0.00E-01 5.77E-C
- Te-131M 9.128 05 4.46E 05 3.72E 05 7.07E 05 4.52E 06 0.00 E-01 4.43E 07 Te-131 1.51 E-15 6.32E-16 4.78 E-16 1.24E-15 6.63E-15 0.00E-01 2.14E-16
) Te-132 4.30E C6 2.78E 06 2.61E 06 3.07E 06 2.68E 07 0.00E-01 1.32E 08 I-130 3.95E 05 1.16E 06 4.57E 05 9.81E 07 1.81E 06 0.00E-01 9.97E 05 I-131 3.08 E 07 1.16E 08 6.62E 07 3.79E 10 1.98E 08 0.00E-01 3.05E 07 I-132 5.77 E 01 1.54E 02 5.40E 01 5.40E 03 2.46E 02 0.00E-01 2.90E 01 1-133 2.09E C6 3.63E 06 1.llE 06 5.33E 08 6.33E 06 0.00E-01 3.26E 06 I-134 9.69E-05 2.63E-04 9.42 E-05 4.56E-03 4.19 E-04 0.00E-01 2.30E-07
)
1 A-91 07-08-85
TABLE A.5-13 (Cont'd) VEGETATION PA'I1MAY FAC'10R ) M2 , MREM /YR PER uCi/sec
>OULT (RI FAC'IDRS)
NUCLIDE B3NE LIVER T BODY 'I11YPOID KIDNEY UJN3 GI-LLI I-135 3.90E 04 1.02E 05 3.77E 04 6.74E 06 1.64E 05 0.00 E-01 1.15E 05 Cs-134 4.67E 09 1.llE 10 9.08E 09 0.00E-01 3.59E 09 1.19E 09 1.94E 08 Cs-136 4.20E 07 1.66E 08 1.19E 08 0.00E-01 9.22E 07 1.26E 07 1.88E 07 Cc-137 6.36E 09 8.70E 09 5.70E 09 0.00E-01 2.95E 09 9.81E 08 1.68E 08 Cs-138 3.94 E-ll 7.78E-ll 3.86E-ll 0.00E-01 5.72 E-ll 5.65E-12 3.32E-16 Ba-139 2.90 E-02 2.07E-05 8.50E-04 0.00E-01 1.93 E-05 1.17E-05 5.15E-02 Ba-140 1.29 E 08 1.61E 05 8.42E 06 0.00E-01 5.49E 04 9.25E 04 2.65E 08 Ba-141 1.28 E-21 9.64 E-25 4.31 E-23 0.00E-01 8.96E-25 5.47E-25 6.01E-31 Ba-142 0.00 E-01 0.00E-01 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 La-140 1.93E 03 9.99E 02 2.64E 02 0.00E-01 0.00 E-01 0.00 E-01 7.33E 07 La-142 1.42 E-04 6.44E-05 1.61E-05 0.00E-01 0.00 E-01 0.00E-01 4.70E-01 Ce-141 1.97E 05 1.33E 05 1.51E 04 0.00E-01 6.19E 04 0.00E-01 5.10E 08 Ce-143 9.93E 02 7.38E 05 8.17E 01 0.00 E-01 3.25E 02 0.00 E-01 2.76E 07 Ce-144 3.29E 07 1.38E 07 1.77E 06 0.00E-01 8.16E 06 0.00 E-01 1.11E 10 Pr-143 6.26E 04 2.51E 04 3.118 03 0.00E-01 1.45E 04 0.00 E-01 2.74E 08 Pr-144 3.13E-26 1.30E-26 1.59E-27 'O.00E-01 7.32 E-27 0.00 E-01 0.00E-01 Nd-147 3.36E 04 3.89E 04 2.32E 03 0.00E-01 2.27E 04 0.00E-01 1.87E 08 W-lS7 3.82E 04 3.20E 04 1.12E 04 0.00E-01 0.00 E-01 0.00 E-01 1.05E 07 No-239 1.43E 03 1.40E 02 7.74E 01 0.00E-01 4.33E 02 0.00E-01 2.8BE 07 A-92 07-08-85
TABLE A.5-14 VEGETATION PA'I1MAY FICIOR 3 MS MREWYR PER uCi/sec
'IEEN (RI PACIORS)
NUCLIDE BCNE LIVER T BODY 'IIIYRDID KIDNEY IFG GI-LLI H-3 0.00E-01 2.59E 03 2.59E 03 2.59E 03 2.59E 03 2.59E 03 2.59E 03 C-14 3.69E 08 7.38E 07 7.38E 07 7.38E 07 7.38E 07 7.38E 07 7.38E 07 Na-24 2.39E 05 2.39E 05 2.39E 05 2.39E 05 2.39E 05 2.39E 05 2.39E 05 P-32 1.61E 09 9.96E 07 6.23E 07 0.00E-01 0.00E-01 0.00E-01 1.35E 08 Cr-51 0.00E-01 0.00E-01 6.17E 04 3.43E 04 1.35E 04 8.81E 04 1.04E 07 Mn-54 0.00E-01 4.54E 08 9.01E 07 0.00E-01 1.36E 08 0.00E-01 9.32E 08 Mn-56 0.00E-01 1.44E 01 2.55E 00 0.00E-01 1.82E 01 0.00E-01 9.45E 02 Fe-55 3.25E 03 2.31E 08 5.38E 07 0.00E-01 0.00 E-01 1.46E 08 9.98E 07 Fe-59 1.79E 08 4.18E 08 1.62E 08 0.00E-01 0.00E-01 1.32E 08 9.90E 08 Co-58 0.00E-01 4.36E 07 1.01E 08 0.00E-01 0.00 E-01 0.00E-01 6.01E 08 Co-60 0.00E-01 2.49E 08 5.60E 08 0.00E-01 0.00E-01 0.00E-01 3.24E 09 Ni-63 1.61E 10 1.13E 09 5.44E 08 0.00E-01 0.00E-01 0.00E-01 1.81E 08 Ni-65 6.45E 01 3.24E 00 3.76E 00 0.00E-01 0.00E-01 0.00E-01 4.47E 02 i Cu-64 0.00E-01 3.34E 03 3.92E 03 0.00E-01 2.11E 04 0.00E-01 6.47E 05 2n-65 4.24E 08 1.47E 09 6.86E 08 0.00E-01 9.42E 08 0.00E-01 6.23E 08 2n-69 3.21E-06 1.56E 05 1.10E-06 0.00E-01 1.02E-05 0.00E-01 2.38E-05 Br-83 0.00E-01 0.00E-01 2.92E 00 0.00E-01 0.00 E-01 0.00E-01 5.08 E-17 Br-84 0.00E-01 0.00E-01 2.27E-ll 0.00E-01 0.00E-01 0.00E-01 3.14 E-28 ./ A-93 07-08-85
TABLE A.5-14 (Cont'd) VEGETATICN PAT!!WAY FACCOR
) M2 MREM /YR PER uCi/sec TEEN (RI FACIORS)
NUCLIDE WNE LIVER T DODY THYROID KIDNEY LUNG GI-LLI Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 2.74E 08 1.29E 08 0.00E-01 0.00E-01 0.00E-01 4.05E 07 Rb-88 0.00E-01 3.21E-22 1.71E-22 0.00E-01 0.00E-01 0.00E-01 2.75E-29 Ra-89 0.00E-01 1.26E-26 8.94E-27 0.00E-01 0.00E-01 0.00E-01 1.94E-35 Sr-89 1.51E 10 0.00E-01 4.34E 08 0.00E-01 0.00E-01 0.00E-01 1.80E 09 Sr-90 7.51E 11 0.00E-01 1.85E 11 0.00E-01 0.00E-01 0.00E-01 2.11E 10 Sr-91 2.83E 05 0.00E-01 1.13E 04 0.00E-01 0.00E-01 0.00E-01 1.28E 06 , Sr-92 3.98E 02 0.00 E-01 1.70E 01 0.00E-01 0.00E-01 0.00E-01 1.01E 04 Y-90 1.24E 04 0.00E-01 3.34E 02 0.00E-01 0.00E-01 0.00E-01 1.02E 08 Y-91M 4.88E-09 0.00E-01 1.87E-10 0.00E-01 0.00E-01 0.00E-01 2.;0E-07 Y-91 7.84E 06 0.00E-01 2.10E 05 0.00E-01 0.00 E-01 0.00E-01 3.:lE 09 Y-92 8.61E-01 0.00E-01 2.49E-02 0.00E-01 0.00E-01 0.00E-01 2.36E 04 Y-93 1.63E 02 0.00E-01 4.47E 00 0.00E-01 0.00E-01 0.00E-01 4.99E 06 l Cr-95 1.72E 06 5.44E 05 3.74E 05 0.00E-01 7.998 05 0.00 E-01 1.25E 09 2r-97 3.12E 02 6.18E 01 2.85E 01 0.00E-01 9.37E 01 0.00E-01 1.67E 07 Nb-95 1.93E 05 1.07E 05 5.88E 04 0.00E-01 1.04E 05 0.00E-01 4.57E 08 lb-99 0.00E-01 5.65E 06 1.08E 06 0.00E-01 1.29E 07 0.00E-01 1.01E 07 Tc-99M 2.74E 00 7.64E 00 9.90E 01 0.00E-01 1.14E 02 4.24E 00 5.02E 03 l I l l A-9'4 07-08-85
TABLE A.5-14 (Cont'd) VEGETATION PAT 1MAY FACTOR ) M2 e MREWYR PER uCi/sec TEEN (RI FACPORS) NUCLIDE DONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI Te-101 7.76E-31 1.10E-30 1.08E-29 0.00E-01 2.00E-29 6.72E-31 0.00E-01 Ru-103 6.81E 06 0.00E-01 2.91E 06 0.00E-01 2.40E 07 0.00E-01 5.69E 08 Ru-105 5.01E 01 0.00E-01 1.94E 01 0.00E-01 6.32E 02 0.00E-01 4.048 04 Ru-106 3.09E 08 0.00E-01 3.90E 07 0.00E-01 5.97E 08 0.00E-01 1.48E 10 Ag-110M 1.52E 07 1.43E 07 8.72E 06 0.00E-01 2.74E 07 0.00E-01 4.03E 09 Te-125M 1.48E 08 5.34E 07 1.98E 07 4.14E 07 0.00E-01 0.00 E-01 4.39E 08 Te-127M 5.52E 08 1.96E 06 6.56E 07 1.31E 08 2.24E 09 0.00 E-01 1.37E 09 Te-127 5.34E 03 1.89E 03 1.15E 03 3.68E 03 2.16E 04 0.00E-01 4.12E 05 Te-129M 3.62E 03 1.34E 08 5.73E 07 1.17E 08 1.51E 09 0.00 E-01 1.36E 04 Te-129 7.16E-04 2.67E-04 1.74E-04 5.12E-04 3.01E-03 0.00E-01 3.92E-03 To-131M 8.44E 05 4.05E 05 3.38E 05 6.09E 05 4.22E 06 0.00E-01 3.25E C7 Te-131 1.41E-15 45.80E-16 4.40E-16 1.08E-15 6.15E-15 0.00E-01 1.15E-16 , Te-132 3.91E 06 2.48E 06 2.33E 06 2.61E 06 2.37E 07 0.00E-01 7.848 07 I-130 3.51E 05 1.02E 06 4.05E 05 8.28E 07 1.56E 06 0.00E-01 7.80E 05 I-131 7.69E 07 1.08E 08 5.78E 07 3.148 10 1.85E 08 0.00 E-01 2.13E 07 I-132 5.20C 01 1.36E 02 4.89E 01 4.59E 03 2.14E 02 0.00E-01 5.93E 01 I-133 1.94E 06 3.29E 06 1.00E 06 4.59E 08 5.77E 06 0.00E-01 2.49E 06 I-134 8.76E-05 2.32E-04 8. 34 E-05 3.87E-03 3.66E-04 0.00E-01 3.06E-06 A-95 07-08-85
TABLE A.5-14 (Cont'd) VEGETATION PATI!WAY FAC'IOR ) M2. MREM /YR PER uCi/sec TEEN (RI F/CIORS) NUCLIDE BONE LIVER T BODY TIIYROID KIDNEY IIRKI GI-LLI I-135 3.52E 04 9.07E 04 3.36E 04 5.84E 06 1.43E 05 0.00E-01 1.01E 05 Cs-134 7.10E 09 1.67E 10 7.75E 09 0.00E-01 5.31E 09 2.03E 09 2.08E 08 Cs-136 4.28E 07 1.68E 08 1.13E 08 0.00 E-01 9.16E 07 1.44E 07 1.35E 07 u Cs-137 1.01E 10 1.35E 10 4.69E 09 0.00E-01 4.59E 09 1.78E 09 1.92E 08 Cs-138 3.64 E-ll 6.98E-ll 3.49E-11 0.00E-01 5.15E-11 6.00E-12 3.17E-14 Ba-139 2.73E-02 1.92E-05 7.96 E-04 0.00E-01 1.81E-05 1.3 2E-05 2.44 E-01 Ba-140 1.38E 08 1.69E 05 8.91E 06 0.00E-01 5.74E 04 1.14E 05 2.13E 08 Ba-141 1.19 E-21 8.90E-25 3.98E-23 0.00E-01 8.27E-25 6.10E-25 2.54E-27 Ba-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 La-140 1.81E 03 8.89E 02 2.37E 02 0.00E-01 0.00E-01 0.00E-01 5.11E 07 La-142 1.30E-04 5.78E- 05 1.44E-05 0.00E-01 0.00E-01 0.00E-01 1.76E 00 Ce-141 2.83E 05 1.89E 05 2.17E 04 0.00E-01 8.90E 04 0.00E-01 5.41E 08 Ce-143 9.33E 02 6.79E 05 7.58E 01 0.00E-01 3.04E 02 0.00E-01 2.04E 07 I Ce-144 5.27E 07 2.18E 07 2.83E 06 0.00E-01 1.30E 07 0.00E-01 1.33E 10 Pr-143 7.01E 04 2.80E 04 3.49E 03 0.00E-01 1.63E 04 0.00E-01 2.31E 08 Pr-144 2.93 E-26 1.20E-26 1.49E-27 0.00E-01 6.88E-27 0.00E-01 3.23E-29 Nd-147 3.66E 04 3.98E 04 2.38E 03 0.00E-01 2.34E 04 0.00E-01 1.44E 08 W-187 3.56E 04 2.90E 04 1.02E 04 0.00E-01 0.00E-01 0.00E-01 7.84E 06 Np-239 1.39E 02 1.31E 02 7.26E 01 0.00E-01 4.10E 02 0.00 E-01 2.10E 07 I l A-96 07-08-85
TABLE A.5-15 VEGETATION PNI1MAY FACIOR
) M2 MRFI1/YR PER uCi/sec CHILD (RI FACIURS)
NUCLIDE BONE LIVER T BODY 'ITIYPOID KIDNEY ILRK; GI-LLI H-3 0.00E-01 4.01E 03 4.01E 03 4.01E 03 4.01E 03 4.01E 03 4.01E 03 C-14 8.89E 08 1.78E 08 1.78E 08 1.78E 08 1.78E 08 1.78E 08 1.788 08 Na-24 3.73E 05 3.73E 05 3.73E 05 3.73E 05 3.73E 05 3.73E 05 3.73E 05 P-32 3.73E 09 1.58E 08 1.30E 08 0.00E-01 0.00E-01 0.00E-01 9.30E 07 Cr-51 0.00E-01 0.00E-01 1.17E 05 6.50E 04 1.78E 04 1.19E 05 6.21E 06 tin-54 0.00E-01 6.65E 08 1.77E 08 0.00E-01 1.86E 08 0.00E-01 5.58E 08 Mn-56 0.00E-01 1.88E 01 4.24E 00 0.00E-01 2.27E 01 0.00E-01 2.72E 03 Fe-55 8.00E 08 4.24E 08 1.31E 08 0.00E-01 0.00E-01 2.40E 08 7.86E 07 Fe-59 3.97E 08 6.43E C8 3.20E 08 0.00E-01 0.00E-01 1.86E 08 6.69E 08 Co-58 0.00E-01 6.44E 07 1.97E 08 0.00E-01 0.00E-01 0.00E-01 3.76E 08 Co-60 0.00E-01 3.78E 08 1.12E 09 0.00 E-01 0.00E-01 0.00E-01 2.10E 09 Ni-63 3.95E 10 2.llE 09 1.34E 09 0.00E-01 0.00E-01 0.00E-01 1.42E 08 Ni-65 1.18E 02 1.11E 01 6.51E 00 0.00E-01 0.00E-01 0.00E-01 1.37E 03 Co-64 0.00E-01 1.10E 04 6.65E 03 0.00E-01 2.66E 04 0.00E-01 5.16E 05 Zn-65 8.12E 08 2.16E 09 1.35E 09 0.00E-01 1.36E 09 0.00E-01 3.80E 08 Zn-69 1.51E-05 2.19E-05 2.02E-06 0.00E-01 1.33E-05 0.00E-01 1.38E-03 Br-83 0.00E-01 0.00E-01 5.38E 00 0.00E-01 0.00E-01 0.00E-01 3.14E-17 Br-84 0.00E-01 0.00E-01 3.85E-ll 0.00E-01 0.00 E-01 0.00E-01 1.94E-28 A-97 07-08-85
r i TABLE A.5-15 (Cont'd) VEGETATICel PA'I1MAY FAC'IOR l M2 +MREWYR PER uCi/sec OIILD (RI FACTORS) NUCLIDE BONE LIVER T BODY 'IlumOID KIDNEY IlJNG GI-LLI Br-85 0.00E-01 0.00E-01 0.00 E-01 0.00E-01 0.00 E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 4.52E 08 2.78E 08 0.00E-01 0.00E-01 0.00E-01 2.91E 07 Rb-f>8 0.00E-01 4.43E-22 3.08E-22 0.00E-01 0.00E-01 0.00E-01 2.17 E-23 Rb-89 0.00E-01 1.67E-26 1.48E-26 0.00E-01 0.00 E-01 0.00 E-01 1.45E-28 Sr-89 3.60E 10 0.00E-01 1.03E 09 0.00E-01 0.00E-01 0.00E-01 1.39E 09 Sr-90 1.24E 12 0.00E-01 3.15E 11 0.00 E-01 0.00E-01 0.00E-01 1.67E 10 Sr-91 5.21E 05 0.00E-01 1.97E 04 0.00E-01 0.00E-01 0.00E-01 1.15E 06 Sr-92 7.29E 02 0.00E-01 2.92E 01 0.00 E-01 0.00E-01 0.00E-01 1.38E 04 Y-90 2.30E 04 0.CCF-01 5.17E 02 0.00E-01 0.00E-01 0.00E-01 6.54E 07 Y-91M 8.95E-09 0.00E-01 3.26E-10 0.00E-01 0.00E-01 0.00E-01 1.75E-05 Y-91 1.86E 07 0.00E-01 4.99E 03 0.00E-01 0.00 E-01 0.00E-01 2.48E 09 Y-92 1.59E 00 0.00E-01 4.54E-02 0.00E-01 0.00E-01 0.00E-01 4.588 04 i Y-93 3.01E 02 0.00E-01 8.26E 00 0.00E-01 0.00E-01 0.00E-01 4.48E 06 Cr-95 3.86E 06 8.49E 05 7.56E 05 0.00 E-01 1.22E 06 0.00 E-01 8.85E 08 Zr-97 5.70E 02 8.24E 01 4.86E 01 0.00E-01 1.18E 02 0.00E-01 1.25E 07 Nb-95 4.11E 05 1.60E 05 1.14E 05 0.00E-01 1.50E 05 0.00E-01 2.96E 08 30-99 0.00E-01 7.71E 06 1.91E 06 0.00E-01 1.65E 07 0.00E-01 6.38E 06 Tc-99M 4.71E 00 9.24E 00 4.86E 01 0.00E-01 1.34E 02 4.69E 00 5.26E 03 ) l l A-98 07-08-85 1 I 1
TABLE A.5-15 (Cont'd) VEGETATION PATIMAY FACIOR ) MDMREM/YR PER uCi/sec OIIID (RI FACIORS) NUCLIDE BCUE LIVER T BODY '11IYROID KIDNEY IIRJG GI-ILI Tc-101 1.43E-30 1.49 E-30 1.89E-29 0.00E-01 2.55E-29 7.90E-31 4.75E-30 Ru-103 1.53E 07 0.00E-01 5.88E 06 0.00E-01 3.85E 07 0.00E-01 3.968 08 Ru-105 9.17E 01 0.00E-01 3.33E 01 0.00E-01 8.06E 02 0.00E-01 5.99E 04 Ru-106 7.45E 08 0.00E-01 9.30E 07 0.00E-01 1.01E 09 0.00E-01 1.16E 10 Ag-110M 3.21E 07 2.17E 07 1.73E 07 0.00E-01 4.04E 07 0.00E-01 2.58E 09 Tu-125M 3.51E 08 9.50E 07 4.67E 07 9.84E 07 0.00E-01 0.00E-01 3.38E 08 Te-127M 1.32E 09 3.56E 08 1.57E 08 3.16E 08 3.77E 09 0.00E-01 1.07E 09 Te-127 9.85E 03 2.66E 03 2.llE 03 6.82E 03 2.80E 04 0.00 E-01 3.85E 05 Te-129M 8.41E 08 2.35E 08 7.88E 07 2.71E 08 2.47E 09 0.00 E-01 1.03E 09 Te-129 1.33E-03 3.70E-04 3.15E-04 9.468-04 3.88 E-03 0.00E-01 8.25E-02 Te-131M 1.54E 06 5.33E 05 5.68E 05 1.10E 06 5.16E 06 0.00E-01 2.16E 07 Te-131 2.59E-15 7.90E-16 7.71E-16 1.98E-15 7.84E-15 0.00E-01 1.36E-14 ., Te-132 7.00E 06 3.10E 06 3.74E 06 4.51E 06 2.88E 07 0.00E-01 3.12E 07 I-130 6.16E 05 1.24E C6 6.41E 05 1.37E 08 1.86E 06 0.00E-01 5.82E 05 I-131 1.43E 08 1.44E 08 8.17E 07 4.76E 10 2.36E 08 0.00E-01 1.28E 07 I-132 9.23E 01 1.70E 02 7.80E 01 7.87E 03 2.60E 02 0.00E-01 2.00E 02 ' I-133 3.53E 06 4.37E 06 1.65E 06 8.12E 08 7.28E 06 0.00E-01 1.76E 06 I-1 34 1.56E-04 2.8 9E-04 1.33E-04 6.65E-03 4.42E-04 0.00E-01 1.92E-04 . l l l ] A'-99 07-08-85
. ~-
TABLE A.5-15 (Cont'd) VEGETATION PATIMAY FAC'IOR ) M2 ,MREWYR PER uCi/sec CHILD (RI FACTORS) NUCLIDE BONE LIVER T BODY 111YPOID KIDNEY UIC GI-[LI I-135 6.268 04 1.13E 05 5.33E 04 9.98E 06 1.73E 05 0.00E-01 8.59E 04 Cs-134 1.608 10 2.63E 10 5.55E 09 0.00E-01 8.15E 09 2.93E 09 1.42E 08 Cs-136 8.04E 07 2.21E 08 1.43E 08 0.00E-01 1.18E 08 1.76E 07 7.77E 06 Cs-137 2.39E 10 2.29E 10 3.38E 09 0.00E-01 7.46E 09 2.68E 09 1.43E 08 Cs-138 6.61E-11 9.20E-11 5.83E-11 0.00E-01 6.47E-11 6.96E-12 4.24E-ll Ba-139 5.04E-02 2.69E-05 1.46E-03 0.00E-01 2.35E-05 1.58E-05 2.91E 00 Ba-140 2.77E 08 2.43E 05 1.62E 07 0.00E-01 7.90E 04 1.45E 05 1.40E 08 Ba-141 2.20E-21 1.23E-24 7.16E-23 0.00E-01 1.07E-24 7.24E-24 1.25E-21 Ba-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 La-140 3.25E 03 1.14E 03 3.83E 02 0.00E-01 0.00E-01 0.00E-01 3.17E 07 La-142 2.36E-04 7.51E-05 2.35E-05 0.00E-01 0.00 E-01 0.00E-01 1.49E 01 Ce-141 6.56E 05 3.27E 05 4.86E 04 0.00E-01 1.43E 05 0.00E-01 4.08E 08 Ce-143 1.72E 03 9.31E 05 1.35E 02 0.00E-01 3.91E 02 0.00E-01 1.36E 07 Ce-144 1.27E 08 3.98E 07 6.78E 06 0.00E-01 2.21E 07 0.00E-01 1.048 10 Pr-143 1.46E 05 4.38E 04 7.23E 03 0.00E-01 2.37E 04 0.00E-01 1.57E 08 Pr-144 5.44E-26 1.68E-26 2.74E-27 0.00E-01 8.90E-27 0.00E-01 3.62E-23 Nd-147 7.24E 04 5.86E 04 4.54E 03 0.00E-01 3.22E 04 0.00E-01 9.298 07 W-187 6.47E 04 3.83E 04 1.728 04 0.00E-01 0.00E-01 0.00E-01 5.388 07 NP-239 2.56E 03 1.84E 02 1.29E 02 0.00E-01 5.31E 02 0.00E-01 1.368 07 ,) A-100 07-08-85 __.__.__._________________..____.____._.__._____.______________._.______________.__.______l
l KANSAS GAS AND ELECTRIC COMPANY T** ELE C T AC CON *PANY l l February 28, 1986 GLENN L ROESTER WE*essoame euctrae Document Control Desk U.S. Nuclear Regulatory Commission Washington, D.C. 20555 l Mr. R. D. Martin, Regional Administrator U.S. Nuclear Regulatory Commission Region IV 611 Ryan Plaza Drive, Suite 1000 Arlington, Texas 76011 KMLNRC 86-036 Re: Docket No. STN 50-482 Subj : Semiannual Radiological Effluent Release Report Gentlemen: Enclosed is the Wolf Creek Generating Station Semiannual Radiological Effluent Release Report covering the period from July 1, 1985, through December 31, 1985. This report is submitted pursuant to section 6.9.1.7 of the Wolf Creek Generating Station Unit 1 Technical Specifications. Yours very truly, W Glenn L. Koester Vice Precident - Nucicar GLK:see , 1 cc: P0'Connor (2), w/a l JTaylor, w/a JCummins , w/a
'(<
201 N Market - Wtchit), Kansas - Mail Address: PO. Don 208 I Wichita. Kansas 67201 - Telephone Area Code (316) 2616451}}